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ABSTRACT OF DISSERTATION

DAIRY CATTLE HOOF DISEASE COSTS
AND CONSIDERATIONS FOR PREVENTION
Lameness is considered one of the most important health and welfare issues in the
dairy industry. Understanding the total cost per case of disease-specific lameness can help
producers select better treatment, prevention, and control strategies for their herds. The
first objective of our research was to calculate the costs associated with 3 lameness causing
hoof diseases: digital dermatitis, sole ulcer, and white line disease. To accomplish this, a
survey of hoof health professionals (hoof trimmers and veterinarians) was conducted to
identify treatment related expenditures per case. Data from the hoof trimmer responses to
the survey and previously published research were incorporated into a farm-level stochastic
simulation model to determine the expected costs per case of each disease and the most
influential factors associated with disease costs. The cost per case was calculated by
disease type, severity (mild or severe), incidence timing (0 to 60 days in milk, 61 to 120
days in milk, 121 to 240 days in milk, or >240 days in milk), and parity group (primiparous
or multiparous). The second objective of our research was to determine the economic value
of investing in different lameness prevention strategies. Two prevention strategies were
considered: 1) prevention of infectious hoof diseases and 2) prevention of non-infectious
hoof diseases. The total expenditures (therapeutics, outside labor, on-farm labor, and
prevention costs) and losses (discarded milk, reduced milk production, extended days open,
increased risk of culling, increased risk of death, and recurrence losses) associated with
each prevention strategy before and after prevention implementation were calculated and
compared to find the breakeven investment cost.
KEYWORDS: lameness, hoof health, animal health economics, decision support
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CHAPTER 1

Review of literature:
Dairy cow lameness expenditures, losses, and total cost
K. A. Dolecheck* and J. M. Bewley†
* Department of Animal and Food Sciences, University of Kentucky, Lexington 40546
†CowFocused Housing, 100 Kilarney Drive, Bardstown, KY 40004
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Abstract
Lameness is one of the most costly dairy cow diseases, yet adoption of lameness
prevention strategies remains low.

Low lameness prevention adoption might be

attributable to a lack of understanding regarding total lameness costs. In this review, we
evaluated the contribution of different expenditures and losses to total lameness costs.
Evaluated expenditures included labor for treatment, therapeutic supplies, lameness
detection, and lameness control and prevention. Evaluated losses included non-saleable
milk, reduced milk production, reduced reproductive performance, increased animal death,
increased animal culling, disease interrelationships, lameness recurrence, and reduced
animal welfare.

The previous literature on total lameness cost estimates was also

summarized. The reviewed studies indicated that previous estimates of total lameness costs
are variable and inconsistent in the expenditures and losses they include. Many of the
identified expenditure and loss categories require further research to accurately include in
total lameness cost estimates. Future research should focus on identifying costs associated
with specific lameness conditions, differing lameness severity levels, and differing stages
of lactation at onset of lameness to provide better total lameness cost estimates that can be
useful for decision making at both the herd and individual cow level.
Keywords: disease economics, animal health economics, hoof health, hoof disease, dairy
health
Introduction
Lameness is a prominent issue in the dairy industry. Adams et al. (2016) estimated
2014 lameness prevalence in United States herds as 10%, whereas other studies have found
lameness prevalence to reach as high as 55% (Von Keyserlingk et al., 2012). Lameness is
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perceived by producers as one of the top three major health concerns in their herds, with
the other two being mastitis and fertility (Leach et al., 2010a). However, understanding of
the actual cost of lameness is lacking. Leach et al. (2010a) found that producers cited lack
of knowledge about lameness costs as one reason less effort was made to prevent lameness
compared to mastitis. If producers estimate lameness costs as less than the cost of
implementing lameness prevention and control strategies, those management practices are
not likely to be adopted (Leach et al., 2010a). This review aims to 1) identify and discuss
the individual factors contributing to total dairy cow lameness costs and 2) summarize
previous estimates of total dairy cow lameness costs.
Calculating disease costs
McInerney et al. (1992) defined the total cost of disease as including two
components: expenditures and losses.

Expenditures focus on disease treatment and

investment in prevention whereas losses are the indirect result of disease occurrence,
including reduced milk production, reduced reproductive performance, and other factors
(McInerney et al., 1992).

Figure 1.1 categorizes common expenditures and losses

associated with dairy cow lameness, as summarized in this review.
Given that numeric values change over time with inflation, this review focuses
more on the contribution of each expenditure and loss category to total lameness costs
rather than exact price estimates. However, the relative importance of different factors
within a study depends on which factors were included in the total cost estimate. For
example, treatment expenditures may contribute a large percentage to total lameness costs
in a study where treatment, reduced milk production, and reduced reproductive
performance are the only factors included. In a different study where the increased risk of
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culling and control and prevention investments are also included, treatment will likely
contribute a reduced percentage to the total cost. When dollar values are given, the
originally reported value was converted to United States dollars and adjusted for inflation
to represent 2017 values.
Lameness expenditures
Two main types of disease expenditures exist: treatment expenditures and
prevention expenditures (McInerney et al., 1992). Treatment expenditures consist of labor
and supplies necessary for treatment (i.e., therapeutics) which are generally reported as a
price per case. These estimates for lameness would be most accurate via surveys of hoof
trimmers, veterinarians, and producers because they are the individuals charging and
paying for them. However, very few large surveys asking for hoof trimmer, veterinary, or
producer perception of treatment expenditures associated with lameness, and especially
specific lameness conditions, have been conducted. Prevention expenditures include
inputs associated with any control or prevention strategy, including management strategies
implemented for early detection. Prevention expenditures could also be thought of as
investment expenditures because money is spent on prevention with the purpose of
reducing total lameness costs (via reductions in lameness incidence). Detection and
prevention expenditures are rarely included in calculations of the cost per case of lameness.
Instead, these expenditures are typically, although incorrectly, classified as general
management costs.
Labor for treatment
On-farm staff, hoof trimmers, or veterinarians most frequently treat lameness. In a
survey of 184 farms across the United States, 77% of farms used a professional hoof
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trimmer for hoof trimming services whereas 16% used a veterinarian or on-farm staff and
7% used no hoof trimming services at all (Adams et al., 2016). Bruijnis et al. (2010)
estimated the likelihood of treatment by a producer, hoof trimmer, or veterinarian for seven
different lameness conditions, based on experiences in the Netherlands. According to their
mathematical model, the probability of a lameness case resulting in labor by the dairy
producer (i.e., pulling the cow out of the herd to examine or treat her) ranged from 20% of
cases for interdigital dermatitis with heel erosion, sole hemorrhage, or corns (interdigital
hyperplasia) to 100% of cases for foot rot. The probability of treatment by a hoof trimmer
for each lameness type ranged from 0% of cases for foot rot to 40% of cases for sole ulcers.
The probability of a veterinarian visit for each lameness type was either 1% of cases
(interdigital dermatitis with heel erosion, digital dermatitis, sole hemorrhage, white line
disease, or corns) or 5% of cases (foot rot or sole ulcer). The estimated involvement by a
hoof trimmer or veterinarian may seem low, but might result from the difficulty of bringing
a hoof trimmer or veterinarian to the farm for every detected lameness case. In other words,
only the cases that exist when hoof trimmers or veterinarians are already physically present
are likely to be treated by them. When the hoof trimmer or veterinarian is not there and
able to treat a case of lameness, lameness conditions that are difficult to treat (e.g., sole
ulcers and white line disease) may be left untreated. For example, Horseman et al. (2013)
found that if lame cows were only treated by a foot trimmer or veterinarian (not on-farm
staff) treatment could be delayed anywhere from 1 week to 1 month.
Table 1.1 includes 7 different studies that calculated total lameness costs per case
(both non-specific and condition-specific) and provided a breakdown of the costs
contributed by at least 6 different expenditures or losses. Within these studies, the
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contribution of producer labor to total lameness cost estimates ranged from 2% to 16%,
making it on average the seventh most important cost category of those evaluated. The
contribution of outside labor (veterinarian or hoof trimmer fees) to total lameness cost
estimates ranged from 1% to 43%, making it on average the fifth most important cost
category of those evaluated. Some of the variation in these observations can be attributed
to labor expenditures being dependent on the type of lameness with some treatments being
more intensive than others. Kossaibati and Esslemont (1997) surveyed 10 veterinarians in
the United Kingdom about the cost of veterinary labor and found that sole ulcers resulted
in the greatest labor charge per affected cow ($66), followed by digital lameness ($49), and
interdigital lameness ($39).

However, the percentage of the total cost attributed to

veterinary labor was actually greatest for interdigital lesions (12%) and least for sole ulcers
(6%). Sole ulcers are expected to have greater losses (e.g., reduced milk yield, reduced
reproductive performance, increased culling risk) than infectious diseases because of their
longer duration (Charfeddine and Pérez-Cabal, 2017); therefore, the percent of costs
associated with labor is smaller. Charfeddine and Pérez-Cabal (2017) surveyed Spanish
hoof trimmers to estimate the total cost of three different lameness conditions while
considering severity of lameness as a factor. In mild lameness cases, they found that the
condition with the greatest contribution of labor (including labor from both hoof trimmers
and producers) to the total cost per case was digital dermatitis (49%), followed by white
line disease (29%), and sole ulcers (25%). The opposite order was true for severe lesions
(23%, 19%, and 15% for sole ulcers, white line disease, and digital dermatitis,
respectively). For all lameness conditions, the contribution of labor to total costs is less in
severe cases compared to mild cases because of the increase in losses (e.g., increased
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chance of culling, greater milk production reduction). Beyond lameness condition type,
location of the study could also influence the contribution of labor to total lameness costs.
For example, involvement by veterinarians is more common, and even required for
treatment, in some countries.
Liang et al. (2017) surveyed 19 veterinarians and industry professionals and used
their estimates to simulate both veterinary and producer labor costs associated with 7
different diseases (mastitis, metritis, hyperketonemia, left displaced abomasum, retained
placenta, lameness, and hypocalcemia). Among all disease, the veterinary and producer
labor costs associated with non-specific lameness were second highest only behind left
displaced abomasum. Therefore, regardless of the percentage of total lameness costs
attributed to labor, labor expenditures due to lameness are substantial compared to other
diseases.
Therapeutics
Therapeutic expenditures include any medications or supplies used to treat
diagnosed cases of lameness. Therapeutic expenditures vary greatly depending on the
cause of lameness. For example, standard treatment of noninfectious hoof lesions like sole
ulcers and white line disease includes trimming and blocking the hoof to reduce weight
bearing on the affected claw (Andrews et al., 2008). Alternatively, digital dermatitis
treatment often involves cleaning and topical application of antibiotics using a foot wrap.
In addition to the type of lameness, the severity of lameness when treated can also influence
therapeutic expenditures (Charfeddine and Pérez-Cabal, 2017). The farm’s hoof trimmer
or veterinarian, depending on who is conducting the diagnosis and treatment of lameness
cases, sets the prices associated with therapeutics.
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Therapeutic expenditure estimates ranged from 2% to 37% of the total cost per case
of lameness, making it on average the fourth most important cost category of those
evaluated in Table 1.1. Excluding Liang et al. (2017), all therapeutic expenditure estimates
included in Table 1.1 were 20% or less, with most being 10% or less. Liang et al. (2017)
conducted a survey of veterinarians and other industry professionals to identify expected
therapeutic expenditures. The considerable variation among respondents ($42 ± 46), likely
due to a small sample size (n = 19), may have contributed to their difference in findings
compared to other studies. The fact that this is the most recent of the studies may also have
contributed to this finding.

Liang et al. (2017) additionally found that therapeutic

expenditures associated with lameness were second highest among common dairy diseases,
only behind left displaced abomasum.
As expected, lameness conditions that require more supplies to treat had an
increased contribution of therapeutics to total costs. Kossaibati and Esslemont (1997)
found that the cost of interdigital lesions was more dependent on therapeutics (8% of the
total cost) than either the cost of digital lesions (5% of the total cost) or sole ulcers (4% of
the total cost). Charfeddine and Pérez-Cabal (2017) found that white line disease had the
greatest contribution of therapeutics to the total cost per case (16% and 12% for mild and
severe lesions, respectively). Second and third were sole ulcers (15% and 12% for mild
and severe lesions, respectively) and digital dermatitis (7% and 4% for mild and severe
lesions, respectively). Increased lameness severity was again associated with greater losses
(reduced milk production, reduced reproductive performance, etc.), decreasing the
therapeutics-associated total cost percentage.
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Lameness detection
When done correctly, monitoring for the presence of disease can lead to detection
at an early stage and allow for earlier treatment, potentially reducing expenditures and
losses associated with that case. Additionally, monitoring disease presence is important
for recognizing a problem and identifying prevention practices that can reduce overall
incidence of disease. Expenditures associated with lameness detection include labor for
implementation and, in some cases, the cost of supplementary supplies or tools.
The simplest form of on-farm lameness detection is visual locomotion scoring. Van
Nuffel et al. (2015a) identified at least 25 different visual scoring systems for dairy cow
lameness characteristics. They noted that although these methods are relatively easy to use
and inexpensive to implement (i.e., the only expenditure is labor), the amount of time it
takes to conduct scoring on an entire herd means they are not often executed. Another
method of lameness detection is identification of lesions during routine visits by a hoof
trimmer. Although no added expenditures are associated with this method, relying on it
alone can result in missed lameness cases between hoof trimmings, leading to increased
severity. This is an especially unreliable lameness detection method in the United States
where Adams et al. (2016) reported that 7% of dairy herds never trim their cows, 20% only
trim cows when they are visibly lame, and 36% only trim once per lactation.
Recently, individual animal monitoring technologies have shown potential for
lameness detection. Walk-over or stand-on load cells, pressure-sensitive position mats,
vision techniques, accelerometers, and other already available sensor data (e.g., milk
production, activity, rumination time) have all been evaluated for the possibility of
automated lameness detection (Van Nuffel et al., 2015b). The economic value of investing
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in an automated lameness detection system remains unquantified. One difficulty of
identifying the value of automated lameness detection is determining what will be done
when a lameness alert is given (Van Nuffel et al., 2015b). If a reason for the lameness alert
is identified, treatment can occur and reduced severity of the condition is beneficial to the
farm. However, if a reason for lameness is not found, the value of the early detection is
negative instead of positive (i.e., labor was used to check the cow and evaluation of the
hooves for a problem could result in hoof damage). One possibility is that the technology
alert occurs before the lameness condition is visibly apparent (i.e., not a false alert, just
early), but without an actionable response to that alert, it has no value. Regardless, the
economic potential of automated estrus detection systems has been quantified (Rutten et
al., 2014, Dolecheck et al., 2016) and it stands to reason that some of these systems could
additionally be used for lameness detection with minimal added expenditures (i.e., only
labor for checking alerted cows).
Regardless of the available options, lameness diagnosis on dairy herds is generally
not proactive. One reason for this may be that producers tend to underestimate the
prevalence of lameness in their herds (Bell et al., 2006, Espejo et al., 2006, Leach et al.,
2010a). Additionally, producers perceive lameness management to be more challenging
to include in daily routines compared to other health issues, like mastitis, which can be
managed in the parlor (Leach et al., 2010a). Instead, lame cows are often only identified
after they become severely lame (Mill and Ward, 1994), completely ignoring mildly lame
cows that would benefit most from early detection. Possibly for this reason, no identified
studies included an estimate for expenditures on lameness diagnosis or detection in their
calculated total lameness cost. However, if detection and diagnosis is proactive, an
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accurate estimate of a herd’s total lameness cost should include the cost of proactive
diagnostic measures.
Lameness control and prevention
Control and prevention strategies for reducing lameness incidence can be either
repetitive actions, or one-time, long-term investments. Examples of repetitive investments
include preventive hoof trimming (Fjeldaas et al., 2006), footbaths (Laven and Hunt, 2002),
hoof health feed additives (Bergsten et al., 2003), or even genetic selection (Pritchard et
al., 2013). An example of a long-term investment in lameness prevention would be the
installation of rubber flooring (Vanegas et al., 2006) or the redesigning of poorly
constructed freestalls (Ito et al., 2010). Expenditures associated with these different
strategies might include labor, supplies, and depreciation.
Although many of these strategies are lameness specific, some lameness control
and prevention expenditures could overlap with control and prevention of other diseases.
For example, updating old freestalls could improve more than just lameness incidence (e.g.,
reduced mastitis incidence, improved cow longevity).

Therefore, identifying the

proportion of prevention costs associated with a specific management change that should
be attributed to lameness is essential for accurate total lameness cost estimates. The effects
of most of these prevention and control strategies are not well studied and are difficult to
quantify. Therefore, how best to account for these expenditures when estimating the total
cost of lameness is unclear.
Very few estimates of total lameness costs include any allocation to prevention
strategies. Kaneene and Hurd (1990) surveyed 60 Michigan (USA) herds to find that, on
average, $4/cow per year was spent on prevention of lameness as estimated by the
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producers. Among 7 other diseases, lameness prevention costs ranked as the third greatest,
only behind mastitis ($9/cow per year) and fertility problems ($7/cow per year). Miller
and Dorn (1990) estimated lameness prevention expenditures (including preventive
trimming, veterinary services, and labor) using data from 16 Ohio dairy farms (1 304 total
cows) to be $2/cow per year. Prevention expenditures for lameness were greater than for
hypocalcemia, displaced abomasum, or dystocia, but less than mastitis, infertility,
pneumonia, or “other” diseases. For both of these studies, prevention cost estimates
focused on disease-specific costs rather than general management practices like nutrition
and housing, likely resulting in under-estimation of prevention costs for all diseases.
Additionally, these estimates of prevention expenditures were all reported as $/cow per
year rather than $/case. Although prevention is generally paid in $/cow per year, producers
should also consider how much they are spending on prevention per case to help determine
if prevention expenditures are beneficial. For example, Bennett et al. (1999) estimated
expenditures on lameness prevention via hoof trimming in the United Kingdom to range
from $6 to $12 per case of non-specific lameness (4% to 7% of total case costs, depending
on the assumptions used in their model).
Ettema and Østergaard (2006) estimated the value of five lameness prevention
strategies (footbathing, rubber flooring, pasture access, trimming, and biotin
supplementation) using a stochastic Monte Carlo model. The model included reduced milk
yield, reduced feed intake, weight loss, reduced conception rate, and increased mortality as
lameness outcomes. Assuming an average Danish dairy herd, all strategies increased the
total profit margin per cow-year with rubber flooring providing the greatest increase
($9/cow-year) and footbathing providing the least increase ($2/cow-year). However, the
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cost associated with each prevention strategy was not included. Therefore, the increase in
profit margin would only be realized if expenditures on the prevention strategy were less
than the potential profit. The expenditures associated with implementation (including
labor, supplies, etc.), the current herd prevalence of lameness, and the effectiveness of the
prevention strategy would influence the overall value of each control and prevention
strategy.
Lameness losses
Whereas expenditures involve increased costs, losses revolve around reduced
returns. The three categories that most losses will fall under are reduced outputs, reduced
output quality, and animal welfare effects. In previous estimates, losses represent 37% to
93% of total lameness costs, outweighing the expenditures in most cases (Table 1.1).
Estimates of disease losses typically come from epidemiological or survey studies.
Commonly, animals are observed over a defined period of time and comparisons (e.g., milk
production, reproductive performance) are made between those cows that became lame and
those cows that did not. Results between studies conducted this way can be difficult to
compare for many reasons. First, the definition and identification of lameness are not
always consistent. Whereas some studies use periodic visual lameness scoring to define
lameness, others use lesion presence, and still others rely on farmer or veterinarian
identified lameness cases. Second, the losses associated with a disease are specific to both
the severity of disease and the timing of disease occurrence within the lactation, which
depends on the disease definition and identification strategy. Studies using periodic visual
lameness scoring will likely identify and treat cows before the time a producer generally
would, resulting in an underestimation of lameness losses because of reduced lameness
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severity. On the contrary, cases defined by farmer or veterinarian diagnosis will likely be
more severe but may mean that mild lameness is entirely overlooked. Third, the potential
confounding factors that studies account for can differ. Some of the losses associated with
lameness, including reduced milk production and reduced reproductive performance, are
related to many other factors (e.g., nutrition, other diseases) that need to be considered to
accurately estimate losses associated with just lameness.

This is different from

expenditures, which are linked to a specific disease or condition.
Undoubtedly, other losses beyond those mentioned exist but are hard to define or
difficult to quantify. Losses are discussed with emphasis on the general influence of
lameness on the amount or quality of the product (e.g., milk production, days open) rather
than the exact value of that amount because market values fluctuate greatly with farm
location and time.
Non-saleable milk
Milk discarding is required after antibiotic treatment. Although antibiotic use is
common for mastitis cases (Rollin et al., 2015), most lameness cases do not require
antibiotics, resulting in no discarded milk. Stricter antibiotic use guidelines worldwide
could further reduce discarded milk associated with lameness and other diseases. Nonsaleable milk loss estimates were consistent between the studies identified, ranging from
1% to 11% of the total cost per case of non-severe lameness, making it on average the least
important cost category of those evaluated in Table 1.1.
Lameness treatments including antibiotic use are more common when lesions are
severe. Charfeddine and Pérez-Cabal (2017) found in their survey that no antibiotics, and
therefore no resulting discarded milk, were needed for mild lesions. However, survey
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respondents did use antibiotics for severe lesions, resulting in some discarded milk (258
kg/treatment, 331 kg/treatment, and 312 kg/treatment for severe digital dermatitis, sole
ulcer, and white line disease, respectively).

They estimated that milk withholding

represented the second most important cost for severe lesions (24%, 20%, and 20% of the
total costs associated with a cow affected by severe digital dermatitis, severe sole ulcers,
and severe white line disease, respectively). The specific dollar value of discarded milk is
dependent on the milk market where a herd is located and the potential alternative uses of
that milk (i.e., feeding discarded milk to calves).
Reduced milk production
Lameness influences milk production via many different and interrelated factors.
Huxley (2013) summarized previous studies that estimated a milk yield loss of 270 to 574
kg per lactation when lameness occurred. Evidence exists that this milk loss occurs during
not only clinical lameness, but also pre-diagnosis and post-recovery depending on
lameness type (Green et al., 2002, Amory et al., 2008, Charfeddine and Pérez-Cabal, 2017).
Because of this, the point in lactation that a lameness case occurs will influence the total
milk loss associated with incidence of the disease (i.e., milk loss may continue until the
end of the lactation). The relationship between lameness and milk production is two-fold.
Although lameness incidence decreases milk production, increased milk production is also
a risk factor for lameness (Barkema et al., 1994, Green et al., 2002, Amory et al., 2008).
Barkema et al. (1994) estimated that for every 100 kg increase in milk production during
the first 100 DIM of the previous lactation, cows experienced a 1.1 times greater chance of
lameness in the current lactation. Therefore, the effect of lameness incidence on milk
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production may lead to some high producing cows becoming average producing cows
rather than average producing cows becoming low producing cows.
The exact dollar value of reduced milk production is dependent on the estimated
yield reduction, the value of milk (milk price plus bonuses), and the change in feed costs
(Charfeddine and Pérez-Cabal, 2017). Because this milk is never produced, as compared
to discarded milk, the feed costs savings are especially important to account for. Reduced
milk production expenditure estimates have ranged from 9% to 39% of the total cost per
case of lameness, making it on average the third most important cost category of those
evaluated in Table 1.1. Variation in the percentage of total lameness costs contributed to
reduced milk production may result from some studies considering higher yielding cows
to be more susceptible to lameness whereas others did not.
Lameness condition type also influences observed reduced milk production.
Charfeddine and Pérez-Cabal (2017) estimated reduced milk production to contribute
between 13% and 18% to total costs per case for mild and severe digital dermatitis, sole
ulcers, and white line disease. The only exception was an increased percentage (34%) for
mild digital dermatitis cases because their shorter duration resulted in reduced expenditures
and other losses. Cha et al. (2010) estimated reduced milk production to represent 27% of
total costs per case for both digital dermatitis and foot rot and an even greater amount (38%
of the total case cost) for sole ulcers. The increased percentages of total cost attributed to
reduced milk production reported by Cha et al. (2010) were likely the result of only 3
factors being included in their estimates: treatment, reduced milk production, and reduced
reproductive performance.
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Reduced reproductive performance
Traditionally, lameness has been thought to reduce reproductive performance via
decreased estrus detection (Lucey et al., 1986). However, Collick et al. (1989) noted that
overall days open was affected by lameness more than the time to first service, suggesting
that reduced estrus detection may not be the only factor contributing to poor reproductive
performance in lame cows. Recently, hormone profiles of lame cows have been studied to
further define the relationship between lameness and reproductive performance (Walker et
al., 2008, Sood et al., 2009, Morris et al., 2011). The exact physiological mechanism by
which lameness affects reproductive performance remains undefined, but is likely a
combination of multiple factors.
Huxley (2013) provided a summary of studies that considered the effect of
lameness on reproductive performance. In the reported papers, lameness resulted in a mean
7 d longer time to first service, 30 d increase in days open, 20% lesser conception rate, and
1.2 more services per conception. The exact value of these adverse effects depends on the
cost of a day open or the value of a pregnancy. Both of these are herd specific, making an
estimate of the economic influence of lameness on reproduction difficult. A critical
contributor to the extent of reduced reproductive performance resulting from lameness is
the timing of the disease (Lucey et al., 1986). If lameness occurs in later lactation, after
pregnancy establishment, its effect on reproduction will likely be lesser than if the
occurrence is before first breeding. However, the effect of late lactation lameness on the
next lactation has not been thoroughly explored.
The reported percentage of total lameness costs attributed to reduced reproductive
efficiency ranged from 0% to 48%, making it on average the second most important cost
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category of those evaluated in Table 1.1. Parity contributed to some of the variation
observed. Liang et al. (2017) found that reproductive losses represented 3% and 25% of
the total costs per case for primiparous and multiparous cows, respectively, noting that
unique market conditions assumed in their study resulted in deviations from previous cost
of days open estimates. On the other extreme, both Kossaibati and Esslemont (1997) and
Esslemont (2005) estimated the greatest percentage of total lameness costs attributed to
reduced reproductive performance (42% and 48%, respectively) when considering
interdigital lameness.

The actual effect (in days open) of interdigital lameness on

reproductive performance was assumed less than a sole ulcer in the same studies, but
because interdigital lameness was assumed to have no effect on culling, the percentage of
the total cost per case attributed to reduced reproductive performance was greater.
As with expenditures and other losses, the type of lameness also influences the
value of reduced reproductive performance. Cha et al. (2010) found that although the
percentage of costs attributable to reduced reproductive performance was similar between
sole ulcers (33%) and digital dermatitis (31%), that percentage was greater (45%) in foot
rot cases partially because of relatively lesser treatment costs for foot rot. However,
Charfeddine and Pérez-Cabal (2017) found a lesser percentage of costs attributable to
reduced reproductive performance with only around 3% for severe digital dermatitis and
white line disease ($12 and $19, respectively), but 6% for severe sole ulcers ($38). Their
lesser contribution of costs to reduced reproductive performance can be attributed to the
reduced effects of lameness on days open in their study compared to those summarized by
Huxley (2013).

18

Increased death and culling
Relatively few animals die as a direct result of lameness. However, welfare
standards requiring cows to be ambulatory to enter a slaughter facility result in euthanasia
of some lame cows on-farm rather than them being sold as cull cows. Thomsen et al.
(2004) found in interviews with Danish producers that although only 2% of unassisted
deaths were attributed to lameness, 40% of euthanized cases were. The USDA (2007)
National Animal Health Monitoring System Dairy Survey reported that 20% of United
States dairy cow deaths resulted from euthanasia after either lameness or injury. McConnel
et al. (2015), utilizing the same data, noted a relationship between lameness and mortality
where mortality was predicted to increase by 0.8% for every 1% increase in the proportion
of lame cows. However, this could be a result of lameness causing other diseases to occur
which are ultimately the cause of euthanasia rather than lameness itself.
The exact percent of lameness cases that result in death remains mostly undefined
in the literature. Based on previous veterinary experience in the United States, Guard
(2008) estimated that 2% of lame cows become disabled to the point that they are not
accepted for slaughter. However, this anecdotal estimate may be more accurate for herds
before the strict non-ambulatory guidelines put into place in the United States in 2004.
Regardless, for any lameness cases that do result in euthanasia, the cost to the producer is
the same as a dead cow plus the cost of euthanasia (captive bolt, gunshot, veterinarian, etc.)
and the emotional toll that does not have a well-defined value.
Alternatively, the effect of lameness on culling has been extensively explored with
the general conclusion being that lameness incidence decreases the productive life of a
dairy cow (Huxley, 2013). Charfeddine and Pérez-Cabal (2017) found that incidence of
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either sole ulcer or white line disease decreased the length of productive life between 35
and 71 d compared to unaffected animals. No significant effect of digital dermatitis on the
length of productive life was found. Similarly, Cramer et al. (2009) identified no effect of
infectious lameness (foot rot, digital dermatitis, and heel horn erosion) on culling.

In

studies where culling has not been found to be affected by non-infectious lameness this is
rationalized because the cows that are more susceptible to culling are also the superior
producing cows and, therefore, they are not viewed by producers as uneconomical
(Barkema et al., 1994, Archer et al., 2010). Additionally, cows might be recorded as
leaving the herd for low production or reproductive failure when lameness was the root
cause of removal (Guard, 2008). This emphasizes the importance of disease incidence
recording and the proper identification of culling reason to be able to accurately estimate
the effects of different diseases on culling.
Estimates for losses associated with an increased risk of culling or death ranged
from 0% to 50% of the total cost per case of lameness, making it on average the most
important cost category of those evaluated in Table 1.1. The extremely low values (0%)
were only found in estimates for interdigital lameness, with most estimates falling between
20% and 40%. Charfeddine and Pérez-Cabal (2017) found that premature culling was the
greatest contributor to the cost of a case of mild or severe sole ulcers or white line disease
and severe digital dermatitis (23% to 40%). The contribution of culling costs to the cost
of mild digital dermatitis was less (10%). Liang et al. (2017) found parity to have little
effect on the portion of total lameness costs attributable to culling which accounted for
14% and 16% in primiparous and multiparous cows, respectively.
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The cost of culling depends greatly on how culling is calculated. Basic culling
costs can be calculated as the cost of a replacement minus the slaughter value of the cull
cow. However, this method only accounts for the financial cost of culling, ignoring the
economic costs (Bewley et al., 2010). More complex and thorough methods, like retention
pay-off, are better for capturing the difference between the potential future value of a cow
and the potential future value of her replacement (Groenendaal et al., 2004) and should be
used for disease culling cost estimates.
Disease relationships and recurrence
Relationships between diseases are complex and not well defined. When lame and
non-lame cows have been compared, similar percentages of common diseases (retained
placenta, metritis, hypocalcemia, left displaced abomasum, and dystocia) have been found
(Melendez et al., 2003, Booth et al., 2004, Hernandez et al., 2005). Contradicting results
exist for hyperketonemia, potentially because of the method of comparison and definitions
of hyperketonemia used. Peeler et al. (1994) noted that both dystocia and mastitis
increased the risk of lameness pre-breeding (odds ratios = 1.5 and 1.5, respectively),
whereas lameness incidence itself increased the risk of mastitis (odds ratio = 1.4).
However, other studies have found no link between lameness and mastitis (Melendez et
al., 2003, Booth et al., 2004, Hernandez et al., 2005). Another investigated relationship
that could be related to the reduced reproductive performance of lame cows is the
connection between ovarian cysts and lameness. Melendez et al. (2003) found that the
odds of a lame cow having an ovarian cyst were 2.63 times greater than the odds of a nonlame cow. However, given that this was an observational study only, it cannot be
concluded that a cause-effect relationship exists.
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In situations where lameness is directly responsible for changing the incidence of
other diseases, the expenditures and losses associated with those diseases should be
included in total lameness costs. Alternatively, if a lameness case is the result of another
disease, costs associated with that case should not be considered as contributing to total
lameness costs. Very few total lameness cost estimates have even attempted to account for
this source of loss. When estimating total lameness costs, Enting et al. (1997) did account
for relationships between lameness and other diseases, finding that the contribution of other
diseases to total lameness costs (i.e., costs associated with other diseases resulting from
lameness) was minimal (1% of total lameness costs).
Not only is the relationship between lameness and other diseases important, but
also the potential for lameness recurrence. Costs associated with recurring cases should be
considered as part of the total cost of the original case, rather than separately. In previous
lameness cost estimates, some studies assume lame cows undergo costs associated with 1.4
cases because of recurrence rates (Kossaibati and Esslemont, 1997, Esslemont, 2005,
Ettema and Østergaard, 2006). Using this assumption, Esslemont (2005) found that repeat
case costs were 3%, 7%, and 3% of total lameness costs per cow affected by digital,
interdigital, and sole ulcer conditions, respectively. However, the recurrence rate of 1.4
appears to be an assumption made by these authors rather than supported by published
literature. More recently, Charfeddine and Pérez-Cabal (2017) recorded relapse rates on
804 Spanish farms, finding a range of 2.0 to 3.1 relapses per case depending on lameness
condition and parity. However, accurate recurrence rate estimates alone do not answer the
question of how much extra cost is attributed to repeat cases. Although recurrence does
incur additional costs, those costs are likely not as great as the original case (i.e., total
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lameness costs do not double with recurrence). Because data is lacking to know how to
handle this, some disease models have assumed that recurring disease cases only increase
direct costs (labor, therapeutics, and non-saleable milk) and have no influence on indirect
costs (milk loss, reproductive performance, culling, etc.; Kossaibati and Esslemont, 1997,
Rollin et al., 2015) . Estimates for losses associated with lameness case recurrence ranged
from 3% to 14% of the total cost per case of lameness, making it on average the sixth most
important cost category of those evaluated in Table 1.1.
Until we have a better understanding of relationships between other diseases and
lameness, lameness recurrence rates, and lameness recurrence costs, estimating the
economic losses associated with these factors is difficult. Regardless, acknowledging these
factors highlights that current estimates may not be accounting for every economic loss
associated with lameness.
Reduced animal welfare
Often, diagnosis of lameness does not occur until the cow is obviously limping
(Mill and Ward, 1994), indicating a high level of pain (Whay et al., 1998). In surveys,
producers have acknowledged the link between lameness and cow pain and suffering (Mill
and Ward, 1994, Leach et al., 2010b), but they do not always acknowledge a cost associated
with pain and suffering. As previously mentioned, the fact that lame cows might also be
the highest yielding cows may influence a producer’s view on the welfare effects of the
disease. In reality, the pain and suffering associated with lameness has at least two
economic consequences.
First, some of the previously mentioned losses associated with lameness (i.e.,
reduced milk production, reduced reproductive performance) are likely a result of

23

responses to pain and suffering. For example, lame cows tend to spend less time feeding
(González et al., 2008) potentially because they spend more time lying down to relieve
pressure from their feet (Ito et al., 2010). The result is reduced milk production and
economic losses.

The association between lameness and reduced reproductive

performance might also be related to increased cortisol levels (caused by pain and stress
that the animal is experiencing from lameness) affecting hormone function (Dobson and
Smith, 2000). In these cases, the economic losses associated with pain and suffering during
lameness are already accounted for within other loss categories.
The second economic consequence of poor animal welfare (i.e., pain and suffering)
is the potential to influence consumer perception. McInerney (1996) pointed out that one
mistake farmers make is assuming lameness costs occur only at the farm level. Recently,
Leach et al. (2010b) found that this view may be changing. Seventy-two percent of
surveyed United Kingdom dairy farms ranked the desire for a good public image as a
“very” or “extremely” important factor contributing to lameness control. However, 35%
of those farmers still felt the risk of lame cows influencing farm accreditation was of “very
little” or “no” importance.
In reality, consumer perception of the quality of life of our livestock animals could
someday result in economic consequences. If consumers lose faith in the production
process of a product and reduce their consumption, the market for that product could be
affected. This may result in indirect economic consequences to the farmer (i.e., a smaller
milk market) or direct consequences in the form of new rules and regulations that dictate
the amount of lameness that can be present on a farm or protocols for handling lameness
cases. For example, Version 3 of the United States FARM (Farmers Assuring Responsible
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Management) program sets the expectation that 95% of the cows on each evaluated dairy
will score a 2 or less for lameness (on a 1 to 3 scale; NMPF, 2016 ). Lameness is a critical
component in farm welfare audits around the world and producers will be (or already are)
required to follow set guidelines to sell their milk. To date, no economic estimates of the
total cost of lameness have included animal welfare.
Total lameness costs
Total lameness cost estimates
Previously reported total lameness cost estimates (expenditures + losses), adjusted
to 2017 US dollar values, are listed in Table 1.2 along with which factors each cost estimate
included. None of the identified studies considered expenditures associated with lameness
detection or losses associated with animal welfare when calculating total lameness costs,
pinpointing these two cost factors as requiring further research to estimate. Very rarely
were costs associated with lameness control or prevention, interactions with other diseases,
or lameness recurrence included. The few studies that did consider these factors were
studies mostly conducted in 2006 or earlier. Although this seems counterintuitive, one
possibility is that authors of more recent estimates purposely avoided including these
factors because they understand the difficulty in accurately accounting for them.
Additionally, some of these factors may be difficult to calculate at the case level rather than
the herd level (e.g., lameness detection and control or prevention strategies). Factors
considered in all or nearly all of the identified studies included labor for treatment (both
producer and veterinary), therapeutics, non-saleable milk, reduced milk production,
reduced reproductive performance, and an increased risk of culling.
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For each study in Table 1.2, cost estimates were calculated as either the cost per
cow per year or the cost per case. In studies where the cost per cow per year was calculated,
lameness costs were spread across all animals in the herd, regardless of which cows
experienced the disease. The resulting cost is highly dependent on the individual farm size
and the prevalence of lameness in the herd. For this reason, the cost per case is preferred.
Estimates of the cost per case of non-specific lameness ranged from $76 to $533, depending
on the location of the study, the calculation method used, and the expenditures and losses
that were selected for inclusion (Table 1.2). Liang et al. (2017) estimated that this total
cost per case of non-specific lameness was less than a case of mastitis or displaced
abomasum, but more than a case of metritis, retained placenta, ketosis, or hypocalcemia.
Although more useful than costs per cow per year, these non-specific lameness total cost
estimates assume all lameness to be identical.
Often, different lameness disease conditions have been classified into categories
and costs are evaluated based on those lameness categories. The most commonly used
categories include interdigital disease, digital disease, and sole ulcers (Esslemont and
Peeler, 1993, Kossaibati and Esslemont, 1997, Esslemont, 2005, Willshire and Bell, 2009).
Among these, sole ulcers are estimated as having the greatest total costs ranging from $232
to $1 073 per case or affected cow (thereby accounting for recurrence), depending on the
location of the study, the calculation method used, and the expenditures and losses that
were selected for inclusion (Table 1.2). Recently, the total costs of specific lameness
conditions have been further explored. Willshire and Bell (2009) added estimates for
digital dermatitis and white line disease in addition to the aforementioned general
categories. Cha et al. (2010) and Charfeddine and Pérez-Cabal (2017) both looked at the
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total costs associated with digital dermatitis and sole ulcers whereas Charfeddine and
Pérez-Cabal (2017) alone looked at white line disease and Cha et al. (2010) alone looked
at foot rot. Based on these limited studies, digital dermatitis appears to have the least total
costs of the evaluated conditions whereas sole ulcers have the greatest total costs (Table
1.2). Charfeddine and Pérez-Cabal (2017) noted that digital dermatitis generated overall
lesser costs than noninfectious disorders mainly because of the reduced length of time the
disease affected the animal, resulting in reduced treatment, labor, discarded milk, and milk
loss; however, none of the studies considered the possibility of digital dermatitis or other
infectious diseases transmitting to other animals. The importance of looking at total
lameness costs specific to disease type was emphasized by Cha et al. (2010) who noted that
the top cost contributors differed by disease. Milk loss contributed the most to the total
cost of sole ulcers (38%), treatment was the greatest contributor to the total cost of digital
dermatitis (42%), and decreased fertility was the greatest contributor to the total cost of
foot rot (50%).
Accuracy of total lameness costs
Although condition-specific lameness costs are an improvement over non-specific
cost estimates, these estimates are still highly dependent on the assumptions used in the
model. In reality, the cost of lameness conditions varies by herd, cow, and lameness case
characteristics. At the herd level, variation in market prices and management styles will
affect lameness incidence, treatment, and recovery. At the cow level, the cost of a case of
lameness depends on an individual cow’s milk production potential, pregnancy status, and
age (Cha et al., 2010). Finally, characteristics of the lameness case beyond disease type,
including the point in lactation when a cow becomes lame and the severity of the lameness
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condition, will affect total lameness costs (Cha et al., 2010, Charfeddine and Pérez-Cabal,
2017). Of all these influential factors, only the severity of the lameness condition has been
considered in any lameness cost estimates and only once by Charfeddine and Pérez-Cabal
(2017). They found that although severe lesions were less common, their cost was almost
3 times greater than the cost of mild lesions because of their effect on the cow’s longevity.
The ideal scenario would be to provide decision support tools that could use herd, cow, and
case-specific information to help a producer determine the best individual treatment and
culling strategies whenever a cow became lame.
Beyond the definition of lameness used in an economic analysis (i.e., overall,
disease type, or cow-specific) the accuracy of these estimates depends on many factors.
First, the correct expenditures and losses for a disease need to be included in the model.
Our understanding of lameness and all of the factors associated with it continues to
develop, as emphasized by the variation in factors included in the 14 studies in Table 1.2.
Likely, past estimates excluded some critical factors and current estimates are still missing
factors we have yet to consider.
Even if researchers agreed on which expenditures and losses to include, this does
not completely solve the problem. The reliability of cost estimates depends on the
accuracy, availability, and reliability of the empirical data used to create them (Dijkhuizen
et al., 1995). Estimates for some of the factors are lacking (e.g., the expenditures associated
with detection and the losses associated with animal welfare issues). Additionally, most
existing estimates for losses associated with lameness were generated from datasets where
lameness was defined by a lameness or gait score rather than by the presence or absence of
specific conditions. Therefore, the ability to generate further condition-specific lameness

28

cost estimates is limited until this data exists. Recently, Charfeddine and Pérez-Cabal
(2017) used a dataset containing over 108,000 records to estimate the effect of three
specific claw disorders (digital dermatitis, sole ulcer, and white line disease) on milk
production, fertility performance, and longevity. More studies of this nature and studies
including additional lameness disease types, severity, and timing of occurrence would be
valuable for improving total lameness cost estimates.
Conclusions
Accurate calculations of total lameness costs should include numerous
expenditures and losses. Most of these require further empirical research to precisely
define, especially with regard to specific lameness disease types, severity level, and the
stage of lactation at occurrence. Total lameness costs are also influenced by many herdand cow- specific factors. Regardless of the limitations of current lameness cost estimates,
having an understanding of the components of total lameness costs can help to guide future
research and to identify the potential effect of control and prevention strategies, leading to
more proactive decision making and management.
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Table 1.1 Contribution of expenditure and loss categories to the total cost of dairy cow lameness across identified studies that
included at least 6 contribution categories
Category contribution to total cost (%)
Expenditures
Study

Producer
labor

Outside
labor1
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Kossaibati and Esslemont (1997)
Digital lameness
6.2
8.1
Interdigital lameness
3.8
11.9
Sole ulcer
5.9
6.1
Esslemont (2005)
Non-specific lameness
3.2
1.7
Digital lameness
2.5
1.7
Interdigital lameness
5.8
2.7
Sole ulcer
2.9
1.4
Guard (2008)
Non-specific lameness
1.7
0.6
Willshire and Bell (2009)
Non-specific lameness
2.0
1.0
Bruijnis et al. (2010)
Non-specific lameness
17.3
6.7
Charfeddine and Pérez-Cabal (2017)
Digital dermatitis, mild
7.0
42.5
Digital dermatitis, severe
8.4
6.3
Sole ulcer, mild
14.6
10.9
Sole ulcer, severe
10.5
12.4
White line disease, mild
16.4
12.3
White line disease, severe
10.4
8.7
Liang et al. (2017)
Non-specific lameness, parity 1
7.1
19.2
Non-specific lameness, parity 2+
4.3
11.6
Mean
7.2
9.2
1Veterinarian or hoof trimmer fees, 2NA = not provided

Therapeutics

Total

Nonsaleable
milk

Reduced
milk
production

Losses
Reduced
Increased risk of
reproductive
culling and death
performance

Repeat
cases

Total

5.4
8.2
3.5

20
24
16

9.0
11.0
4.0

10.0
9.2
8.5

14.5
41.9
31.6

35.3
0.0
32.6

11.5
14.0
7.8

80
76
84

3.7
3.0
6.8
3.2

9
7
15
8

0.7
0.4
2.1
0.3

30.9
38.8
27.6
23.1

25.9
13.7
48.1
30.0

30.1
36.9
0.0
36.0

3.7
3.0
7.0
3.1

91
93
85
92

4.3

7

0.6

36.0

6.4

50.3

NA

93

10.0

13

24.0

39.0

24.0

NA

87

2.0

26

5.7

28.4

7.4

32.5

NA

74

7.0
4.2
14.6
11.7
16.4
11.6

57
19
40
35
45
31

0.0
24.4
0.0
20.2
0.0
20.1

33.8
16.4
18.3
15.8
13.4
16.6

0.0
2.9
1.5
6.1
3.0
3.2

9.6
37.4
40.2
23.3
38.5
29.5

NA
NA
NA
NA
NA
NA

43
81
60
65
55
69

37.1
22.4
9.7

63
38

1.1
0.7
5.9

12.9
12.3
20.9

3.1
27.2
23.6

19.5
21.5
27.6

NA2
NA
7.6

37
62

NA

Table 1.2 Detailed summary of published research estimates of total dairy cow lameness costs, including lameness definition used,
estimation method, and expenditure and loss categories accounted for within the estimates.
Study

Lameness definition

Estimation method

Harris et al. (1988)
Kaneene and Hurd (1990)
Miller and Dorn (1990)
Esslemont and Peeler (1993)

Feet problems
Lameness, foot rot, corns
Lameness (nonspecific)
Lameness categories

One-time farm survey
Longitudinal farm survey
Longitudinal farm survey
Farm surveys and industry
means

Enting et al. (1997)
Kossaibati and Esslemont (1997)

Esslemont (2005)

Ettema and Østergaard (2006)

Guard (2008)

Willshire and Bell (2009)
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Bruijnis et al. (2010)

Cha et al. (2010)

Charfeddine and Pérez-Cabal (2017)

Liang et al. (2017)
1

Clinical digital disease
Lameness categories

Lameness categories

Observable
lameness
without inspection of the
claw or trimming
Limping or reluctance to
move because of painful
conditions of the digit(s)
Lameness categories and
specific lesion types

Specific lesion types

Specific lesion types

Specific lesion types

Undefined

Partial budget model
Farm and expert opinion
surveys
Expert
surveys
published means

Expenditures included1
L
V T
D P
X
X
X
X
X X
X
X
X X
X

N
X

X

X

X

M
X
X
X

Losses included2
F
C
X O
X X
X X
X X

X

X

X

X

X

X

X

X
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

R

X
X

and
X

Simulation model
X

Cost estimate3,4
$76/case
$13/cow/y
$15/cow-y
$201/case of interdigital disease
$404/case of digital disease
$982/case of sole ulcer
$174/case
$607/cow affected with digital disease
$331/cow affected with interdigital disease
$1 073/cow affected with sole ulcer
$417/cow affected with digital disease
$176/cow affected with interdigital disease
$699/cow affected with sole ulcer
$307/affected cow

X

Partial budget

$533/case
X

X

X

Partial budget
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Simulation model

Simulation model

Deterministic model

Simulation model

W

X
X

$140/digital dermatitis case
$344/digital lameness case
$286/interdigital lameness case
$960/sole ulcer case
$555/white line disease case
$8/cow/y for interdigital phlegmon
$7/cow/y for interdigital dermatitis and heel erosion
$22/cow/y for digital dermatitis
$6/cow/y for sole hemorrhage
$3/cow/y for white line disease
$11/cow/y for sole ulcer
$2/cow/y for interdigital hyperplasia
$243/sole ulcer case
$149/digital dermatitis case
$136/foot rot case
$53 to $402/cow affected with digital dermatitis
$232 to $622/cow affected with sole ulcer
$221 to $590/cow affected with white line disease
$185 to $333/case

L = producer labor; V = veterinary or hoof trimmer labor; T = therapeutics; D = lameness detection; P = lameness control and prevention
2
N = non-saleable milk; M = reduced milk production; F = reduced reproductive performance; C = increased risk of culling; X = increased risk of death; O = relationships with other diseases; R =
recurrence of lameness; W = animal welfare
3
All foreign cost estimates were adjusted from the value reported to United States dollars using the mean exchange rate for the year of publication
4
All costs were adjusted for inflation from the year of publication to 2017

Figure 1.1 Categorization of expenditures and losses that contribute to the total cost of dairy cow lameness
Total lameness
costs

Expenditures

Treatment

Losses
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Outside labor
i.e., veterinarian or
hoof trimmer

Detection
e.g., visual observation, precision
dairy technology

Producer labor

Facility design
e.g., bedding, flooring

Therapeutics
i.e., treatment
supplies and drugs

Non-saleable
milk

Prevention

Management practices
e.g., footbaths, hoof trimming,
pasture access, supplements

Reduced milk
production

Increased risk of
death and culling
Increased
incidence of
other diseases

Reduced
reproductive
performance
Lameness
recurrence

Reduced animal
welfare
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Abstract
The objective of this study was to collect and summarize information on hoof
disease specific treatment costs charged by hoof trimmers and veterinarians to dairy
producers. Additional insight was provided into hoof trimmers’ general billing practices
and views on the amount and importance of different hoof diseases and the value of
reducing lameness incidence. Responses were gathered from veterinarians (n = 18) and
hoof trimmers (n = 116) through both online and paper survey platforms. Because of the
limited number of respondents, veterinarian responses were not further analyzed. Of the 6
hoof diseases included in the survey, the treatment cost per case was greatest for toe ulcers
($20.2 ± 8.5), sole ulcers ($19.7 ± 8.6), white line disease ($19.5 ± 8.1), and thin soles
($18.1 ± 8.1), and least for infectious diseases (foot rot and digital dermatitis; $8.0 ± 7.6
and $7.5 ± 9.6, respectively). Of these diseases, digital dermatitis represented most of the
lameness cases treated by respondents over the past year (43.9 ± 20.4%) whereas toe ulcers
and thin soles represented the least (5.3 ± 4.1% and 5.3 ± 5.7%, respectively). Respondents
that served mostly large herds (> 500 lactating cows) reported a lower prevalence of digital
dermatitis and a higher prevalence of sole ulcers. Respondents from the Northeast reported
a higher prevalence of sole ulcers than other regions outside the Midwest; both were similar
to the prevalence of sole ulcers reported in the Midwest.
When respondents were asked which disease was associated with the greatest total
cost per case to the producer (treatment and labor costs plus the reduction in milk yield,
reduced reproductive performance, etc.), hoof trimmers ranked digital dermatitis as having
the greatest total cost per case and thin soles as having the least total cost per case. This
result may have been biased by respondents thinking about the cost of each hoof disease at
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the herd level rather than at the individual case level. Finally, respondents indicated that
the most important benefits of reducing lameness were enhanced animal welfare and
increased milk production whereas the least important benefit was reduced veterinary and
hoof trimmer fees. This survey provided insight into the amount charged by hoof trimmers
for hoof disease treatment, which can be used to improve the accuracy of hoof disease cost
estimates and lead to better decision-making regarding both lameness treatment and
prevention.
Keywords: lameness, hoof health, disease treatment costs, animal health economics
Introduction
The main cause of lameness in dairy cattle is hoof diseases (Van Nuffel et al.,
2015a). Accurate estimates of the total cost of hoof diseases are essential for identification
of the best lameness prevention and control strategies to incorporate into herd management
(Dijkhuizen et al., 1995, Hogeveen et al., 2011). The total cost of any disease is comprised
of the expenditures applied to treat and prevent the disease and the losses associated with
disease occurrence (e.g., reduced milk yield, reduced reproductive performance, increased
culling; McInerney et al., 1992). Losses associated with hoof diseases are defined using
empirical studies that compare cows with and without lameness over time, often throughout
a lactation. Many studies have been conducted with the objective of defining these losses
associated with hoof diseases as summarized by Huxley (2013). Less emphasis has been
placed on defining the expenditures associated with a hoof disease case.
Expenditures are divided between disease prevention and treatment costs
(McInerney et al., 1992). Prevention expenditures are commonly ignored in hoof disease
cost estimates because of their difficulty to calculate (Chapter 1). Treatment expenditures
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within hoof disease cost estimates are often based on the author’s opinion or outdated and
non-specific values. For example, treatment costs are assumed to be the same regardless
of the hoof disease causing lameness and are not broken down into labor vs. supplies. In
reality, these costs depend on the type of hoof disease, the severity of the condition, the
treatment used, and the person treating the case (i.e., producer, hoof trimmer, or
veterinarian). The best estimate of these costs would come from those that charge the
producer for them (i.e., hoof trimmers and veterinarians), but limited published data from
these sources exist.
This study aimed to collect and summarize information on hoof disease treatment
costs charged by hoof trimmers and veterinarians to dairy producers. Additional insight
was provided into hoof trimmers’ general billing practices and views on the amount and
importance of different hoof diseases and the value of reducing lameness incidence.
Materials and Methods
Survey development
A survey was drafted with the goal of defining treatment costs for a variety of hoof
diseases as charged to producers by hoof trimmers and veterinarians. The drafted survey
was reviewed by industry veterinarians (n = 2), academic veterinarians (n = 5), academic
professionals (n = 7), and animal science graduate students (n = 10) to collect feedback on
content and organization. Based on collected feedback, revisions were made before the
survey was sent to survey participants.

The final survey questions are included in

Appendix Table A1. The revised survey was also reviewed by the University of Kentucky
Institutional Review Board and found exempt from human subject protection regulations
as described in 45 CFR 46.101(b).
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Demographic information elicited by the survey included profession (veterinarian,
hoof trimmer, or other), the location of practice (country or states served, if within the
United States), herd sizes served, and the mean number of dairy cows trimmed per week
(broken out into preventive and treatment trimmings). Respondents selecting “other” for
their profession were removed from the survey results because they were outside of the
target audience. General lameness questions were formulated to evaluate the rate charged
by hoof trimmers and veterinarians to come to a farm and conduct either preventive or
treatment trimmings. These questions included 1) asking respondents if they charged a
visit, daily, or set-up fee and, if so, how much, 2) the on-farm rate ($/h or $/cow) charged
for preventive trimming, and 3) the mean number of cows trimmed per hour.
Condition-specific lameness questions focused on 6 diseases: digital dermatitis,
foot rot, sole ulcer, thin sole, toe ulcer, and white line disease. These diseases were chosen
based on their expected prevalence and feedback from those who reviewed the first version
of the survey. All diseases were defined within the survey according to industry standards
(Zinpro, 2014; Appendix Figure A1). Condition-specific questions included the total
amount charged to the producer for treatment of each disease along with the percent of the
total cost attributed to labor and the percent of the total cost attributed to supplies.
Additionally, respondents were asked to estimate the amount of time spent to treat a case
of each disease, the percent of lameness cases treated in the past year attributed to each
disease, and milk withhold recommendations following treatment. Retrospectively, the
question about milk withhold recommendations was removed from the study results
because of United States regulations restricting hoof trimmers from prescribing antibiotics.
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Finally, respondents were asked to answer two rank order questions. First, they
were asked to rank the 6 hoof diseases based on their opinion of the total cost per case to
the producer (treatment and labor costs plus the reduction in milk yield, reduced
reproductive performance, etc.) from most expensive (1) to least expensive (6). Second,
they were asked to rank the importance to producers of 8 potential benefits (identified by
the authors) of reducing dairy cow lameness from most important (1) to least important (8).
The potential benefits included decreased incidence of other diseases (not lameness),
enhanced animal welfare, increased milk production, increased reproductive performance,
increased cow longevity, reduced drug and supply costs, reduced producer labor costs, and
reduced veterinary and hoof trimmer fees.
Survey distribution
The target audience for the survey was veterinarians and hoof trimmers. Therefore,
the American Association of Bovine Practitioners (AABP) and the Hoof Trimmers
Association (HTA) were identified as potential respondent sources. Based on the response
rates from AABP and HTA members to a previous lameness survey (Kleinhenz et al.,
2014), the decision was made to create an online version of the survey for AABP members
and a paper version of the survey for HTA members.
The online survey was created using Qualtrics (Qualtrics Research Suite, Provo,
UT). We identified that the best way to distribute the online survey to AABP members
would be through their member e-mail listserv (n ≈ 2,000 recipients). A link to the survey
was first sent to the AABP listserv on June 12, 2017. Follow-up e-mails were sent to the
AABP listserv 1 week and again 4 weeks after the original e-mail solicitation to remind
potential respondents to complete the survey. The final e-mail to the AABP listserv, sent
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on August 1st, 2017, indicated that the survey would be closing on August 15th, 2017. All
e-mails sent to AABP members and the online survey itself included instructions for
accessing and returning (via mail at their own expense) a downloadable paper version of
the survey in case that was the respondent’s preference. All online surveys submitted by
and paper surveys received by August 31st, 2017 were included in the analysis.
Hoof trimmers identified by the HTA (n = 548) were mailed a paper survey with
identical questions as the online survey on June 12, 2017, using a third-party mailing
company selected by the HTA. The paper survey included pre-paid envelopes to return the
survey to the University of Kentucky. The paper survey also included instructions to access
the online version of the survey in case that was the respondent’s preference. One week
after the first paper survey mailing, a follow-up postcard was sent to all original recipients
to remind them to return the survey. A difference in postage class resulted in the reminder
postcards arriving before the originally mailed paper survey. Because of this, the second
and final mailing of the paper survey (only sent to non-respondents) was delayed until 5
weeks after the original mailing (July 17, 2017). Non-respondents were identified by
labeling the originally mailed surveys with a number that corresponded to a recipient. The
list of recipients was not referenced after the final mailing. All paper surveys received by
August 31st, 2017 were included in the analysis.
At survey closure, 83 people had started the online survey and 16 completed the
entire online survey (completion rate = 19%). One hundred and twenty-three paper surveys
were returned, and only 1 was from a veterinarian. Therefore, we obtained a 22% response
rate from the targeted mailing list. Nine paper survey respondents indicated that they were
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retired, 1 respondent indicated that they only trimmed beef cattle, and 1 other indicated that
they only trimmed for their own herd; these 11 surveys were removed from the dataset.
Statistical analysis
Responses from paper surveys were manually entered into the online survey to
standardize data from both sources. When respondents reported a range for any answer
(e.g. indicated that they trimmed 10 to 15 cows per hour), the mean of the range was
calculated for further analysis (e.g. 12.5 cows per hour). For questions where answers were
supposed to add up to 100%, (i.e., the percent of each type of hoof disease treated and the
percent of the total cost attributed to labor and supplies), if the total was not 100% the
answers were standardized to total 100%. For rank order questions, if two or more options
were ranked the same, the tied rankings were removed from the dataset (n = 4 for the rank
order question about the total cost per case of disease and n = 5 for the rank order question
about the importance of potential benefits of reducing lameness). Finally, any unanswered
questions were removed from the dataset.
Respondents were categorized by profession (veterinarian or hoof trimmer), region
of practice, herd sizes served, and trimming frequency. The region of practice was defined
based on a respondent’s answer to which states they served in the United States. The region
classifications included Midwest (states represented included IA, IL, IN, KS, MI, MN, ND,
NE, OH, SD, and WI), Northeast (states represented included CT, MA, MD, ME, NH, NY,
PA, RI, and VT), Southeast (states represented included AL, AR, FL, GA, KY, MO, MS,
TN, and VA), Southwest (states represented included NM and TX), and West (states
represented included CO, ID, MT, OR, and WA). If the respondent indicated they served
herds in more than one region, their region was defined based on the category representing
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most of the listed states. Eighty-two percent of respondents were from either the Midwest
or the Northeast; therefore, the remaining regions were grouped into an “other” region
category. Only 3 usable responses were from outside the United States; these responses
were removed from the dataset because of the inability to distinguish which currency
answers were given in.
Herd size served was based on each respondent’s answer to the question, “Estimate
the number of farms you perform preventive or corrective trimming for each year that
would fall under each category: small herds (fewer than 100 lactating cows), medium herds
(between 100 and 500 lactating cows), and large herds (over 500 lactating cows).”
Respondents were placed into 1 of 3 categories based on which size herds represented most
of their clientele. A respondent with most of their clientele classified as small herds was
categorized as “small” herd size served, a respondent with most of their clientele classified
as medium herds was categorized as “medium” herd size served, and a respondent with
most of their clientele classified as large herds was categorized as “large” herd size served.
In cases where the respondent served the same number of herds in two categories,
preference was given to the extreme value (i.e. if the same number of small and mediumsized herds were served, the respondent was classified as “small” herd size served, and if
the same number of medium and large herds were served, the respondent was classified as
“large” herd size served; in no cases were the same number of small and large sized herds
served).
Trimming frequency was based on the response to the question, “On average, how
many dairy cows do you conduct preventive trimming for weekly (i.e., routine trimming)?”
Tertiles were calculated from the responses used in linear regression analysis and were
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used to classify trimming frequency as either low (≤ 150 trims per week), medium (between
150 and 250 trims per week), or high (≥ 250 trims per week).
Statistical analyses were conducted using SAS Version 9.4 (SAS Institute Inc.,
Cary, NC). For both online and paper surveys, provided answers were included in the
descriptive statistics even if a respondent did not finish the survey (22% and 78%
completion rate for online and paper surveys, respectively). The MEANS procedure was
used to summarize how many cows were trimmed per hour when conducting preventive
trims, the rate charged for preventive trimming, the percent of lameness treatments
attributed to each hoof disease, the time spent treating each hoof disease, the total cost per
case of each hoof disease, the percent of the total costs of each hoof disease attributed to
labor, and the percent of the total costs of each hoof disease attributed to supplies. The
FREQ procedure was used to summarize if an extra fee was charged (yes or no) and the
frequency of ranking for both rank-order questions.
Because very few responses were received from veterinarians (n = 18), only hoof
trimmer responses were analyzed for statistical difference by demographics. The GLM
procedure of SAS was used to analyze the effects of region, herd size served, and trimming
frequency on the preventive trimming rate, the number of cows trimmed per hour, the
percent of treated lameness cases attributed to each hoof disease, the amount of time spent
treating each hoof disease, the total cost charged to producers for treatment of each hoof
disease, the percent of the total cost of each hoof disease attributed to labor, and the percent
of the total cost of each hoof disease attributed to supplies:
𝑦𝑦𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖 = 𝜇𝜇 + 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑖𝑖 + 𝐻𝐻𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑗𝑗 + 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑘𝑘 + 𝑒𝑒𝑖𝑖𝑖𝑖𝑖𝑖𝑖𝑖
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where y is the outcome variable of interest for the lth respondent classified in the kth
trimming frequency category, the jth herd size served category, and the ith region; µ is the
intercept; i is Midwest, Northeast, or Other; j is small, medium, or large; k is low, medium,
or high; and eijkl is residual error. For all models, differences were considered significant
when P < 0.05 and all effects were retained regardless of significance.
Results and Discussion
The objective of this study was to gain insight into hoof disease treatment costs
charged to dairy producers by hoof trimmers and veterinarians. Table 1 summarizes the
distribution of respondents used in at least one descriptive statistic calculation by
profession, survey type returned, region of practice, herd size served, and trimming
frequency. The survey distribution methods used in our study (i.e., online surveys for
veterinarians and mailed surveys for hoof trimmers) were based on results from Kleinhenz
et al. (2014) who surveyed the same population. Different from Kleinhenz et al. (2014),
we received very few completed AABP responses to our online survey.

The low

completion rate of online surveys could indicate that veterinarians who started the survey
deemed the topic inapplicable to them.

To support the idea that the veterinarian

respondents were less involved in lameness treatment than the hoof trimmer respondents,
all veterinary respondents to the survey were categorized in the low trimming frequency
group (Table 1). Additionally, one veterinary respondent stated, “I rarely get asked to work
on lame cows.” In agreement, Adams et al. (2016) reported that 77% of United States dairy
farms used a professional hoof trimmer for hoof health services compared to only 16%
using a veterinarian or on-farm staff. Still, one limitation of the current study is that the
received responses, especially from veterinarians, may not be entirely representative of the
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target population because of nonresponse bias. Because of this, veterinarian response
summary statistics are only included in the Appendix (Tables A2 to A4). Interpretation of
veterinarian responses should be conducted carefully, keeping in mind the limited response
rate.
General lameness
On average, hoof trimmers reported trimming 10.0 ± 5.0 cows per hour (n = 116).
The number of cows trimmed per hour differed by trimming frequency with low and
medium frequency trimmers trimming fewer cows per hour than high frequency trimmers
(7.66 ± 0.66, 9.34 ± 0.79, and 13.70 ± 0.66 cows/h, respectively; n = 111; P < 0.01). This
could be because trimmers who trim more frequently are better practiced or have better
equipment than trimmers that trim less frequently. Alternatively, trimmers who trim more
frequently may have regular clients, making trimming visits quicker (because the cows’
hooves are in better shape) than a farm that is not visited by a hoof trimmer regularly.
Ninety-nine percent (n = 114) of hoof trimmer respondents billed per cow, rarely
charging an extra fee (visit, daily, or set-up) of any kind (only 12% of respondents, mean
± SD = 87.9 ± 133.4, n = 14). The mean ± SD rate charged by hoof trimmers was $12.55
± 2.38/cow (n = 113). Trimming rate ($/cow) differed by region and herd size served.
Hoof trimmers from the Midwest charged a greater fee ($13.21 ± 0.31/cow) than hoof
trimmers from either the Northeast ($11.73 ± 0.33/cow) or other regions in the United
States ($10.89 ± 0.47/cow; n = 108; P < 0.01). A large portion of dairy farms in the United
States are located in the Midwest (USDA, 2017b), potentially contributing to a greater
demand for hoof trimmers and the ability to charge an increased fee. Hoof trimmers
serving mostly large herds charged a reduced fee ($11.10 ± 0.43) compared to those serving
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mostly medium sized herds ($12.54 ± 0.33/cow, P = 0.04). Neither was different from
hoof trimmers serving mostly small herds ($12.19 ± 0.35/cow). The effect of herd size on
fees charged by hoof trimmers could be attributed to economies of scale where large farms
would be charged less because the fixed costs of hoof trimming (e.g., travel expenses)
could be spread over more cows. Although interactions weren’t tested in the model, it was
noted that the ranking of rates charged to different herd sizes differed numerically by region
with hoof trimmers in the Midwest charging the most to large herds, hoof trimmers in the
Northeast charging the most to medium herds, and hoof trimmers in other regions charging
the most to small herds.
Condition-specific lameness
Prevalence of hoof diseases. Among treated cases over the past year, respondents
estimated that digital dermatitis was most prevalent, followed by sole ulcers, white line
disease, other lameness, foot rot, toe ulcers, and thin soles (Table 2). Very few studies
identifying specific lesions have been conducted in the United States, making an estimate
of actual hoof disease prevalence or incidence difficult. Bicalho et al. (2007) found in 459
cows on a New York dairy that the most common hoof diseases were a sole ulcer (52%),
digital dermatitis (20%), white line disease (15%), other lameness (10%), toe ulcers (3%),
and foot rot (1%). Similarly, other studies have identified sole ulcers as the most common
condition causing lameness in dairy cows, but rarely do studies include identification of
toe ulcers or thin soles (Amory et al., 2008, Gernand et al., 2012). Sanders et al. (2009)
found in a Florida herd of 4,915 cows that 38% of lameness cases were attributed to other
lameness (including digital dermatitis, foot rot, heel ulcers, leg injuries, sole punctures, and
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others), 20% to thin sole induced toe ulcers, 16% to sole ulcers, 13% to thin soles, 10% to
white line disease, and 2% to toe ulcers.
Inconsistent with previous research, hoof trimmer respondents to this survey
reported the percentage of treated cases attributed to digital dermatitis as much greater than
the cases attributed to sole ulcers (44% vs. 16%). One factor that might contribute to this
is that hoof trimmers conduct more preventive trimming and are more likely to see both
lame and non-lame cows, thereby observing both mild and severe conditions. Additionally,
the types and prevalence of hoof diseases present in a herd depend on both management
and the environment (Cook and Nordlund, 2009).

Therefore, variation among herds is

expected and likely contributed to the variation in reported prevalence of hoof diseases
seen in our study. Regardless, the viewpoint of the surveyed hoof trimmers likely does not
represent the true occurrence of different hoof disease because they do not always examine
every lame cow.
Region, herd size served, and trimming frequency did not influence the percent of
treatments over the past 12 months classified as foot rot, thin soles, toe ulcers, white line
disease, or other lameness (P > 0.05). The percent of digital dermatitis was influenced by
herd size served (P = 0.02, n = 107) where hoof trimmers serving mostly large herds
reported less digital dermatitis (31.6 ± 4.2%) than hoof trimmers serving mostly small or
medium-sized herds (44.4 ± 3.4% and 46.7 ± 3.2%, respectively).

One possible

explanation for this observation is that large farms may have protocols and consistent labor
available to prioritize footbath use. However, the exact reason for this observation cannot
be extrapolated from the data available in this study. The percent of sole ulcers reported
was influenced by region and herd size served (P = 0.03 and P = 0.03, respectively; n =
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107). Respondents from the Northeast reported more sole ulcers (22.1 ± 2.3%) than
respondents from other regions in the United States (12.4 ± 3.3%); neither differed from
Midwestern respondents (15.2 ± 2.1%). It is possible that differences in style and age of
housing contributed to these reported differences, however, an exact reason for this
observation is not clear. Respondents serving mostly large herds reported more sole ulcers
(23.1 ± 3.0%) than respondents serving either medium sized herds (13.3 ± 2.3%) or small
sized herds (13.4 ± 2.4%). This could be because large herds from the Midwest and
Northeastern regions (most respondents) are more likely to house cows on concrete
(NAHMS, 2014), which is a risk factor for sole ulcer development (Zinpro, 2014).
Treatment time. Among all respondents, the mean time to treat a case of lameness
was longest for toe ulcers, followed by white line disease, sole ulcers, thin soles, foot rot,
and digital dermatitis (Table 2). Conditions requiring more remodeling of the foot, like
ulcers and white line disease (Andrews et al., 2008), required more time to treat. Region,
herd size served, and trimming frequency did not influence the time required to treat foot
rot, sole ulcers, thin soles, toe ulcers, or white line disease (P > 0.05). The time to treat
digital dermatitis differed by trimming frequency where hoof trimmers classified as high
trimming frequency spent less time treating digital dermatitis (1.6 ± 0.3 min) than those
with a low trimming frequency (3.0 ± 0.3 min; P < 0.01, n = 108). Hoof trimmers classified
as medium trimming frequency fell in between the two extremes (2.1 ± 0.3 min). Although
numerical differences were minimal, hoof trimmers with a high trimming frequency may
be quicker because they have had more practice and additionally might have equipment
that allows for quicker treatments.
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Cost per case. The mean total charged per case of each hoof disease was greatest
for toe ulcers, followed by sole ulcers, white line disease, thin sole, foot rot, and digital
dermatitis (Table 2). Previous studies focused on veterinarian and hoof trimmer opinions
about hoof disease costs are limited. Similar to our findings, Charfeddine and Pérez-Cabal
(2017) found in a survey of Spanish hoof trimmers that the cost to treat sole ulcers and
white line disease were similar to each other, with the treatment of digital dermatitis being
less. We observed that many of the respondents indicated that they charged equal amounts
for the two infectious diseases (digital dermatitis and foot rot) and identical, but larger,
amounts for non-infectious diseases (sole ulcers, white line disease, thin soles, and toe
ulcers). This observation is likely because similar supplies would be used to treat infectious
(wrap) and non-infectious (block) hoof diseases. The hoof trimmer reported cost per case
did not differ by region, herd size served, or trimming frequency for any of the hoof
diseases (P > 0.05).
Costs attributed to labor vs. supplies. The percent of the total cost attributed to
either labor or supplies by hoof disease is included in Table 2. The difference in the percent
of the cost attributed to labor between diseases is likely the result of different treatment
methods for different diseases. Traditional infectious lameness treatments often involve
cleaning and topical application of antibiotics in a foot wrap whereas non-infectious lesions
involve trimming and blocking the hoof to reduce weight bearing on the affected claw
(Andrews et al., 2008). Some paper survey respondents wrote in comments about the cost
per block or per wrap used. Mean wrap price was $3.92 ± 1.71 (n = 13) and mean block
price was $16.00 ± 6.15 (n = 18). Therefore, it is not surprising that we found a greater
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percentage of costs attributed to labor for infectious diseases and a greater percentage of
costs attribute to supplies for non-infectious diseases.
Region, herd size served, and trimming frequency did not influence the percent of
total costs attributed to labor or supplies for digital dermatitis, sole ulcers, thin soles, toe
ulcers, or white line disease (P > 0.05). The percent of the total cost of foot rot attributed
to supplies did not differ by region, herd size served, or trimming frequency, but the percent
of the total cost of foot rot attributed to labor differed by region (P = 0.03, n = 81). For
unknown reasons, hoof trimmers from the Midwest attributed more of the foot rot costs to
labor (75.6 ± 4.2%) than hoof trimmers from the Northeast (60.6 ± 4.2%).
Rank order responses
Hoof disease total costs. Respondents were asked to rank the selected hoof diseases
based on the total cost per case to the producer (treatment and labor costs plus the reduction
in milk yield, reduced reproductive performance, etc.) from most expensive (1) to least
expensive (6).

The frequency of responses is reported in Table 3.

Hoof trimmer

respondents most often ranked digital dermatitis total cost per case to the producer as
greatest. Conversely, multiple previously published economic estimates of lameness costs
agree that sole ulcers are the most expensive hoof disease per case whereas infectious
conditions, including digital dermatitis and foot rot, tend to be the least expensive per case
(Willshire and Bell, 2009, Cha et al., 2010, Charfeddine and Pérez-Cabal, 2017). The
survey question about the cost ranking of different hoof diseases tried to emphasize the
cost per case component, but the ranking of digital dermatitis total costs per case as first
by hoof trimmers could indicate that some respondents focused more on the total cost to
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the herd. This is especially possible given that respondents reported charging producers
more to treat either sole ulcers or white line disease than digital dermatitis (Table 2).
Interestingly, among hoof trimmer respondents that did not rank digital dermatitis
as first, most ranked the total cost per case of digital dermatitis as last. This indicates that
some of the respondents likely did consider the per-case portion of the question more
seriously than others. Thin soles were most commonly ranked as the lowest cost per case
to the producer. No previous lameness cost estimate studies have included either toe ulcers
or thin soles and rarely have epidemiological studies included these conditions. Therefore,
it is unclear if ranking of thin soles as having the least total cost per case is consistent with
reality or not; more research on the effects of this condition on cow performance is needed.
Lameness reduction benefits. Respondents were asked to rank selected potential
benefits of reducing lameness from most important (1) to least important (8). The
frequency of responses is reported in Table 4. Among hoof trimmers, enhanced animal
welfare and increased milk production were the most important benefits identified.
Chapter 1 summarized that the top contributing categories to the total cost of lameness
have traditionally been calculated as increased culling and death, reduced reproductive
performance, and decreased milk yield. However, no previous literature has considered
the costs of lameness attributed to negative animal welfare, excluding it from consideration
in that study. In agreement with respondents to this survey, recent studies have highlighted
the connection between animal welfare and lameness (Von Keyserlingk et al., 2009,
Barkema et al., 2015).
Reduced veterinary and hoof trimmer fees were ranked as the least important potential
benefit associated with reducing lameness. This was in agreement with Chapter 1 which
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found that previous total cost of lameness estimates have ranked reduced drug and supply
costs, reduced outside labor, and reduced producer labor as less important cost categories.
The second least important response was decreased incidence of other diseases. Evidence
of the connection between lameness and other diseases is mixed (Chapter 1). Overall,
respondent’s answers indicate that hoof trimmers have a good understanding of the
contribution of different cost categories to the total cost of lameness as defined in currently
available literature. However, the voluntary survey strategy may have selected for hoof
trimmers that are more interested in research and up-to-date on published literature,
potentially influencing rank order responses.
Conclusions
The goal of this study was to collect information on hoof disease treatment costs
charged by hoof trimmers and veterinarians to dairy producers. Low responses rates from
veterinarians limited our study to hoof trimmer opinions only. Hoof trimmers reported that
hoof disease treatment cost per case was greatest for toe ulcers, followed by sole ulcers,
white line disease, thin sole, foot rot, and digital dermatitis. Additional insight was
provided into hoof trimmers’ general billing practices and views on the amount and
importance of different hoof diseases and the value of reducing lameness incidence.
Minimal effects of region, herd size served, or trimming frequency were found on
responses. The treatment cost estimates found in this study can aid in improving economic
estimates of the total cost per case of different hoof diseases. More accurate hoof disease
total cost per case estimates could help improve decisions regarding the treatment of
individual hoof disease cases and the adoption of lameness prevention strategies.
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Table 2.1 Distribution of respondents to a survey1 about dairy hoof disease treatment costs
by profession, survey type, region, herd size served, and trimming frequency
Profession
Category
Total
Veterinarian
Hoof Trimmer
Survey type
Online
17
5
22
Paper
1
111
112
Region2
Midwest
11
55
66
Northeast
3
41
44
Other
4
20
24
3
Herd size served
Small (< 100 cows)
7
45
52
Medium (100 to 500 cows)
7
42
49
Large (> 500 cows)
0
25
25
Trimming frequency4
Low (< 150 cows/wk)
18
32
50
Medium (150 to 250 cows/wk)
0
41
41
High (>250 cows/wk)
0
42
42
Total
18
116
1
An online version of the survey was sent to the American Association of Bovine
Practitioners listserv (n ≈ 2,000 members) and a paper version of the survey was mailed to
548 hoof trimmers identified by the Hoof Trimmers Association
2
Midwest states represented included IA, IL, IN, KS, MI, MN, ND, NE, OH, SD, and WI;
Northeast states represented included CT, MA, MD, ME, NH, NY, PA, RI, and VT; Other
states represented included AL, AR, FL, GA, KY, MO, MS, TN, VA, NM, TX, CO, ID,
MT, OR, and WA.
3
Herd size served was categorized based on if the respondent’s clients were mostly small
herds (fewer than 100 lactating cows), medium herds (between 100 and 500 lactating
cows), or large herds (over 500 lactating cows). Eight respondents did not provide
sufficient information to classify them according to herd size served but were still included
in descriptive statistics.
4
Trimming frequency was categorized based on the calculated tertiles of responses used in
linear regression analysis; 1 respondent did not provide sufficient information to classify
hoof trimming frequency but was still included in descriptive statistics
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Table 2.2 Hoof trimmer responses to a survey regarding dairy hoof disease prevalence,
time to treat, treatment costs, and the percentage of costs attributed to labor or supplies
Number of responses
Response
(n)
(mean ± SD)
Hoof disease
Digital dermatitis
% of total
112
43.9 ± 20.4†
Time to treat (min)
113
2.2 ± 1.9‡
Total charged ($/case)
98
7.5 ± 9.6
% attributed to labor
92
65.1 ± 21.8
% attributed to supplies
92
34.9 ± 21.8
Foot rot
% of total
112
6.5 ± 7.0
Time to treat (min)
111
3.7 ± 2.7
Total charged ($/case)
90
8.0 ± 7.6
% attributed to labor
85
66.0 ± 21.8⁎
% attributed to supplies
85
32.8 ± 20.8
Sole ulcer
% of total
112
15.9 ± 14.2⁎†
Time to treat (min)
114
6.2 ± 3.5
Total charged ($/case)
95
19.7 ± 8.6
% attributed to labor
90
58.8 ± 19.8
% attributed to supplies
90
41.2 ± 19.8
Thin sole
% of total
112
5.3 ± 5.7
Time to treat (min)
107
5.1 ± 3.3
Total charged ($/case)
89
18.1 ± 8.1
% attributed to labor
82
56.7 ± 20.7
% attributed to supplies
82
43.3 ± 20.7
Toe ulcer
% of total
112
5.3 ± 4.1
Time to treat (min)
111
7.1 ± 3.6
Total charged ($/case)
96
20.2 ± 8.5
% attributed to labor
91
57.5 ± 20.5
% attributed to supplies
91
42.5 ± 20.5
White line disease
% of total
112
14.2 ± 10.2
Time to treat (min)
113
6.5 ± 3.1
Total charged ($/case)
96
19.5 ± 8.1
% attributed to labor
90
57.9 ± 21.2
% attributed to supplies
90
42.1 ± 21.2
Other lameness
% of total treatments
112
8.9 ± 9.3
⁎Indicates

a statistical difference between hoof trimmers by region (Midwest, Northeast, or other region of the United
States; P < 0.05); further details included in the text
†Indicates a statistical difference between hoof trimmers by herd size served (small, medium, or large; P < 0.05); further
details included in the text
‡Indicates a statistical difference between hoof trimmers by trimming frequency (low, medium, or high; P < 0.05); further
details in the text
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Table 2.3 Ranking frequency of the estimated total cost per case to the producer (treatment
and labor costs plus the reduction in milk yield, reduced reproductive performance, etc.) of
selected hoof diseases as evaluated by a survey of hoof trimmers. Ranking was from most
expensive (1) to least expensive (6).
Response frequency (%)
Disease
n
1
2
3
4
5
6
Digital dermatitis
112
33.9
9.8
4.5
9.8
13.4
28.6
Toe ulcer

109

22.9

19.3

15.6

19.3

12.8

10.1

Foot rot

111

19.8

11.7

9.9

20.7

19.8

18.0

Sole ulcer

111

11.7

27.0

26.1

17.1

13.5

4.5

White line disease

112

7.1

23.2

30.4

20.5

8.9

9.8

Thin sole

111

6.3

7.2

13.5

12.6

30.6

29.7
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Table 2.4 Ranking frequency of the potential benefits to producers of reducing dairy cow
lameness as evaluated by a survey of hoof trimmers. Ranking was from most important
(1) to least important (8).
Response frequency (%)
Potential benefit
n
1
2
3
4
5
6
7
8
Enhanced animal welfare 106 36.8 12.3 13.2 17.9 6.6 4.7
2.8 5.7
Increased milk production

105

32.4

24.8 18.1

7.6

6.7

1.0

3.8

4.8

Increased cow longevity

106

20.8

21.7 22.6 15.1 13.2

5.7

0.0

0.9

Reduced veterinary and
hoof trimmer fees

103

4.9

1.0

2.9

Decreased incidence of
other diseases (not
lameness)

105

2.9

7.6

7.6 11.4 20.0 13.3 11.4 25.7

Increased reproductive
performance

106

2.8

Reduced drug and supply
costs

105

1.0

2.9

4.8 12.4 13.3 31.4 21.0 13.3

Reduced producer labor
costs

106

0.0

3.8

3.8

8.7 14.6 17.5 21.4 29.1

27.4 26.4 20.8 10.4
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6.6

4.7

0.9

6.6 14.2 18.9 34.9 17.9

CHAPTER 3

Use of a stochastic simulation model to estimate the cost per case of digital
dermatitis, sole ulcer, and white line disease by severity, incidence timing, and
parity group in dairy cattle
K. A. Dolecheck*, M. W. Overton†, T. B. Mark‡, and J. M. Bewley§
*Department of Animal and Food Sciences, University of Kentucky, Lexington 40546
†Elanco Animal Health, 2500 Innovation Way, Greenfield, IN 46140
‡
Department of Agricultural Economics, University of Kentucky, Lexington 40546
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Abstract
A farm-level stochastic simulation model was modified to estimate the cost per case
of 3 hoof diseases (digital dermatitis, sole ulcer, and white line disease) by severity,
incidence timing, and parity group. Disease expenditures considered within the model
included therapeutics, outside labor, and on-farm labor. Disease losses considered within
the model included discarded milk, reduced milk production, extended days open, an
increased risk of culling, an increased risk of death (natural or euthanized), and disease
recurrence.

All estimates of expenditures and losses were defined using data from

previously published research in stochastic distributions. Monte Carlo simulation was used
to account for variation within the farm model; 1,000 iterations were run. Sensitivity of
hoof disease costs to selected market prices (milk price, feed price, replacement heifer
price, and slaughter price) and herd specific performance variables (rolling herd average
milk production and pregnancy rate) was analyzed. Using our model assumptions, the cost
per case of disease over all combinations of severity, incidence timing, and parity group
was lowest for digital dermatitis (mean ± SD = $137 ± 36), followed by white line disease
(mean ± SD = $203 ± 33), and sole ulcer (mean ± SD = $227 ± 35). Disease costs were
greater in severe vs. mild cases and multiparous vs. primiparous cows and were always
highest at the beginning of lactation. The greatest contributing cost categories were
decreased milk production, an increased risk of culling, disease recurrence, and, in severe
cases, an increased risk of death. The contribution of cost categories to the total cost of
disease varied by disease type, severity, incidence timing, and parity group. For all
diseases, the average cost per case of disease increased as milk price, rolling herd average
milk production, or replacement heifer price increased and decreased as feed price,
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pregnancy rate, or slaughter price increased. Understanding how hoof disease costs change
according to cow-specific conditions (i.e., severity level, DIM at incidence, and parity
group) and herd-specific conditions (i.e., market prices and performance variables) can
help improve on-farm decisions about treatment and prevention of hoof diseases.
Key Words: lameness, disease cost, hoof health, animal health economics
Introduction
Lameness is a widespread issue in the dairy industry, with prevalence ranging from
5.5% to 70.1% (mean = 27.2 ± 11.9%) on United States and Canadian dairy farms (Costa
et al., 2017). Although often referred to as a disease itself, lameness is actually a clinical
sign associated with multiple different hoof diseases. Each case of lameness, and the
associated hoof disease that is causing it, is associated with both direct expenditures (e.g.,
on-farm labor, hoof trimmer labor, and therapeutics) and indirect losses (e.g., discarded
milk, reduced milk production, reduced reproductive performance, increased risk of death,
increased risk of culling, and disease recurrence; Chapter 1). Understanding the total cost
per hoof disease case is valuable for improving management at both the cow and herd level
by aiding in the selection of lameness treatment strategies, culling strategies, and
prevention investments.
Most previous lameness cost estimates have focused on either the cost of lameness
at the herd level (Kaneene and Hurd, 1990, Miller and Dorn, 1990), the cost per case of
non-specific lameness (Harris et al., 1988, Guard, 2008, Liang et al., 2017), or the cost per
case of lameness categorized as interdigital, digital, or sole ulcer (Esslemont and Peeler,
1993, Kossaibati and Esslemont, 1997, Esslemont, 2005). More recently, specific hoof
diseases have been considered when calculating the cost per case of lameness (Willshire

59

and Bell, 2009, Bruijnis et al., 2010, Cha et al., 2010, Charfeddine and Pérez-Cabal, 2017).
However, Chapter 1 highlighted that these costs often still fail to consider how severity,
incidence timing relative to calving, or parity affects the cost of the disease even though
previous literature supports that these differences exist. Charfeddine and Pérez-Cabal
(2017) identified differences in both direct (trimmer fees, treatment fees, producer labor,
and discarded milk) and indirect (milk loss, days open, and length of productive life)
negative consequences when comparing mild and severe lesions, emphasizing the need to
account for this factor in cost estimates. Booth et al. (2004) demonstrated how the effect
of hoof diseases on survival differed depending on disease diagnosis timing. Logically,
incidence timing would also influence discarded milk and reduced milk production because
of yield changes throughout lactation and reduced reproductive performance, assuming a
reduced effect of lameness on reproduction after pregnancy is established. Liang et al.
(2017) found that the total cost per case of non-specific lameness was 1.8 times greater in
multiparous cows than primiparous cows. The authors attributed most of the difference to
increased multiparous cow losses associated with reduced milk yield, culling, and extended
days open.
The objective of this study was to build a stochastic simulation model capable of
estimating hoof disease costs depending on disease type, severity level, incidence timing,
and parity group. Other studies (Ettema and Østergaard, 2006, Bruijnis et al., 2010, Liang
et al., 2017) have also used stochastic simulation to estimate disease costs which allows
evaluation of how disease costs change with variation in farm specific and market values.
To demonstrate usefulness, the model was used to calculate the cost per case of digital
dermatitis, sole ulcer, and white line disease in an example United States dairy herd.
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Materials and Methods
Model overview
A pre-existing farm-level, Monte Carlo simulation model was adapted for use in
this study (Bewley et al., 2010, Liang et al., 2017). The model was created using Excel
2016 (Microsoft, Seattle, Washington) and stochastic features were applied using the
@Risk add-in (Version 7, Palisade Corporation, Ithaca, New York).

As described

previously by Liang et al. (2017), the model worked by calculating the milk yield
(estimated via the lactation curve described by Skidmore (1990)), body weight, dry matter
intake (estimated via equations found in NRC (2001)), and pregnancy status of the average
cow in the herd every day for 6 parities. This average cow was assumed to represent all
cows in the herd and information about the cow was used to calculate disease costs.
The Monte Carlo simulation method is a technique that allows re-running of a
simulation model repeatedly while key variables vary stochastically. When a variable was
modeled stochastically, a distribution was defined for that variable based on previously
published literature or industry averages. During each iteration of the model, a different
value from that distribution was selected for use. For this study, variables assumed to
influence the cost of lameness were modeled stochastically, resulting in unique cost per
case estimates for each hoof disease each time the model was run.
Disease case definitions
For this study, three hoof diseases were selected for modeling: digital dermatitis,
sole ulcer, and white line disease. These conditions were selected because they are
considered the most prevalent lameness causing diseases in United States dairy herds
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(DeFrain et al., 2013). Additionally, these 3 hoof diseases have the most published data
available to be able to specify costs by severity, incidence timing, and parity group.
Based on the availability of data for modeling, severity was categorized as mild or
severe. Most assumptions about differences between mild and severe cases were taken
from Charfeddine and Pérez-Cabal (2017). In that study, severity was classified based on
how deep or superficial the lesion was, the expected recovery time, and if further treatment
was needed. To evaluate how incidence timing affected the cost of disease, 4 incidence
periods were selected: 0 to 60 DIM, 61 to 120 DIM, 121 to 240 DIM, and >240 DIM.
These incidence timings were selected from Booth et al. (2004), who reported culling risk
associated with different hoof diseases by incidence timing. Two parity groups were
selected for inclusion: primiparous and multiparous. In some cases, no differences in
disease affect by severity level, incidence timing, or parity group was modeled because of
a lack of data rather than a belief that no difference existed.
Calculation of lameness expenditures and losses
The expenditures and losses associated with lameness were already reviewed in
Chapter 1. For this study, only losses and expenditures with enough data to estimate for
individual hoof diseases were incorporated, as determined by the authors. Modeled
expenditures included outside (hoof trimmer) labor, therapeutics, and on-farm labor.
Modeled losses included discarded milk, reduced milk production, extended days open, an
increased risk of culling, an increased risk of death (natural or euthanized), and disease
recurrence. All expenditure and loss categories were calculated individually for each
combination of disease type (digital dermatitis, sole ulcer, or white line disease), severity
level (mild or severe), incidence timing (0 to 60 DIM, 61 to 120 DIM, 121 to 240 DIM, or
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>240 DIM), and parity group (primiparous or multiparous) for a total of 48 case cost
estimates. The total cost per case was the sum of all individual loss and expenditure
categories. Separate modules within the model were used to calculate each cost category
and necessary precursors for those categories.
Market prices module. Current market prices (milk price, feed price, replacement
heifer price, slaughter price, heifer calf price, and bull calf price) were necessary to
accurately calculate many of the disease-related losses. Historical price variation and
future price baseline data were used to create stochastic predicted prices for 2017, identical
to the process described by Bewley et al. (2010) and Liang et al. (2017). To summarize,
the historical prices were used to create simulated error terms that could be added to the
expected 2017 price to account for variation in the prediction. Additionally, a correlation
matrix between historical values over the past 10 years was implemented to prevent
unrealistic price combinations (e.g., high corn price and low soybean price).
Annual historical United States prices for milk, alfalfa, corn, soybean, slaughter,
and replacement heifers from the previous 10 years (2007 to 2016) were collected from the
Understanding Dairy Markets website (Gould and Bozic, 2017). Heifer and bull calf prices
for 2007 to 2016 were collected from the USDA Agricultural Market Service website
(USDA, 2017a). The expected 2017 prices for milk, alfalfa, corn, soybean, and slaughter
price were collected from the Food and Agricultural Policy Research Institute’s 2017 U.S.
Baseline Briefing Book: Projections for Agricultural and Biofuel Markets (FAPRI, 2017).
Feed price was subsequently estimated from corn, soybean, and alfalfa prices using the
equation published by Bailey and Ishler (2007).
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Expected 2017 replacement heifer, heifer calf, and bull calf prices were calculated
using regression analysis between historical values for each variable and other historical
prices, similar to Bewley et al. (2010) and Liang et al. (2017). For our model, regressions
were calculated using the REG procedure in SAS (version 9.4, SAS Institute, Inc., Cary,
NC). Historical replacement heifer price records were found back to 1971 (Gould and
Bozic, 2017); therefore, data from 1971 to 2016 was included in the regression equation.
Historical calf price (bull and heifer) records were found back to 1991 (Robin L. CusatoWood,

USDA

Agricultural

Marketing

Service,

Moses

Lake,

WA,

personal

communications and USDA (2017a)); therefore, data from 1991 to 2016 was included in
those regression equations. All historical prices for slaughter, feed (calculated using alfalfa
price, corn price, and soybean price), and milk that were included in each regression
equation

were

collected

from

the

Understanding

Dairy

Markets

website

(http://future.aae.wisc.edu/; Gould and Bozic, 2017).
Regression equations were built by offering each model the following variables:
slaughter price, feed price, milk price, lag of slaughter price, lag of feed price, lag of milk
price, and year where lag indicates the previous year’s price for the specific variable. The
regression equation for replacement heifer price was also offered the lag of heifer calf price
and the lag of bull calf price. The regression equation for heifer calf price was also offered
the lag of replacement heifer price and the lag of bull calf price. The regression equation
for bull calf price was also offered the lag of replacement heifer price and the lag of heifer
calf price. Year was forced into all models to account for time. Other covariates were
removed when non-significant (P ≥ 0.05) via backward step-wise elimination. The final
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equations generated adjusted R2 values of 0.97, 0.78, and 0.85 for replacement heifer price,
heifer calf price, and bull calf price, respectively:

Replacement heifer price ($) = -23,161 (± 4,644.29) – 47.56 (± 11.79) × feed price ($/cwt)
+ 48.79 (± 6.87) × milk price ($/cwt) + 482.68 (± 95.55) × slaughter price lag ($/lb) – 53.13
(± 14.23) × feed price lag ($/cwt) + 37.52 (± 7.38) × milk price lag ($/cwt) + 0.78 (± 0.10)
× heifer calf price lag ($) + 11.72 (± 2.37) × year

Heifer calf price ($) = 6,447.10 (± 8,551.59) + 33.88 (± 8.67) × milk price ($/cwt) – 59.99
(± 9.35) × feed price lag ($/cwt) + 0.47 (± 0.10) × replacement price lag ($) – 3.51 (± 4.38)
× year

Bull calf price ($) = 2,645.27 (± 1,213.77) + 442.60 (± 41.86) × slaughter price ($/lb) –
15.31 (± 4.02) × feed price ($/cwt) – 12.60 (± 5.03) × feed price lag ($/cwt) + 8.50 (± 2.72)
× milk price lag ($/cwt) – 1.35 (± 0.62) × year

Retention pay-off module. The stochastic market prices and the daily simulated
cow data (i.e., milk yield, body weight, dry matter intake, and pregnancy status) were
combined to calculate the retention pay-off (RPO) value for every day over the lifetime of
the average cow. Retention pay-off compares the value of the current cow with her
potential replacement, considering both cows’ expected future profits based on daily
revenues (milk sales, calf value, and slaughter value) and costs (feed costs, veterinary costs,
breeding costs, and disposal losses). The RPO value represents a cow’s worth beyond her
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slaughter value and can be used to estimate losses resulting from early or non-optimal
culling and death (Groenendaal et al., 2004). For additional details regarding how RPO is
calculated, see Groenendaal et al. (2004). In this model, the RPO value was used in the
calculation of losses associated with extended days open and an increased risk of culling.
Treatment module. The treatment module calculated expenditures associated with
outside labor, on-farm labor, and therapeutics, and the losses associated with discarded
milk. Expenditures on outside labor and therapeutics were disease-specific, expenditures
on on-farm labor were disease and severity specific, and losses associated with discarded
milk were disease, severity, incidence timing, and parity group specific. Estimates used in
the model for outside labor and therapeutics were taken from a survey of hoof trimmers
and veterinarians (Chapter 2; Table A5). The responses from hoof trimmers (n = 90 for
digital dermatitis; n = 88 for sole ulcer and white line disease) to questions about the
amount charged to a producer for labor and supplies per case by disease type were used to
create stochastic distributions for disease-specific outside labor and therapeutic costs per
case. This dataset was evaluated using the “distribution fitting” feature in @Risk and the
best distribution was identified using the AIC value. An extreme values distribution,
related to the Weibull distribution, was chosen to represent therapeutic costs associated
with sole ulcer treatment. All other distributions for both outside labor and therapeutics
were log logistic distributions. Log-logistic distributions are similar in shape to log-normal
distributions, but have thicker tails. All distributions were truncated at a minimum of 0,
meaning if a value less than 0 was drawn from the distribution, the distribution was
resampled assuming there would never be decreased costs associated with outside labor or
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therapeutics resulting from a hoof disease case. Outside labor and therapeutic expenditures
were assumed to be identical regardless of severity, incidence timing, and parity group.
Charfeddine and Pérez-Cabal (2017) reported the mean cost of on-farm labor per
mild and severe case of digital dermatitis, sole ulcer, and white line disease. These means
and corresponding standard deviations, calculated as a 10% coefficient of variation from
the mean, were used in normal distributions to create stochastic disease and severity
specific on-farm labor cost estimates (Table A5). All values drawn from these distributions
were truncated at a minimum of 0, meaning if a value less than 0 was drawn from the
distribution, the distribution was resampled assuming there would never be decreased costs
associated with on-farm labor resulting from a hoof disease case. The cost associated with
on-farm labor was assumed identical regardless of incidence timing and parity group.
Data from the survey conducted in Chapter 2 were also used to define discarded
milk per case, as required after treatment with antibiotics. It was assumed that only digital
dermatitis would result in discarded milk because antibiotic use was reported as rare for
both sole ulcers and white line disease cases. Survey respondents were asked to indicate
the number of days required for milk discard (on-average) for a case of digital dermatitis
(n = 22 responses). The digital dermatitis days to discard milk data was fit to a single
stochastic distribution using the “distribution fitting” feature in @Risk (Table A5). That
stochastic distribution was chosen to represent severe digital dermatitis cases; an
assumption was made that mild digital dermatitis cases would not require antibiotic
treatment and, therefore, would require no milk discard. The fitted distribution for days to
discard milk following a severe case of digital dermatitis was an exponential distribution.
To account for differences in milk production, discarded milk losses associated with digital
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dermatitis were made both parity group and incidence timing specific.

This was

accomplished by multiplying the stochastic number of days of milk discard by the average
milk production per day for a cow with digital dermatitis in the appropriate parity group
(primiparous or multiparous) and time period (0 to 60 DIM, 61 to 120 DIM, 121 to 240
DIM, and >240 DIM). Lastly, the resulting pounds of milk lost per case was multiplied by
the stochastic milk price to calculate the value of discarded milk associated with each
lameness event. In this study, we assumed discarded milk was not fed to calves. If
discarded milk were fed to calves, losses associated with discarded milk would be reduced,
therefore reducing the cost of a severe case of digital dermatitis.
Milk loss module. The milk loss module calculated the losses associated with the
reduced production potential of cows experiencing hoof diseases. Milk losses were
disease, severity, incidence timing, and parity group specific. Charfeddine and PérezCabal (2017) reported the mean and SE ECM loss (kg/d) associated with a case of mild
and severe digital dermatitis, sole ulcer, and white line disease for 4 weeks before and after
disease occurrence for primiparous and multiparous cows separately. Those reported
values were chosen for use in our model because other studies have not considered severity
when calculating milk loss associated with specific hoof diseases. However, that study did
not account for culling bias (i.e., culled cows were not included in all milk loss calculations)
or the increased likelihood that a higher producing cow would get a hoof disease; therefore,
the estimates for reduced milk production are likely biased low. As a result, we may have
underestimated the losses associated with reduced milk production in our disease cost
estimates and, therefore, underestimated the cost per case of each hoof disease.
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The mean and SE ECM loss (kg/d) for each disease, severity, and parity
combination from Charfeddine and Pérez-Cabal (2017) was used to calculate the expected
2.5th and 97.5th percentiles which were used in program evaluation and review technique
(PERT) distributions to create stochastic estimates for milk loss associated with each hoof
disease combination for each of the 4 weeks before and after occurrence (Table A6). The
PERT distribution is a type of β distribution adjusted for skewness by defining the
minimum, mean, and maximum values or, alternatively, the 5th and 95th percentile can be
defined (Bewley et al., 2010). If the distribution parameters were positive, they were
adjusted to zero, assuming this was because higher producing cows are more susceptible
to disease rather than the disease actually increases milk production (Bewley et al., 2010).
For all disease cases, an assumption was made that all weeks post-disease incidence ≥ 4
were identical. This meant that milk production potential was reduced for the remainder
of the lactation after lameness incidence, making losses associated with reduced milk
production incidence timing specific. Altogether, the total milk loss per case of hoof
disease was the sum of milk loss for every week from 4 weeks before disease occurrence
until the end of the lactation.
Milk loss per case for each incidence timing (0 to 60 DIM, 61 to 120 DIM, 121 to
240 DIM, and >240 DIM) was calculated by summing the milk loss associated with a case
occurring every day within that incidence timing and taking the average of all of those
cases. Milk loss per case was multiplied by the 2017 stochastic milk price to calculate
reduced milk revenues. The feed costs associated with producing that milk were subtracted
from the total reduced milk revenue losses to account for the fact that the cow responds to
reduced milk production by eating less. Reduced feed costs were calculated by multiplying
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the estimated reduction in dry matter intake (calculated as the average cow’s daily intake
over the lactation divided by the average cow’s daily production over the lactation) by the
stochastic feed price.
Days open module. The days open module calculated the losses associated with
extended days open resulting from cows experiencing hoof diseases. Extended days open
losses were disease, severity, incidence timing, and parity-specific. Charfeddine and
Pérez-Cabal (2017) reported the mean and SE increase in days open associated with mild
and severe digital dermatitis, sole ulcer, and white line disease for primiparous and
multiparous cows combined. Similar to the milk loss module parameters, these reported
values were chosen for use in our model because other studies have not considered severity
when calculating days open losses associated with specific hoof diseases. However,
culling bias also affected these estimates because Charfeddine and Pérez-Cabal (2017) only
considered those cows that became pregnant within their analysis (i.e., the impact of cows
who did not become pregnant was not included). As a result, we may have underestimated
the losses associated with extended days open in our disease cost estimates and, therefore,
further underestimated the cost per case of each hoof disease.
The mean and SE increase in days open for each disease and severity combination
from Charfeddine and Pérez-Cabal (2017) was used to calculate the expected 2.5th and
97.5th percentiles which were used in PERT distributions to create stochastic estimates for
the number of extended days open associated with each hoof disease and severity
combination (Table A7). For each distribution, if the mean or 2.5th percentile were negative
(indicating a decrease in days open) they were adjusted to zero, assuming no positive effect
of disease on days open.

70

The losses associated with extended days open were calculated separately for
parities 1, 2, and 3 using RPO values. For each parity, the RPO of an average cow in the
herd on the first day of that parity was compared to the RPO of a diseased cow on the first
day of that parity. The only difference between the two cows was the difference in days
open during that parity, so the difference in RPO represented the total loss in the cow’s
value associated with extended days open for that case. For example, if the RPO of the
average cow without any disease on day 1 of lactation 1 was $825 and the RPO of the
average cow with a severe sole ulcer (+ 17 days open) on day 1 of lactation 1 was $800,
then the total losses associated with extended days open for a parity 1 cow experiencing a
severe sole ulcer were $25. This method has previously been described by Dolecheck et
al. (2016) and was applied in the model by Liang et al. (2017).
The multiparous parity group extended days open cost per case was a weighted
average of the calculated cost of extended days open per case for parity 2 cows and parity
3 cows, based on the assumed distribution of cows among parities (Table 3.1). To calculate
costs by incidence timing, an assumption was made that disease cases occurring before the
average cow became pregnant resulted in all losses associated with extended days open
and disease cases occurring after the average cow became pregnant resulted in no losses
associated with extended days open. For incidence timings that contained the average
cow’s DIM at conception, a portion of the losses associated with extended days open were
included to account for some cases occurring before the average cow becomes pregnant
and some cases occurring after the average cow becomes pregnant. For example, if the
average cow’s days open is 150 d and the days open losses per case are $20, then the losses
per case associated with days open for the incidence timing 121 to 240 DIM would be $5
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($20 x (150-121)/(240-121)). The DIM at conception for the average cow was calculated
using the equation by Pecsok et al. (1994) with the voluntary waiting period and days in
milk do not breed set deterministically at 60 and 250 DIM, respectively, and pregnancy
rate calculated using stochastic distributions for estrus detection rate and conception rate
defined by data from DairyMetrics (Dairy Records Management Systems, Raleigh, NC;
Table 3.1 and Table 3.2).
Culling and death module. The culling and death module calculated the losses
associated with an increased risk of culling and death resulting from hoof diseases. The
losses associated with an increased risk of culling and death were disease, severity,
incidence timing, and parity group specific. Mean, 5th percentiles, and 95th percentiles
culling hazard ratios associated with digital dermatitis and sole ulcers were reported by
Booth et al. (2004), specifically considering how the incidence of disease in one period (0
to 60 DIM, 61 to 150 DIM, 151 to 240 DIM, or > 240 DIM) influenced culling in both that
time period and future time periods.

These values were used to create stochastic

distributions for disease-specific culling risk ratios, assuming white line disease culling
risk ratios were identical to sole ulcers (Table A8). The assumption about similarities
between sole ulcer and white line disease were made because they are both non-infectious
hoof diseases and Charfeddine and Pérez-Cabal (2017) reported similar effects of both
diseases on the length of productive life.
To account for severity, two different stochastic distributions were created for each
disease using PERT distributions. For the “mild” distributions, a mean 0.5 times that of
the mean reported by Booth et al. (2004) was used whereas for the “severe” distributions,
a mean 1.5 times that of the reported mean was used. The same 5th and 95th percentiles
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were used in both mild and severe distributions for each disease. This method allowed for
the same minimum and maximum values, regardless of severity, but skewed the
distributions to the lower or upper ends for mild and severe cases, respectively. All
distributions were truncated at a minimum of 1.0, meaning if a value less than 1.0 was
drawn from the distribution (indicating a decreased risk of culling) the distribution was
resampled, assuming no positive effect of disease on culling. The culling risk ratios were
used to calculate the number of extra culls resulting from each hoof disease case, as
previously described by Bewley et al. (2010). To calculate losses associated with the extra
culls, the RPO value of the average cow for each combination of parity and incidence
timing was multiplied by the number of extra culls per case in that parity and incidence
timing. Culling losses per case were calculated separately for parities 1, 2, 3, 4, 5, and 6.
The weighted average of parities ≥ 2, based on the distribution of cows among parities
(Table 3.1), was used to represent culling losses associated with the multiparous parity
group.
An assumption was made in this model that only severe lameness cases would have
the potential to result in death and that no cases of digital dermatitis would result in death.
Therefore, losses associated with an increased risk of death for all mild conditions and
severe digital dermatitis cases were $0. No previous research has estimated the percentage
of hoof disease cases resulting in death so for other severe conditions (sole ulcer and white
line disease) an assumption was made that 5% of cases occurring at any incidence timing
would result in death. Disease related death losses were calculated for each incidence
timing and parity (1, 2, 3, 4, 5, or 6). To summarize, the number of deaths per case for
each incidence timing and parity was multiplied by the mean slaughter value (calculated
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as the body weight of the cow multiplied by the stochastic slaughter price) for that specific
time period in that specific lactation. Death losses per case for multiparous cows were the
weighted average of each parity, based on the assumed distribution of cows among parities
(Table 3.1).
Disease recurrence module. The disease recurrence module calculated losses
linked to cases recurring in the same animal. Disease recurrence losses were disease,
severity, incidence timing, and parity group specific. Charfeddine and Pérez-Cabal (2017)
reported mean relapse rates (episodes per infected cow) for both primiparous and
multiparous cows experiencing either mild or severe digital dermatitis, sole ulcers, and
white line disease. Each of these assumptions was modeled stochastically using a PERT
distribution (Table A9) with minimum and maximum values assumed identical for all hoof
diseases using the general lameness relapse rate values reported by Ettema and Østergaard
in 2006 (min = 1.5, max = 4.0). The stochastic relapse rate minus 1 was the number of
repeat cases expected per original case. However, incidence timing and disease length
logically influence how many repeat cases per original case can occur within the same
lactation. Therefore, disease length estimates were incorporated into the model.
Bruijnis et al. (2010) reported mean, 5th percentile, and 95th percentile disease
length for subclinical and clinical digital dermatitis, sole ulcer, and white line disease. An
assumption was made that subclinical would represent mild cases and clinical would
represent severe cases. These values were used in PERT distributions to create stochastic
estimates for disease length for each hoof disease (Table A9). By multiplying the disease
length by the relapse rate, the length of time (d) required for all cases (original plus relapse
cases) to occur was calculated.
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To make losses associated with disease recurrence incidence timing specific, a
comparison was made between the length of time required for all cases (original and
relapse) to occur and the number of days remaining in the lactation. An assumption was
made that a new case occurring within each incidence timing occurred at the midpoint of
that period (e.g., for incidence timing 0 to 60 DIM, incidence occurred at 30 DIM). The
remaining days left in the lactation were calculated by subtracting the incidence timing
from the average cow’s length of lactation, as determined by the calving interval. For
example, if the average cow’s length of lactation was 375 days, then there would be 345 d
left in the lactation for the incidence timing 0 to 60 DIM (375 to 30). By comparing this
to the time required for all lameness cases (original and relapse) to occur, we could
calculate the number of actual recurrences that would happen within a lactation. Using this
method, more recurring cases were assumed for a case of lameness occurring in early
lactation than a case occurring in later lactation, simply because the days remaining in the
lactation would not permit the case to recur at the same rate. We assumed no adverse
effects of hoof diseases occurring in late lactation on the subsequent lactation because of
lacking published data on this relationship.
For recurring cases, treatment, labor, and discarded milk costs were assumed to
reoccur at 100% of the price of the first episode whereas no extra losses were associated
with reduced milk production, extended days open, an increased risk of culling, or an
increased risk of death.

This assumption is likely conservative but was necessary

considering the lack of data available to show how recurring cases influence a cow’s milk
yield, reproductive performance, risk of culling, and risk of death. As a result of this
assumption, we may have underestimated the losses associated with disease recurrence in
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our disease cost estimates and, therefore, underestimated the cost per case of each hoof
disease.
Model demonstration
To demonstrate model usefulness, 1,000 iterations of the model were run using Latin
Hypercube sampling. The mean ± SD cost per case of hoof disease across all disease type,
severity level, incidence timing, and parity group combination was reported. Default
deterministic variable assumptions used to define the herd and the average cow were
collected from Dairy Records Management Systems (Raleigh, NC) using limitations of
only Holstein herds with ≥ 200 cows, published literature, or the authors’ expertise (Table
3.1). The resulting distributions of herd-level stochastic variables can be found in Table
3.2. Inputs used in the model for this study were meant to represent a United States dairy
herd. However, model inputs could be adjusted to herd-specific values to calculate the cost
of hoof diseases for a specific herd.
Sensitivity analysis
As described for each module, many variables were stochastic within the model
including labor costs, therapeutic costs, days of discarded milk, expected milk loss,
extended days open, culling risk ratios, disease recurrence rates, and disease length.
However, only selected market prices and herd specific performance variables were
included in a sensitivity analysis to test how they affected the disease costs because these
variables are either more controllable by or more readily available to the producer. The
selected variables included: milk price, feed price, replacement heifer price, slaughter
price, rolling herd average milk production, and pregnancy rate (calculated as the
multiplication of estrus detection rate and conception rate). Using the @Risk sensitivity
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analysis function, a multivariate regression analysis was conducted between these
stochastic variables and the mean total cost per case of each hoof disease across all
combinations of severity level, incidence timing, and parity group. The results of this
analysis show how the cost per case of disease changes with a 1 standard deviation increase
in each stochastic factor.
Results and Discussion
The objective of this study was to build a stochastic simulation model capable of
estimating hoof disease costs per case depending on disease, severity level, incidence
timing, and parity group. This was accomplished by incorporating modules to account for
outside (hoof trimmer) labor, therapeutics, on-farm labor, discarded milk, reduced milk
production, extended days open, an increased risk of culling, an increased risk of death
(natural or euthanized), and disease recurrence into a pre-existing stochastic simulation
model. Model accuracy may be limited by the fact that few previous studies have
considered hoof disease expenditure and loss estimates specific to disease, severity level,
incidence timing, and parity group. In particular, estimates used in this study for reduced
milk production, extended days open, and disease recurrence may underestimate the total
effects of hoof diseases. Additionally, little data exists on the effects of hoof diseases
beyond the current lactation. Therefore, our hoof disease cost estimates only included
expenditures and losses within the same lactation as disease occurrence. The disease cost
estimates from our model demonstration should be interpreted carefully while keeping
these limitations in mind.
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Disease cost estimates
Digital dermatitis. The simulated mean ± SD cost per case of digital dermatitis by
severity, incidence timing, and parity group is presented in Table 3.3 and patterns among
results are presented in Figure 3.1a. Over all combinations, the mean ± SD cost per case
of digital dermatitis was $137 ± 36, ranging from a low of $30 ± 21 for a mild case in a
post-peak lactation (121 to 240 DIM), primiparous cow to a high of $399 ± 116 for a severe
case in an early lactation, multiparous cow. Previous estimates of the cost of digital
dermatitis have been similar to the mean found in this study ($133 and $149/case after
adjustment to 2017 USD; Willshire and Bell, 2009; Cha et al., 2010); although those
estimates did not differentiate by severity or parity and did not include the cost of recurring
cases within the same cow.
Charfeddine and Pérez-Cabal (2017) estimated a mild and severe case of digital
dermatitis to be $53 and $402 (adjusted to 2017 USD), respectively, including the cost of
recurrence. The mean ± SD mild or severe cost per case of digital dermatitis in our study,
regardless of parity group or incidence timing, was $59 ± 40 and $215 ± 117, respectively.
It is difficult to compare estimates from Charfeddine and Pérez-Cabal (2017) to the current
study because 1) our study breaks costs down by not only severity but also incidence timing
and parity group and 2) Charfeddine and Pérez-Cabal (2017) included recurrence costs
within the other cost categories whereas recurrence costs were a separate category within
our estimates. However, some major differences in calculations likely contributed to our
difference in severe case cost estimates. First, our study did not differentiate expenditures
on therapeutics or outside labor by severity level, whereas Charfeddine and Pérez-Cabal
(2017) did. Additionally, the estimates for therapeutics and outside labor assumed in this
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study (from Chapter 2) were lesser than those found by Charfeddine and Pérez-Cabal
(2017), likely because of differences in study location (United States vs. Spain) and the
increased likelihood of veterinary involvement in Spain as compared to the United States.
Second, discarded milk was assumed to be minimal in our study compared to Charfeddine
and Pérez-Cabal (2017) who reported that antibiotic use was standard for all severe lesions.
Third, our study assumed that the cost of a recurring case only included direct costs
(therapeutics, outside labor, on-farm labor, and discarded milk) because minimal evidence
exists to differentiate milk loss, extended days open, risk of culling, and risk of death
associated with the first vs. second case of a hoof disease. Comparatively, Charfeddine
and Pérez-Cabal (2017) assumed recurring cases to have the same cost as the first case.
As shown in Figure 3.1a, cases in primiparous cows were less expensive than
comparable cases (same severity level and incidence timing) in multiparous cows.
Compared to multiparous cows, primiparous cows experienced less milk production losses,
losses associated with extended days open, losses associated with an increased risk of
culling, and recurrence losses (Table 3.3). Within parity group, severe cases were more
expensive than mild cases, regardless of incidence timing. Mild cases were associated with
less on-farm labor, less milk production losses (from both discarded milk and reduced
yield), lower costs associated with extended days open, lower losses associated with an
increased risk of culling, and fewer recurrence costs. Across incidence timing, mean severe
case costs decreased over the lactation of the cow whereas mean mild case costs were
bimodal, peaking at the beginning and end of the lactation but with minimal variation
among incidence timings (Figure 3.1a). All variable cost categories decreased as DIM at
incidence increased except for culling losses. Losses associated with culling were bimodal,
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peaking in both early and late lactation. Our assumptions about the effects of hoof diseases
on culling were taken from Booth et al. (2004), who found that the 95% confidence interval
for the risk of culling when hoof diseases occurred in later lactation was wider than the
95% confidence interval for the risk of culling when hoof diseases occurred in earlier
lactation. This resulted in our model estimating an increased risk of culling for cases
occurring in later lactation, which may be overestimated. More research is needed to
accurately estimate the effects of hoof disease timing on culling.
For mild digital dermatitis cases, losses associated with an increased risk of culling
represented the greatest contribution to the total cost per case (mean = 55% of the total
cost) in both parities and at all incidence timings except for multiparous cows in the postpeak period (121 to 240 DIM). During that period, losses associated with decreased milk
production represented the largest portion of the total cost (mean = 39% of the total cost).
For severe digital dermatitis cases, regardless of parity group, losses associated with
decreased milk production represented the greatest contribution to the total cost per case at
all incidence timings except late lactation (mean = 43% of the total cost). During late
lactation, losses associated with an increased risk of culling contributed the most to the
total cost per case (mean = 38% of the total cost). The remaining contributions of each
cost category varied by severity, parity group, and incidence timing (Table 3.3).
Charfeddine and Pérez-Cabal (2017) found that expenditures on outside labor and losses
associated with reduced milk production contributed the most to the cost per affected cow
in mild digital dermatitis cases (43% and 34%, respectively) and losses associated with an
increased risk of death and culling and discarded milk contributed the most to the cost per
affected cow in severe digital dermatitis cases (37% and 24%, respectively). As previously
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mentioned, recurrence losses were not considered as their own category by Charfeddine
and Pérez-Cabal (2017), making direct comparisons difficult.
It is worth noting that none of the current cost estimates for digital dermatitis,
including those in this study, have included the cost of transmission. Digital dermatitis is
a contagious disease and ignoring the costs of additional cases of digital dermatitis resulting
from one original case ignores the full economic losses of the disease. Döpfer et al. (2012)
estimated the reproductive ratio of digital dermatitis to be between 0.5 and 3.3, depending
on the prevention strategy used. Therefore, this cost category could make up a large portion
of the cost per case of digital dermatitis, depending on herd level prevention strategies in
place. Modeling of contagious diseases is complex, which is why this cost category is
typically not included in digital dermatitis case cost estimates.
Sole ulcer. The simulated mean ± SD cost per case of a sole ulcer by severity,
incidence timing, and parity group is presented in Table 3.4 and patterns among results are
presented in Figure 3.1b. Over all combinations, the mean cost per case of sole ulcers was
$227 ± 35, ranging from a low of $111 ± 41 for a mild case in a late lactation, primiparous
cow to a high of $486 ± 87 for a severe case in an early lactation, multiparous cow. Our
reported mean was similar to the sole ulcer cost estimate of $243 (adjusted to 2017 USD)
by Cha et al. (2010). The mean ± SD mild or severe cost per case of sole ulcer in our study,
regardless of parity group or incidence timing, was $170 ± 65 and $283 ± 109, respectively.
Charfeddine and Pérez-Cabal (2017) estimated the cost per case of a mild and severe sole
ulcer to be $232 and $622, respectively (adjusted to 2017 USD). The lower cost estimates
found in our study, especially for severe cases, may be for similar reasons as the differences
found for digital dermatitis.
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Unlike digital dermatitis, parity group appeared to minimally affect the cost per
case of mild sole ulcer (Figure 3.1b). In fact, mild cases occurring at any incidence timing
except early lactation were within $15 of each other (Table 3.4). Parity group did affect
the cost per case of severe sole ulcers with severe sole ulcers in multiparous cows resulting
in greater losses associated with decreased milk production throughout lactation and
greater losses associated with increased culling or death in early lactation. Within parity
group, severe cases were always more expensive than mild cases occurring at the same
incidence timing. Mild cases were associated with less on-farm labor and fewer losses
associated with extended days open, disease recurrence, and an increased risk of culling or
death. Milk production losses were greater in severe cases compared to mild cases for
multiparous cows, but in primiparous cows, mild cases resulted in greater (though
numerically similar) decreased milk production losses than severe cases. This was because
milk production losses for week 4 post-diagnosis were estimated by Charfeddine and
Pérez-Cabal (2017) to be greater in mild cases than severe cases, and week 4 post-diagnosis
losses were assumed to continue until the end of lactation. Unfortunately, no alternative
literature sources were identified that considered milk loss associated with hoof diseases
while also considering severity of the disease and parity group of the affected animal.
However, it is possible that a mild case of lameness might go undetected (and untreated)
longer than a severe case of lameness, potentially increasing losses associated with reduced
milk production.
Across incidence timing, both mild and severe case costs decreased over the
lactation of the cow (Figure 3.1b). The decrease in mild case costs for sole ulcers over the
lactation of the cow was more apparent than the decrease in mild case costs for digital
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dermatitis over the lactation of the cow. Compared to digital dermatitis, sole ulcers were
associated with more extreme effects on reduced milk yield, extended days open, and an
increased risk of culling or death, which were all influenced by stage of lactation. Similar
to digital dermatitis, all variable cost categories decreased further in lactation except for
those associated with an increased risk of culling or death. The peak in losses associated
with an increased risk of death differed by parity group, but was bimodal in both cases with
losses being highest at the beginning and end of lactation. This resulted from the slaughter
value of the cow being highest at the beginning and end of lactation, following body weight
patterns.
Across all sole ulcer cases, regardless of severity, the losses associated with reduced
milk production, an increased risk of culling, and disease recurrence made up most of the
total cost per case (mean = 24%, 24%, and 23% of the total cost, respectively). In severe
sole ulcer cases, losses associated with an increased risk of death were also a top contributor
to the total cost per case (mean = 18% of the total cost). The remaining contributions of
each cost category varied by parity group (Table 3.4). Similarly, Kossaibati and Esslemont
(1997) and Esslemont (2005) estimated that the combined costs of culling and death
contributed most to the total cost of sole ulcers (33% to 36%). However, they estimated
reduced reproductive performance to contribute the second most to total sole ulcer costs
(30% to 32%). Losses associated with extended days open in this study were based on the
assumption that mild and severe sole ulcers resulted in 2.1 ± 1.1 and 17.4 ± 6.0 extended
days open, respectively, whereas both Kossaibati and Esslemont (1997) and Esslemont
(2005) assumed sole ulcers resulted in 40 extended days open, which partially explains our
difference in findings. Additionally, our method of calculating the cost per day open tends
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to be more conservative than other estimates (Dolecheck et al., 2016). Charfeddine and
Pérez-Cabal (2017) estimated that the losses associated with an increased risk of culling
contributed most (40% and 23% for mild and severe cases, respectively) to the total cost
of a sole ulcer, followed by discarded milk (20% in severe cases) and reduced milk yield
(18% and 16% for mild and severe cases, respectively).
White line disease. The simulated mean ± SD cost per case of white line disease
by severity, incidence timing, and parity group is presented in Table 3.5 and patterns among
results are presented in Figure 3.1c. Over all combinations, the mean cost per case of white
line disease was $203 ± 33, ranging from a low of $97 ± 39 for a mild case in a late
lactation, primiparous cow to a high of $471 ± 90 for a severe case in an early lactation,
multiparous cow. Willshire and Bell (2009) estimated costs associated with white line
disease to be greater ($555/case after adjustment to 2017 USD), but assumed 30 extended
days open resulting from the disease, whereas our assumed mean extended days open for
a mild and severe case of white line disease was 3.3 ± 1.5 d and 10.3 ± 5.0 d, respectively.
The mean ± SD mild or severe cost per case of white line disease in our study, regardless
of parity group or incidence timing, was $135 ± 55 and $271 ± 106, respectively. These
estimates are less than those of Charfeddine and Pérez-Cabal (2017), who found a mild
case of white line disease to cost $221 and a severe case to cost $590 assuming greater
therapeutic and supply costs, as well as the possibility of discarded milk losses, which were
not included in our study.
Similar to sole ulcers, parity group appeared to minimally affect the cost per case
of mild white line disease while having greater effects on severe white line disease. In
severe cases, multiparous cows had increased losses associated with reduced milk
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production throughout lactation and increased losses associated with an increased risk of
culling or death in early lactation. Within parity group, severe cases were always more
expensive than mild cases. Losses associated with decreased milk production were greater
in severe cases compared to mild cases regardless of parity group, but within mild cases
were greater for primiparous cows than multiparous cows for similar reasons as for our
sole ulcers estimates. Across incidence timing, both mild and severe case costs generally
decreased over the lactation of the cow (Figure 3.1c).
For mild cases of white line disease, regardless of parity group, the cost categories
that contributed the most to the total cost per case were losses associated with an increased
risk of culling (mean = 33% of the total cost) and disease recurrence (mean = 23% of the
total cost). For severe cases of white line disease, losses attributed to disease recurrence
and an increased risk of culling contributed most to the cost per case in primiparous cows
(mean = 22% and 21% of the total cost, respectively) whereas losses attributed to decreased
milk production and an increased risk of culling contributed most to the cost per case in
multiparous cows (mean = 27% and 22% of the total cost, respectively). Losses associated
with an increased risk of death were also a large contributor to the total cost per case of
severe white line disease (mean = 18% of the total cost). The remaining contributions of
each cost category varied by parity group (Table 3.5). Only Charfeddine and Pérez-Cabal
(2017) have previously broken down cost categories for white line disease, with very
similar estimates to sole ulcers (30% to 39% increased risk of culling or death, 13% to 17%
reduced milk production, and 20% discarded milk in severe cases).
Sensitivity Analysis. The change in the mean (across all severity level, incidence
timing, and parity group combinations) total cost per case of each disease as selected
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market prices and herd specific performance variables increased by 1 standard deviation is
displayed in Figure 3.2. Across all diseases, the cost per case of hoof disease increased in
response to a 1 standard deviation increase in milk price, rolling herd average milk
production, or replacement heifer price. As either milk price or rolling herd average milk
production increased the cost per case increased because there was more potential income
from milk production being lost through both discarded milk and reduced milk yield. Milk
price and the rolling herd average milk production level influenced the cost per case more
in higher milk production potential situations: multiparous cows, severe cases, and earlier
incidence timing (because milk loss would continue throughout lactation). As replacement
price increased, the cost to replace an animal that was culled or died increased, thereby
increasing the cost of disease. The change in the cost per case in response to changing
replacement price was greatest in severe cases when culling or death was more likely.
Across all diseases, the cost per case of hoof disease decreased in response to a 1
standard deviation increase in feed price, pregnancy rate, or slaughter price. In response
to disease and the resulting lower milk production, cows were assumed to eat less.
Therefore, a cow with a disease would have lower feed costs and the cost of disease would
be lowered when feed costs are high. As with milk price, the feed price influenced the cost
per case more in higher milk production potential situations. As pregnancy rate increased,
the adverse effects of disease on reproduction became less detrimental, therefore lowering
the cost of disease. In other words, if a herd was already getting cows pregnant quickly,
adding a few more days open would be less detrimental than in a herd that was already
struggling to get cows pregnant. Finally, as slaughter price increased, the cost of culling a
cow decreased, therefore lowering the cost of disease.

86

The two most important of the selected market prices and herd specific performance
variables appeared to be the milk price and replacement price. Changing milk price
resulted in the largest change in the mean cost of either digital dermatitis or sole ulcer
($15.3 and $17.1 increase, respectively) whereas changing replacement price resulted in
the largest change in the mean cost of white line disease ($13.5 increase). The reason these
two market prices had the greatest influence on the cost of hoof diseases is likely linked to
their heavy involvement in calculating losses associated with reduced milk production, an
increased risk of culling, and an increased risk of death; these 3 cost categories were among
the largest contributors in all cost per case estimates.
Hoof disease cost estimates summary. Across all 3 hoof diseases considered in this
study, severity had the largest effect on the total cost per case. The percent increase from
mild to severe cases within the same incidence timing and parity group ranged from 45%
to 364%. Understanding the differences between the cost of a mild and severe hoof disease
highlights the need for early intervention when a cow becomes lame. For digital dermatitis,
parity group had a greater effect on the total cost per case than incidence timing. For sole
ulcers and white line disease, both incidence timing and parity group affected the total cost
per case of disease. Understanding the cost per case of disease for different categories of
animals (e.g., parity group, DIM) can help guide treatment and culling decisions at the
individual animal level. Understanding how incidence timing influences the cost of a
disease can additionally help focus prevention strategies on certain groups of animals
within a herd (i.e., early vs. late lactation) if prevention is not implemented across the whole
herd. Based on results using the assumptions in this study, implementing hoof disease
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prevention strategies would be most beneficial in early lactation. Additionally, this might
indicate that prevention in the dry and close-up periods would also be beneficial.
The results from the sensitivity analysis highlight the importance of considering the
cost of hoof diseases at the herd level as changes in market prices and herd performance
can change the cost of disease. In the future, models like this one could aid in the
construction of decision support tools to improve herd and cow level decisions regarding
lameness treatment and prevention.
Conclusions
The ability to estimate the cost per case of 3 hoof diseases (digital dermatitis, sole
ulcer, and white line disease) was incorporated into a pre-existing stochastic simulation
model. Through this process, missing data in the literature was identified, indicating
potential areas for future research. In particular, expenditures and losses specific to
individual hoof diseases, severity of disease, timing of disease, and parity group affected
by the disease should be considered.
Using assumptions meant to represent a United States dairy herd, disease cost estimates
calculated using the model varied by not only disease type, but also severity, incidence
timing, and parity group. These differences indicate that the cost per case of hoof disease
differs by cow. This knowledge could help guide on-farm decisions about hoof disease
treatment, culling strategies, and investment in lameness prevention. Hoof disease costs
were also influenced by market prices and herd specific performance variables, indicating
that hoof disease costs should be considered at the individual herd level.
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Table 3.1 Deterministic farm performance and financial inputs used in a stochastic model
to estimate the cost of 3 different dairy cow hoof diseases
Input
Value
Source1
Age at first calving (m)
24.3
DairyMetrics
Baseline culling rate (%)
13.0
Bewley et al. (2010)
Breeding costs ($/insemination)
15.512
VanRaden and Cole (2014)
Butterfat yield (%)
3.7
DairyMetrics
Calf birth weight (kg)
41.7
Kertz et al. (1997)
Close up dry cow feed price ($/kg DM)
0.22
Authors’ expertise
Close up dry period length (d)
21
Authors’ expertise
Days dry
56.2
NAHMS (2014)
Days in milk designated do not breed
250
Bewley et al. (2010)
Discount rate (%)
Disposal losses ($)
Far off dry cow feed price ($/kg DM)
Gestation length (d)
Mature cow live weight (kg)
Percent heifer calves
Percent of herd in 1st parity
Percent of herd in 2nd parity
Percent of herd in 3rd parity
Percent of herd in 4th parity
Percent of herd in 5th parity
Percent of herd in 6th (or greater) parity
Protein yield (%)
Voluntary waiting period (d)

8.0
652
0.15
280
723
46.7
36.1
26.0
17.7
11.0
5.8
3.4
3.1
59.3

1

Hyde and Engel (2002)
Groenendaal et al. (2004)
Authors’ expertise
Norman et al. (2007)
NRC (2001)
Del Río et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
DairyMetrics
DairyMetrics

DairyMetrics information was collected on October 1, 2017 from Dairy Records
Management Systems (Raleigh, NC). Values gathered from DairyMetrics included 1,987
United States Holstein herds with at least 200 cows.
2
Adjusted for inflation to 2017 prices
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Table 3.2 Simulated market price and farm performance inputs used in a stochastic model
to estimate the cost of 3 different dairy cow hoof diseases
Input
Calf value ($/bull)
Calf value ($/heifer)
Slaughter value ($/kg)
Milk price ($/kg)
Lactating feed price ($/kg DM)
Replacement heifer price ($)
RHA milk production (kg)
Pregnancy rate (%)

Simulated range
(min – max)
72.35 – 224.25
234.00 – 674.92
1.03 – 1.78
0.29 – 0.50
0.21 – 0.38
1,437 – 2,122
4,899 – 18,113
2.8 – 74.7

1

Simulated
mean ± SD
130.74 ± 41.27
395.16 ± 143.51
1.43 ± 0.20
0.40 ± 0.06
0.29 ± 0.04
1,718 ± 216
11,459 ± 2,002
22.5 ± 11.4

Source1
Regression model
Regression model
FAPRI (2017)
FAPRI (2017)
FAPRI (2017)
Regression model
DairyMetrics
DairyMetrics

DairyMetrics information was collected on October 1, 2017 from Dairy Records
Management Systems (Raleigh, NC). Values gathered from DairyMetrics included 1,987
United States Holstein herds with at least 200 cows.
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Table 3.3 Mean ± SD expenditures, losses, and total cost per case of digital dermatitis by severity, incidence timing, and parity group
as estimated using a stochastic simulation model (n = 1,000 iterations). Bolded values indicate the cost category contributing most to
the total cost per case for each combination of severity, incidence timing, and parity group.
Therapeutics
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Primiparous (mild)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Primiparous
(severe)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Multiparous (mild)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Multiparous
(severe)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
1

Expenditures
($/case)
Outside
labor

On-farm labor

Discarded
milk

Decreased milk
production

Losses1
($/case)
Extended days
open

Recurrence

Culling

Total
($/case)

1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41

4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99

1.73 ± 0.43
1.73 ± 0.43
1.73 ± 0.43
1.73 ± 0.43

NA
NA
NA
NA

0.59 ± 0.35
0.59 ± 0.35
0.59 ± 0.35
0.55 ± 0.33

0.67 ± 0.70
0.61 ± 0.62
0.12 ± 0.18
0.00 ± 0.00

10.41 ± 13.77
9.88 ± 12.93
7.54 ± 9.05
2.58 ± 3.11

27.10 ± 18.33
26.84 ± 23.47
12.71 ± 11.23
31.77 ± 27.21

47.39 ± 28.42
46.55 ± 31.71
29.57 ± 21.23
43.52 ± 29.61

1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41

4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99

20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20

14.99 ± 16.57
14.78 ± 16.33
12.46 ± 13.75
9.02 ± 10.02

81.34 ± 50.81
67.53 ± 40.36
45.95 ± 24.96
17.43 ± 7.19

11.31 ± 9.66
10.56 ± 9.18
2.17 ± 3.38
0.00 ± 0.00

53.15 ± 35.66
50.30 ± 32.31
36.70 ± 21.90
11.54 ± 6.82

28.95 ± 18.93
27.07 ± 20.81
12.14 ± 10.04
41.48 ± 25.94

217.45 ± 76.73
197.95 ± 67.36
137.11 ± 47.65
107.17 ± 33.38

1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41

4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99

1.73 ± 0.43
1.73 ± 0.43
1.73 ± 0.43
1.73 ± 0.43

NA
NA
NA
NA

31.47 ± 14.58
27.56 ± 12.02
20.13 ± 8.07
10.15 ± 3.26

0.97 ± 0.70
0.91 ± 0.66
0.20 ± 0.28
0.00 ± 0.00

11.81 ± 14.20
10.97 ± 12.86
8.07 ± 9.01
2.75 ± 3.12

66.36 ± 33.51
27.91 ± 17.97
13.97 ± 11.41
39.92 ± 28.35

119.23 ± 44.11
75.96 ± 31.94
50.98 ± 23.40
61.42 ± 31.30

1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41
1.98 ± 2.41

4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99
4.91 ± 8.99

20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20

19.60 ± 21.31
17.98 ± 19.54
12.10 ± 13.10
5.80 ± 6.32

194.33 ± 76.00
162.85 ± 62.21
110.66 ± 41.56
41.57 ± 14.81

15.00 ± 12.22
14.07 ± 11.63
3.06 ± 4.67
0.00 ± 0.00

74.72 ± 47.56
65.83 ± 40.55
41.50 ± 23.32
11.83 ± 6.42

67.96 ± 31.66
28.58 ± 14.97
13.42 ± 9.42
51.99 ± 26.00

399.30 ± 115.94
316.99 ± 94.36
208.43 ± 62.76
138.88 ± 36.66

NA indicates a cost category that was assumed not applicable to the total cost for that specific severity, incidence timing, and parity
group combination

Table 3.4 Mean ± SD expenditures, losses, and total cost per case of sole ulcer by severity, incidence timing, and parity group as
estimated using a stochastic simulation model (n = 1,000 iterations). Bolded values indicate the cost category contributing most to the
total cost per case for each combination of severity, incidence timing, and parity group.
On-farm
labor

Decreased milk
production

Extended days
open

Recurrence

Culling

8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69

12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16

13.88 ± 3.48
13.88 ± 3.48
13.88 ± 3.48
13.88 ± 3.48

75.30 ± 30.68
62.96 ± 25.18
42.72 ± 16.94
15.82 ± 5.97

1.98 ± 1.33
1.84 ± 1.27
0.38 ± 0.53
0.00 ± 0.00

51.03 ± 21.18
50.35 ± 20.43
43.74 ± 17.50
16.58 ± 7.65

45.47 ± 33.00
40.23 ± 30.59
18.02 ± 15.35
44.20 ± 37.30

NA
NA
NA
NA

207.68 ± 50.60
189.29 ± 46.76
138.77 ± 33.80
110.51 ± 40.57

8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69

12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16

20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20

55.92 ± 35.06
49.42 ± 28.42
36.42 ± 18.35
18.85 ± 6.81

21.59 ± 11.03
20.07 ± 10.55
3.99 ± 4.70
0.00 ± 0.00

80.91 ± 25.67
77.90 ± 24.58
62.95 ± 22.07
22.32 ± 9.26

62.16 ± 38.73
58.18 ± 34.68
21.87 ± 16.76
53.17 ± 35.76

39.25 ± 5.68
40.12 ± 5.80
41.70 ± 6.04
46.63 ± 6.84

300.66 ± 60.58
286.53 ± 53.97
207.76 ± 39.63
181.81 ± 39.76

8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69

12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16

13.88 ± 3.48
13.88 ± 3.48
13.88 ± 3.48
13.88 ± 3.48

70.72 ± 22.99
61.12 ± 19.64
43.43 ± 14.08
19.89 ± 6.20

2.77 ± 1.69
2.60 ± 1.66
0.57 ± 0.80
0.00 ± 0.00

52.67 ± 21.14
51.69 ± 20.09
44.24 ± 16.53
16.72 ± 7.37

99.59 ± 52.71
43.33 ± 25.41
19.19 ± 14.99
53.25 ± 36.20

NA
NA
NA
NA

259.65 ± 66.11
192.64 ± 43.50
141.34 ± 32.34
123.76 ± 40.08

8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69
8.01 ± 4.69

12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16
12.01 ± 6.16

20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20

114.67 ± 45.21
100.30 ± 37.88
72.41 ± 26.12
35.08 ± 10.91

27.35 ± 13.96
25.54 ± 13.61
5.30 ± 6.46
0.00 ± 0.00

81.51 ± 26.66
78.53 ± 25.05
62.91 ± 21.64
22.27 ± 9.06

137.67 ± 51.36
62.33 ± 23.93
22.65 ± 14.13
64.41 ± 34.06

84.38 ± 12.20
41.63 ± 6.02
41.91 ± 6.08
44.10 ± 6.41

486.41 ± 87.49
349.15 ± 63.35
246.02 ± 46.45
206.70 ± 41.52

Therapeutics

92

Primiparous (mild)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Primiparous (severe)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Multiparous (mild)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Multiparous (severe)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
1

Losses1
($/case)

Expenditures
($/case)
Outside
labor

Death

Total
($/case)

NA indicates a cost category that was assumed not applicable to the total cost for that specific severity, incidence timing, and parity
group combination

Table 3.5 Mean ± SD expenditures, losses, and total cost per case of white line disease by severity, incidence timing, and parity group
as estimated using a stochastic simulation model (n = 1,000 iterations). Bolded values indicate the cost category contributing most to
the total cost per case for each combination of severity, incidence timing, and parity group.
On-farm
labor

Decreased milk
production

Extended days
open

Recurrence

8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74

11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85

13.88 ± 3.47
13.88 ± 3.47
13.88 ± 3.47
13.88 ± 3.47

36.63 ± 20.87
31.32 ± 16.90
21.99 ± 10.89
9.60 ± 4.11

3.09 ± 1.76
2.88 ± 1.69
0.57 ± 0.71
0.00 ± 0.00

46.96 ± 17.59
40.99 ± 15.30
28.45 ± 11.09
9.60 ± 4.11

45.10 ± 32.12
40.05 ± 30.08
18.39 ± 16.81
43.90 ± 37.13

8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74

11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85

20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20

56.68 ± 38.89
50.60 ± 31.52
37.63 ± 20.26
20.20 ± 7.44

11.30 ± 7.35
10.53 ± 6.98
2.15 ± 2.91
0.00 ± 0.00

71.58 ± 26.16
66.67 ± 25.34
52.29 ± 23.37
18.92 ± 10.22

62.60 ± 39.74
58.09 ± 35.37
22.12 ± 16.55
53.73 ± 36.74

8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74

11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85

13.88 ± 3.47
13.88 ± 3.47
13.88 ± 3.47
13.88 ± 3.47

23.34 ± 11.42
22.06 ± 9.63
17.24 ± 6.61
10.74 ± 3.18

4.23 ± 2.27
3.96 ± 2.24
0.83 ± 1.04
0.00 ± 0.00

48.97 ± 17.49
42.37 ± 15.16
29.17 ± 11.17
9.85 ± 4.23

99.60 ± 51.62
42.85 ± 24.44
19.31 ± 15.78
53.32 ± 36.38

NA
NA
NA
NA

210.09 ± 60.89
145.19 ± 35.66
100.50 ± 26.63
107.85 ± 39.08

8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74
8.20 ± 6.74

11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85
11.86 ± 5.85

20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20
20.81 ± 5.20

120.36 ± 51.15
104.92 ± 42.39
75.33 ± 28.62
35.91 ± 11.56

14.70 ± 9.51
13.74 ± 9.04
2.92 ± 4.02
0.00 ± 0.00

73.16 ± 25.32
67.76 ± 24.50
52.58 ± 22.16
19.12 ± 10.25

137.65 ± 53.18
62.44 ± 24.64
22.72 ± 13.91
64.62 ± 34.40

84.38 ± 12.20
41.63 ± 6.02
41.91 ± 6.08
44.10 ± 6.41

471.13 ± 89.89
331.36 ± 65.46
236.33 ± 47.55
204.62 ± 43.17

Therapeutics
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Primiparous (mild)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Primiparous (severe)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Multiparous (mild)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
Multiparous (severe)
0 to 60 DIM
61 to 120 DIM
121 to 240 DIM
>240 DIM
1

Losses1
($/case)

Expenditures
($/case)
Outside
labor

Culling

Death
NA
NA
NA
NA
39.25 ± 5.68
40.12 ± 5.80
41.70 ± 6.04
46.63 ± 6.84

Total
($/case)

165.72 ± 45.78
149.19 ± 39.75
103.34 ± 27.65
97.03 ± 39.01
282.28 ± 62.39
266.88 ± 56.01
196.76 ± 40.57
180.35 ± 40.95

NA indicates a cost category that was assumed not applicable to the total cost for that specific severity, incidence timing, and parity
group combination

Total cost per case of
digital dermatitis ($)

Figure 3.1 Variation in the total cost per case of a) digital dermatitis, b) sole ulcer, and c)
white line disease by severity, incidence timing, and parity group as estimated using a
stochastic simulation model (n = 1,000 iterations). Incidence timing represents the timing
of diseases occurrence. Open squares ( ) represent mild cases in primiparous cows, solid
squares ( ) represent severe cases in primiparous cows, open circles ( ) represent mild
cases in multiparous cows, and solid circles ( ) represent severe cases in multiparous
cows.
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Figure 3.2 Tornado graphs indicating the change ($) in digital dermatitis (a), sole ulcer (b),
and white line disease (c) mean total cost per case with a 1 SD increase in selected
stochastic market prices and herd specific performance variables (RHAM = rolling herd
average milk production, PR = pregnancy rate) as estimated using a stochastic simulation
model (n = 1,000 iterations).
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CHAPTER 4 UR
Estimating the dairy farm value of infectious or non-infectious lameness prevention
strategies, as influenced by pre-prevention hoof disease incidence rates and
prevention effectiveness
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Abstract
A farm-level stochastic simulation model was adapted to estimate the value of
implementing lameness prevention on a dairy farm by calculating the change in the herdlevel total cost of lameness from pre- to post- lameness prevention implementation. Two
potential lameness prevention strategies were tested: strategy 1 was prevention focused on
reducing the infectious hoof diseases in the model (digital dermatitis) and strategy 2 was
prevention focused on reducing the non-infectious hoof diseases in the model (sole ulcer
and white line disease). For each strategy, the effect of the pre-prevention investment hoof
disease incidence on prevention value was evaluated by setting pre-prevention incidence
of hoof diseases at 3 different levels. For strategy 1, digital dermatitis incidence level preprevention investment was 20%, 40%, or 60% while the incidence level of the noninfectious hoof diseases in the model were held constant. For strategy 2, sole ulcer and
white line disease incidence level pre-prevention investment were both 5%, 15%, or 25%
while the incidence level of the infectious hoof diseases included in the model were held
constant. Overall, 6 different scenarios were run; 1 scenario for each prevention strategy
and pre-prevention investment hoof disease incidence rate combination. To evaluate how
the effectiveness of each prevention strategy would influence the investment value, the
effectiveness of prevention was allowed to vary from a disease incidence risk ratio of 0.0
(100% reduction in disease incidence) to 1.0 (0% reduction in disease incidence). For both
prevention strategies, the value of prevention (i.e., change in the herd-level total cost of
lameness) increased as the pre-prevention incidence rate of hoof diseases and the
effectiveness of prevention increased (i.e., the disease incidence risk ratio became smaller).
However, the profitability of investing in lameness prevention would depend on the cost
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of the prevention strategy and the other benefits association with the selected prevention
strategy. If a herd manager knows the current herd-level incidence of hoof diseases and
the expected effectiveness of a potential lameness prevention strategy, this model could be
used as a decision support tool to help identify the amount that could be paid to implement
that prevention strategy.
Key words: lameness, hoof health, decision support, animal health economics
Introduction
Lameness is considered one of the most important animal welfare issues in the dairy
industry today (Von Keyserlingk et al., 2009) and is also estimated to be one of the most
expensive dairy diseases per case (Liang et al., 2017). In North American herds, reported
lameness prevalence has ranged from 10% (Adams et al., 2016) to 55% (Von Keyserlingk
et al., 2012) between 2012 and 2017.
There are many lameness prevention strategies available for dairy herds to use,
including footbaths (Speijers et al., 2012) and preventive hoof trimming (Manske et al.,
2002). Yet a recent survey of 184 United States dairies indicated that producers are not
consistently using recommended lameness prevention and control strategies (Adams et al.,
2016). Thirty-five percent of surveyed farms never used a footbath and 13% of farms only
used a footbath seasonally or occasionally. Additionally, 7% of herds never performed
preventive hoof trimming, 20% of farms only conducted trimming when cows were visibly
lame, and 36% of farms only performed preventive hoof trimming once per lactation.
Leach et al. (2010a) found that the reasons producers did not focus on lameness
prevention included a false perception that no lameness problem existed in their herd, a
lack of time, or a lack of understanding surrounding the economic consequences of
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lameness. Further, when producers were asked what could motivate other farms to reduce
lameness, the most frequent response was to provide more information on lameness costs
(Leach et al., 2010b). Disease costs are difficult to understand because the total cost is
composed of 2 different components: expenditures and losses (McInerney et al., 1992).
Expenditures are the direct costs associated with treatment (i.e., labor and therapeutics) and
prevention of disease. These are the costs producers often recall because they are obvious.
Losses are the indirect costs associated with existing disease. For example, reduced milk
yield, reduced reproductive performance, increased risk of culling, increased risk of death,
and risk of disease recurrence are all disease losses.
Morris (1969) defined optimum disease management as increasing disease
prevention expenditures only to the point that the additional money spent would be equal
to the resulting additional returns (i.e., reduced losses). In this study, we used a pre-existing
farm-level stochastic simulation model to estimate the change in the herd-level total cost
of lameness when prevention strategies were implemented. By doing this, the model could
be used to calculate the amount a producer should be willing to spend on prevention, given
the expected returns (i.e., reduced hoof disease losses). Our objective was to estimate the
value of infectious or non-infectious lameness prevention strategies when pre-prevention
hoof disease incidence rates and prevention effectiveness varied.
Materials and Methods
Model overview
The herd-level stochastic simulation model used in this study was previously
described in Chapter 3. The deterministic portion of the model was created using Excel
2016 (Microsoft, Seattle, Washington) and was supplemented with stochastic features
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using the @Risk add-in (Palisade Corporation, Ithaca, New York). The model calculates
the revenues (milk sales, calf value, and slaughter value) and expenses (feed costs,
veterinary costs, breeding costs, and disposal losses) associated with the average cow in
the herd every day for 6 lactations. Information about the average cow is used to estimate
the herd-level revenues and expenses over a year-long period.
Within the model, the cost per case of 3 hoof diseases (digital dermatitis, sole ulcer,
and white line disease) was calculated based on assumed changes in cow performance in
response to disease, as collected from previously published research (Chapter 3). The cost
per case of hoof disease varied by not only disease type, but also severity level (mild or
severe), incidence timing (0 to 60 DIM, 61 to 120 DIM, 121 to 240 DIM, or >240 DIM),
and parity group (primiparous or multiparous). The total cost per case of each hoof disease
included the current lactation expenditures associated with outside (hoof trimmer) labor,
therapeutics, and on-farm labor, and losses associated with discarded milk, reduced milk
production, extended days open, an increased risk of culling, an increased risk of death
(natural or euthanized), and disease recurrence (within the same animal). Variables
assumed to influence the cost of hoof diseases were modeled stochastically to account for
variation among herds or uncertainty in their values. For stochastically modeled variables,
a distribution was defined using previously published literature or industry averages (Table
4.1). Each time the model was run, a value from that distribution was selected and used in
the model to calculate a unique cost per case of hoof disease.
Lameness prevention assumptions
In this study, the pre-existing model was adapted to estimate the economic outcome
associated with implementing lameness prevention strategies on a dairy farm. As an
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example, we focused on two potential lameness prevention methods: strategy 1 was
assumed to reduce infectious hoof diseases only (i.e., digital dermatitis) and strategy 2 was
assumed to reduce both non-infectious hoof diseases only (i.e., sole ulcer and white line
disease). To calculate the value of implementing strategies which prevented each type of
lameness, the herd-level total cost of lameness would need to be calculated pre- and postlameness prevention implementation. To calculate the herd-level total cost of lameness
from the cost per case of lameness estimates already provided by the model, the following
additional information was needed in the model: pre- and post- lameness prevention
implementation hoof disease incidence rates and the distribution of hoof diseases among
different classifications (i.e., mild vs. severe cases, the distribution of disease occurrence
across the lactation, and the distribution of cases among parities).
Hoof disease incidence rates. For the base scenario, when no lameness prevention
was used, an estimate of the incidence of each hoof disease was needed. No United States
studies were identified that evaluated incidence levels of specific hoof diseases while
reporting the prevention strategies used on the evaluated herds. Additionally, incidence
rates will vary across farms. Therefore, in this study we tested 3 possible pre-prevention
implementation incidence rates of hoof diseases within each strategy to see how variation
would influence the investment outcome. Each different pre-prevention incidence rate was
run as a separate simulation within the model. For strategy 1, the incidence of digital
dermatitis was assumed to be 20%, 40%, or 60%, while the incidence of sole ulcer and
white line disease were held constant (15%). For strategy 2, the incidence of both sole
ulcers and white line disease was assumed to be 5%, 15%, or 25%, while the incidence of
digital dermatitis was held constant (30%). To summarize, 6 different scenarios were
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tested: in 3 scenarios the economic effect of implementing infectious hoof disease
prevention was tested, assuming 3 different pre-prevention incidence rates for digital
dermatitis and in 3 scenarios the economic effect of implementing non-infectious hoof
disease prevention was tested, assuming 3 different pre-prevention incidence rates for sole
ulcers and white line disease.

The values chosen to represent pre-prevention

implementation incidence rates for all diseases were selected to represent variation around
the mean prevalence rates reported by DeFrain et al. (2013), but do not necessary represent
the true incidence rates found on farms in the United States.
When lameness prevention strategies were used, we assumed that lameness
incidence would be affected. Disease incidence risk ratios (RR) were used to adjust the
base incidence of each hoof disease as prevention strategies were implemented. Limited
published data on how different lameness prevention strategies change hoof disease
incidence exists. Therefore, instead of assuming a particular prevention strategy, we
allowed the effect of prevention strategies on hoof disease incidence (disease risk ratios)
to vary stochastically. Hoof disease risk ratios were modeled using a triangle distribution
with the minimum, most likely, and maximum values set to 0.0, 0.5, and 1.0, respectively,
for all simulations. The hoof disease risk ratio distributions were truncated at a minimum
of 0.0 and a maximum of 1.0, meaning the model input was re-drawn from the distribution
if a value outside of that range was selected, assuming that lameness prevention strategy
implementation would never increase the risk of diseases incidence. To summarize, the
effect of prevention in all 6 scenarios varied from no effect (risk ratio = 1.0) to 100%
reduction in the selected hoof diseases (risk ratio = 0.0). For the first 3 scenarios, this risk
ratio was applied to the incidence of digital dermatitis (to allow analysis of the value of

102

infectious hoof disease prevention) and for the remaining 3 scenarios, this risk ratio was
applied to the incidence of sole ulcers and white line disease (to allow analysis of the value
of non-infectious hoof disease prevention). Allowing variation in the disease incidence
risk ratios allowed us to evaluate the value of lameness prevention strategies with varying
levels of effectiveness.
Hoof disease case classification. The model calculated the cost per case of hoof
disease by disease type, severity level, incidence timing, and parity. Therefore, the
distribution of occurring hoof disease cases among these combinations was needed for an
accurate estimation of herd-level lameness costs. The same hoof disease incidence rates
were assumed for primiparous and multiparous cows and parities 1, 2, 3, 4, 5, and 6 were
modeled to represent 36.1%, 26.0%, 17.7%, 11.0%, 5.8%, and 3.4% of the herd,
respectively (Table 4.1; Dhuyvetter et al., 2007). The percent of severe vs. mild cases was
defined by observations from Charfeddine and Pérez-Cabal (2017) who estimated severe
cases to represent 6%, 14%, and 16% of primiparous digital dermatitis, sole ulcer, and
white line disease, and 6%, 13%, and 14% of multiparous digital dermatitis, sole ulcer, and
white line disease, respectively. Disease incidence timing was modeled to match timing
as reported by Booth et al. (2004), assuming white line disease to follow a similar pattern
to sole ulcer because both are non-infectious diseases. The percentage of digital dermatitis
cases occurring at ≤ 60 DIM, 61 to 120 DIM, 121 to 240 DIM, and >240 DIM was 27%,
31%, 30%, and 12%, respectively. The percentage of sole ulcer and white line disease
cases occurring at ≤ 60 DIM, 61 to 120 DIM, 121 to 240 DIM, and >240 DIM was 26%,
32%, 31%, and 10%, respectively.
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Calculation of lameness prevention value
In both pre- and post- lameness prevention implementation simulations, hoof
disease incidence rates were multiplied by the number of cows in each parity to calculate
the number of cases of each hoof disease occurring in one year. To find the number of
cows in each parity, the percent of cows in each parity (Table 4.1) was multiplied by the
milking herd size.

Milking herd size was modeled stochastically using a PertAlt

distribution with the 5th percentile, mean, and 95th percentile set to 50, 250, and 1,000 cows
to represent a wide range of herd sizes (Table 4.2). These calculations resulted in the total
number of cases of each hoof disease in each parity per year in both the pre- and postlameness prevention implementation scenarios. The number of cases within each parity
per year were then classified by severity and incidence timing using model assumptions,
and a cost was assigned to each case by calculating the lameness associated expenditures
and losses as described in Chapter 3.
In each scenario, the herd-level total cost of lameness was calculated as the sum of
all expenditures (outside labor, therapeutics, on-farm labor, and prevention) and losses
(discarded milk, reduced milk production, increased days open, an increased risk of culling,
an increased risk of death, and disease recurrence) for all 3 hoof diseases over a one-year
period. This value was converted to the total cost of lameness per lactating cow-year by
dividing the herd-level total cost of lameness by the lactating herd size. Within this cost
of lameness, we did not include the cost of prevention since we were not attempting to
model specific prevention strategies. Instead, by comparing the herd-level total cost of
lameness per cow-year pre- and post - lameness prevention implementation, the change in
the herd-level total cost of lameness per cow-year can be calculated, which would represent
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the maximum amount that could be spent on the lameness prevention strategy in each
scenario to breakeven. How this value varied with varying pre-prevention incidence rate
of hoof diseases and effectiveness of the implemented prevention strategy was also
considered.
Simulation methods
For this study, 12 simulations of the model were run as described in Table 4.3. In
6 simulations, the value of infectious hoof disease prevention was estimated (strategy 1)
assuming varying pre-prevention implementation digital dermatitis incidence levels (20%,
40%, and 60% for simulations 1 and 2, 3 and 4, and 5 and 6, respectively, where odd
numbered simulations were pre-prevention implementation and even numbered
simulations were post-prevention implementation) . In the remaining 6 simulations, the
value of non-infectious hoof disease prevention was estimated (strategy 2) assuming
varying pre-prevention implementation sole ulcer and white line disease incidence levels
(5%, 15%, and 25% for simulations 7 and 8, 9 and 10, and 11 and 12, respectively, where
odd numbered simulations were pre-prevention implementation and even numbered
simulations were post-prevention implementation). For each simulation, 300 iterations
were run using Latin Hypercube sampling. To confirm that all simulations used the same
drawn stochastic variables for each iteration (making them comparable) a static seed was
set to 31,517. Default deterministic variable assumptions used to define the herd and the
average cow were collected from Dairy Records Management Systems (Raleigh, NC)
using limitations of only Holstein herds with ≥ 200 cows, published literature, or the
authors’ expertise (Table 4.2). The resulting distributions of herd-level stochastic variables
can be found in Table 4.1. Inputs used in the model for this study were meant to represent
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a United States dairy herd. However, model inputs could be adjusted to herd-specific
values to calculate the cost of hoof diseases for a specific herd.
Results and Discussion
The objective of this study was to use an existing stochastic simulation model to
estimate the value of lameness prevention strategies when pre-prevention hoof disease
incidence rates and prevention effectiveness varied. The mean ± SD total herd-level cost
of lameness per cow-year for each simulation is presented in Table 4.3. Over the 12
simulations, the herd-level total cost of lameness varied depending on the assumed preprevention disease incidence rates, if lameness prevention was used or not, and how
effective the lameness prevention method was. The change in the herd-level total cost of
lameness per cow-year between simulations using and not using prevention could be used
to identify the maximum amount a producer should be willing to pay for implementing a
prevention strategy.
Infectious hoof disease prevention
Figure 4.1 shows the change in the herd-level total cost of lameness per cow-year
when infectious hoof disease prevention was implemented as affected by prevention
effectiveness across the 3 different pre-prevention digital dermatitis incidence rates.
Regardless of pre-prevention digital dermatitis incidence rate, the value of prevention (i.e.,
change in the herd-level total cost of lameness) increased as the effectiveness of prevention
increased (i.e., the disease incidence risk ratio became smaller) because less lameness cases
were occurring and, therefore, there were less expenditures and losses associated with
lameness. Additionally, as the pre-prevention incidence rate of digital dermatitis increased,
the value of prevention (i.e., change in the herd-level total cost of lameness between pre-
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and post- lameness prevention implementation) increased. The mean ± SD change in the
herd-level total cost of lameness per cow-year when digital dermatitis was original 20%,
40%, or 60% was $6.9 ± 3.3, $13.8 ± 6.5, and $20.6 ± 9.8, respectively. In this example,
we assumed prevention focused on infectious hoof diseases would reduce the incidence of
digital dermatitis only so changes in the herd-level total cost of lameness per cow-year
were not affected by changes in the cost of other hoof diseases included in the model (i.e.,
sole ulcer and white line disease). The pre-prevention incidence rate of digital dermatitis
influences the value of prevention because as pre-prevention incidence increases, the
potential to reduce lameness costs increases.
Although the herd-level total cost of lameness per cow-year always decreased when
infectious hoof disease prevention was implemented, this is only beneficial to the herd if
the decrease in costs is greater than or equal to the cost of prevention. In the simulation
where pre-prevention incidence of digital dermatitis was 20%, the maximum decrease in
the herd-level total cost of lameness per cow-year was $17 when the digital dermatitis
incidence risk ratio associated with prevention was 0.20 and the minimum decrease in the
herd-level total cost of lameness per cow-year was $0.1 when the digital dermatitis
incidence risk ratio associated with prevention was 0.99. This indicates that, using our
model assumptions, the most that could be spent on prevention per cow-year when your
herd has a pre-prevention incidence rate of 20% is $17, but only if the prevention strategy
is highly effective (reduces digital dermatitis incidence by > 80%). If the prevention
strategy is not very effective, a herd in this scenario could only spend up to $0.1 per cowyear before the benefits of prevention are not paying for the prevention strategy itself.
Similarly, if pre-prevention incidence rate of digital dermatitis was 40%, the maximum that

107

could be paid for prevention was $34, but if the effectiveness of prevention was low then
the maximum that could be paid for prevention was only $0.3. Finally, if pre-prevention
incidence rate of digital dermatitis was 60%, the maximum that could be paid for
prevention was $51, but if the effectiveness of prevention was low then the maximum that
could be paid for prevention was only $0.4.
The most common infectious lameness disease prevention strategy in the United
States dairy industry is footbaths. Multiple options exist for footbath solutions, with the 2
most common being 5% copper sulfate and formalin. If we assume that a 5% copper sulfate
solution footbath costing $50 per bath is utilized 1 time per day, 3 times per week, and
changed after 200 cow passes, 0.78 baths would be needed per cow-year, for a total cost of
prevention of $39/cow-year. In our model, the mean change in the herd-level total cost of
lameness per cow-year was not enough to pay for using this prevention strategy, regardless
of the pre-prevention incidence level of digital dermatitis. Even if copper sulfate footbath
use was highly effective at reducing digital dermatitis, the maximum change in the herdlevel total cost of lameness per-cow year was only high enough to pay for prevention if
pre-prevention incidence rate of digital dermatitis was 60%; there were no scenarios when
pre-prevention incidence of digital dermatitis was 20% or 40% that the value of prevention
was enough to offset the cost of this prevention strategy, regardless of prevention
effectiveness. However, reduced footbath frequency or a less expensive supply of copper
sulfate could change these results if no negative effects on footbath effectiveness were
seen. Additionally, if more benefits beyond digital dermatitis reduction are seen after
footbath implementation (e.g., reduced foot rot) the footbath could still be profitable.
Alternatively, if we assume a formalin footbath costing $12 per bath and utilized at the
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same rate as we assumed for the 5% copper sulfate bath, the total cost of prevention would
be $9/cow-year. In our model, the mean change in the herd-level total cost of lameness
per cow-year would cover the cost of this prevention method if pre-prevention incidence
of digital dermatitis was 40% or 60%. Additionally, implementation of this prevention
strategy would be economically beneficial when pre-prevention digital dermatitis
incidence was only 20% if prevention effectiveness was high.
Non-infectious hoof disease prevention
Figure 4.2 shows the change in the herd-level total cost of lameness per cow-year
when non-infectious hoof disease prevention was implemented, as affected by prevention
effectiveness across the 3 different pre-prevention non-infectious hoof disease incidence
rates. Similar to the infectious hoof disease prevention scenario, the value of prevention
(i.e., change in the herd-level total cost of lameness from pre- to post- lameness prevention
implementation) increased as the effectiveness of prevention increased (i.e., the disease
incidence risk ratio became smaller) and as the pre-prevention incidence rate of noninfectious diseases increased. The mean ± SD change in the herd-level total cost of
lameness per cow-year when non-infectious hoof disease incidence levels were original
5%, 15%, or 25% was $8.7 ± 3.9, $26.2 ± 11.6, and $43.6 ± 19.3, respectively. Compared
to when infectious hoof disease prevention was used, the value of prevention was greater
in this scenario even though the pre-prevention incidence rate of selected disease was
lower. This resulted from non-infectious diseases costing more per case (Table 4.1) and
the prevention strategy impacting the incidence of more than just 1 disease.
Using our model assumptions in the simulation where pre-prevention incidence of
non-infectious hoof diseases was 5%, the most that could be spent on prevention per cow-
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year was $20, but only if the prevention strategy was highly effective (risk ratio = 0.05).
If the prevention strategy effectiveness was poor (risk ratio = 0.99) then the most that could
be spent on prevention per cow-year was only $0.2. Similarly, if pre-prevention incidence
rate of non-infectious diseases was 15%, the maximum that could be paid for prevention
was $59, but if the effectiveness of prevention was low then the maximum that could be
paid for prevention was only $0.7. Finally, if the pre-prevention incidence rate of noninfectious hoof diseases was 25%, the maximum that could be paid for prevention was $98,
but if the effectiveness of prevention was low then the maximum that could be paid for
prevention was only $1.
Multiple non-infectious hoof disease prevention strategies exist; for example,
preventive hoof trimming, biotin supplementation, and rubber flooring (Ettema and
Østergaard, 2006). An estimated cost of preventive hoof trimming could be taken from the
survey of hoof trimmers in Chapter 2 where the mean ± SD charged for trimming per cow
was $12.55 ± 2.39 (n = 113 survey respondents). Assuming the implementation of one
additional trimming per cow-year, the mean value of this prevention strategy would be
positive if pre-prevention incidence of non-infectious diseases was either 15% or 25%.
Only in cases where this prevention strategy was highly effective was the change in the
herd-level total cost of lameness per cow-year enough to pay for implementation if preprevention incidence of non-infectious hoof diseases was only 5%. Other non-infectious
hoof disease prevention strategies are more difficult to calculate the cost of because they
are typically not charged per cow. For example, reduction in lameness may be seen after
installing rubber flooring (Vanegas et al., 2006) or redesigning poorly constructed freestalls
(Ito et al., 2010), but the cost of doing so is a long-term investment that will also have
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benefits beyond lameness incidence reduction (e.g., reduced mastitis incidence, improved
cow longevity). Correctly identifying what portion of this cost should be considered
expenditures on lameness prevention will influence if the prevention investment is
beneficial or not.
Interpretation of results
Within this study we focused on estimating the value of implementing either
infectious or non-infectious lameness prevention. Based on the results in this study, the
value of lameness prevention strategies depends on the pre-prevention incidence rate of
hoof diseases, the effectiveness of the prevention strategy implemented, and the cost of the
prevention strategy implemented.
This model could be useful as a decision support tool to help guide decisions about
investment in lameness prevention strategies. However, some limitations exist within the
model. First, the model only accounted for 3 hoof diseases. These hoof diseases were
selected because they are the most prevalent lameness causing diseases in United States
dairy herds (DeFrain et al., 2013) and have had their effects on cow productivity studied
more extensively than other hoof diseases. However, by not including other hoof diseases
(e.g., foot rot, toe ulcers, thin soles) we may be underestimating the herd-level total cost of
lameness and, therefore, the value of lameness prevention strategies.
Secondly, we did not account for the possibility that the proportion of mild and
severe cases could change with lameness prevention implementation.

If prevention

strategies do reduce the proportion of severe hoof diseases, we may have underestimated
the value of prevention. Third, the model did not account for a herd potentially improperly
implementing prevention strategies.

In reality, a positive response to prevention
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implementation will only be seen in herds with correct stocking density, appropriate time
budgets, and proper implementation of the prevention strategies. Poor implementation,
including improper hoof trimming practices or footbath design, could lead to increased
rather than decreased hoof disease incidence.
Finally, the accuracy of model results is limited by the accuracy of the information
provided to it. To accurately calculate the value of lameness prevention strategies, correct
estimates are needed for the cost of hoof diseases, the pre-prevention hoof disease
incidence rates within a herd, and the effectiveness of prevention. Although our cost
estimates were taken from Chapter 3, those did not account for the animal welfare impact
of lameness, which could be an economic contributor in the future. Improved on-farm
records of hoof disease incidence at the cow level, further research considering the effects
of specific hoof diseases on cow performance, and further research on the effects of
prevention strategies on hoof disease incidence is needed.
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Table 4.1 Simulated market price and herd performance inputs used in a stochastic model
to estimate the value of infectious and non-infectious lameness prevention strategies
Simulated range
Simulated
Input
Source1
(min – max)
mean ± SD
Calf value ($/bull)
72 – 224
131 ± 41
Chapter 3
Calf value ($/heifer)
234 – 675
395 ± 144
Chapter 3
Authors’
Milking herd size (c)
68 – 968
434 ± 205
expertise
Slaughter value ($/kg)
Milk price ($/kg)
Lactating cow feed price ($/kg)
Replacement heifer price ($)
RHA milk production (kg)
Pregnancy rate (%)

1.03 – 1.78
0.29 – 0.50
0.21 – 0.37
1,437 – 2,122
5,993 – 17,136

1.43 ± 0.20
0.40 ± 0.06
0.29 ± 0.04
1,718 ± 217
11,461 ± 1,994

FAPRI (2017)
FAPRI (2017)
FAPRI (2017)
Chapter 3
DairyMetrics

3.3 – 72.6

22.1 ± 11.0

DairyMetrics

Cost of digital dermatitis
64 – 248
137 ± 31
Chapter 3
($/case)1
Cost of sole ulcer ($/case)1
130 – 325
227 ± 37
Chapter 3
Cost of white line disease
138 – 435
202 ± 33
Chapter 3
($/case)1
Prevention effect on hoof
Authors’
0.01 – 0.99
0.50 ± 0.20
diseases (risk ratio)
expertise
1
Mean cost per case across all combinations of severity level, incidence timing, and parity
group
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Table 4.2 Deterministic herd performance and financial inputs used in a stochastic model
to estimate the value of infectious and non-infectious lameness prevention strategies
Input
Value
Source1
Age at first calving (m)
24.3
DairyMetrics
Baseline culling rate (%)
13.0
Bewley et al. (2010)
Breeding costs ($/insemination) 2
15.51
VanRaden and Cole (2014)
Butterfat yield (%)
3.7
DairyMetrics
Calf birth weight (kg)
41.7
Kertz et al. (1997)
Close up dry cow feed price ($/kg DMI)
0.22
Model input
Close up dry period length (d)
21
Model input
Days dry
56.2
NAHMS (2014)
Days in milk designated do not breed
250
Bewley et al. (2010)
Discount rate (%)
Disposal losses ($)2
Far off dry cow feed price ($/kg DMI)
Gestation length (d)
Mature cow live weight (kg)
Percent heifer calves
Percent of herd in 1st parity
Percent of herd in 2nd parity
Percent of herd in 3rd parity
Percent of herd in 4th parity
Percent of herd in 5th parity
Percent of herd in 6th (or greater) parity
Protein yield (%)
Voluntary waiting period (d)

8.0
65
0.15
280
723
46.7
36.1
26.0
17.7
11.0
5.8
3.4
3.1
59.3

1

Hyde and Engel (2002)
Groenendaal et al. (2004)
Model input
Norman et al. (2007)
NRC (2001)
Del Río et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
Dhuyvetter et al. (2007)
DairyMetrics
DairyMetrics

DairyMetrics information was collected on October 1, 2017 from Dairy Records
Management Systems (Raleigh, NC). Values gathered from DairyMetrics included 1,987
United States Holstein herds with at least 200 cows.
2
Adjusted for inflation to 2017 prices
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Table 4.3 Outline of simulations run to estimate the value of either infectious or non-infectious hoof disease prevention strategies, as
influenced by pre-prevention hoof disease incidence rates and prevention effectiveness. The mean ± SD total herd-level total cost of
lameness per cow-year as estimated using a stochastic simulation model is reported for each simulation (n = 300 iterations).
Pre-prevention disease incidence rate (%)
Herd-level total
Prevention
Simulation
cost of lameness
Digital
White line implemented
number
Sole ulcer
(mean ± SD $/cow-year)
Prevention focus
dermatitis
disease
(Yes or No)
1
Infectious diseases
20
15
15
No
66.3 ± 10.5
2
Infectious diseases
20
15
15
Yes
59.5 ± 9.9
3
Infectious diseases
40
15
15
No
80.2 ± 66.4
4
Infectious diseases
40
15
15
Yes
66.4 ± 12.3
5
Infectious diseases
60
15
15
No
94.0 ± 16.4
6
Infectious diseases
60
15
15
Yes
73.4 ± 9.8
No
7
Non-infectious diseases
30
5
5
38.3 ± 7.1
8
Non-infectious diseases
30
5
5
Yes
29.5 ± 7.3
9
Non-infectious diseases
30
15
15
No
73.3 ± 11.8
10
Non-infectious diseases
30
15
15
Yes
47.1 ± 13.9
11
Non-infectious diseases
30
25
25
No
108.2 ± 17.1
12
Non-infectious diseases
30
25
25
Yes
64.6 ± 21.3

Change in the herd-level
total cost of lameness per
cow-year ($)

Figure 4.1 Change in the total herd-level total cost of lameness per cow-year when
infectious hoof disease prevention was implemented, as calculated using a stochastic
simulation model (n = 300 iterations). Three pre-prevention herd-level digital dermatitis
incidence rates were tested: 20% (a), 40% (b), and 60% (c). The prevention effect on
digital dermatitis incidence (risk ratio) was allowed to vary between 0.0 and 1.0.
a)
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10
0
0.00

0.20
0.40
0.60
0.80
Prevention effect on digital dermatitis incidence
(risk ratio)

1.00

0.20
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0.60
0.80
Prevention effect on digital dermatitis incidence
(risk ratio)

1.00

0.20
0.40
0.60
0.80
Prevention effect on digital dermatitis incidence
(risk ratio)

1.00
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cow-year ($)

b)
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c)
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50
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0.00
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Change in the herd-level
total cost of lameness per
cow-year ($)

Figure 4.2 Change in the total herd-level total cost of lameness per cow-year when noninfectious hoof disease prevention was implemented, as calculated using a stochastic
simulation model (n = 300 iterations). Three pre-prevention herd-level non-infectious hoof
disease (sole ulcer and white line disease) incidence rates were tested: 5% (a), 15% (b),
and 25% (c). The prevention effect on non-infectious hoof disease incidence (risk ratio)
was allowed to vary between 0.0 and 1.0.
a)
100
80
60
40
20
0
0.00
0.20
0.40
0.60
0.80
1.00
Prevention effect on non-infectious hoof disease incidence
(risk ratio)

Chang ein the herd-level
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b)
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Prevention effect on non-infectious hoof disease incidence
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cow-year ($)

c)
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0.80
1.00
Prevention effect on non-infectious hoof disease incidence
(risk ratio)
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CHAPTER 5
Research Summary
Two objectives were focused on throughout this research. The first was to calculate
the costs associated with hoof diseases causing lameness in dairy cattle. To accomplish
this, we had to collect estimates for all disease associated expenditures (therapeutics,
outside labor, and on-farm labor) and losses (discarded milk, reduced milk production,
extended days open, increased risk of culling, increased risk of death, and disease
recurrence) from previously published epidemiological studies. Many gaps in the literature
were identified through our search. In particular, very few studies have focused on the
expenditures and losses associated with lameness at the hoof disease level. Originally we
had planned to estimate the costs per case for 6 different hoof diseases (digital dermatitis,
foot rot, sole ulcer, thin sole, toe ulcer, and white line disease), but missing data narrowed
our focus to 3 hoof diseases (digital dermatitis, sole ulcer, and white line disease). Further
research considering the many different conditions classified as lameness, rather than
lameness as a disease itself, is needed. This area of focus is especially necessary given the
prevalence of lameness reported in many recent studies and the increasing animal welfare
concerns for the dairy industry.
One hole identified in the literature was a lack of estimates for disease-specific
therapeutic and outside labor costs (fees charged by hoof trimmers or veterinarians to visit
and treat lameness cases) in the United States. Therefore, a survey of hoof trimmers and
veterinarians was conducted to estimate those costs for the 3 hoof diseases of interest, along
with additional hoof diseases (foot rot, toe ulcers, and thin soles). Answers from 116 hoof
trimmers and 18 veterinarians were obtained through both online and paper survey
methods. Because of the low response rates from veterinarians, our analysis focused on
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hoof trimmer respondents only. Hoof trimmers indicated that digital dermatitis, sole ulcer,
and white line disease were the most commonly treated hoof diseases, confirming our
decision to focus our research on those 3 diseases. However, toe ulcers were identified as
the most expensive hoof disease to treat. This is interesting given the lack of published
literature on toe ulcers. Further research into less understood hoof diseases, like toe ulcers
and thin soles, could increase understanding of those diseases and potentially reduce their
treatment costs.
Survey estimates for therapeutics and outside labor were combined with other
literature-derived values in a stochastic simulation model used to estimate cost of 3 specific
hoof diseases. To improve on previous studies, costs per case were differentiated not only
by disease, but also by severity (mild vs. severe), incidence timing (0 to 60 DIM, 61 to 120
DIM, 121 to 240 DIM, or >240 DIM), and parity group (primiparous or multiparous). Our
results indicate similar mean costs per case to previous hoof disease cost estimates, but
provide beneficial insight into how costs vary by severity, incidence timing, and parity
group. Having an understanding of how disease costs differ by cow (depending on parity,
DIM, etc.) could help producers make cow specific treatment decisions. Additionally, this
knowledge can help prioritize investment in prevention to focus on cases that are most
costly to the producer. The sensitivity of hoof disease costs to market prices (milk price,
feed price, replacement price, and slaughter price) and herd performance factors (rolling
herd average milk production and pregnancy rate) highlights the need to consider lameness
costs at the herd level rather than the industry level. In other words, a good treatment or
prevention decision for one herd may be a poor treatment or prevention decision for another
herd. Future efforts could be made to incorporate our hoof disease cost estimates into
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decision support tools that could be used at the herd level to aid in treatment and prevention
investment decisions.
A variety of lameness prevention recommendations are made to dairy producers with
little scientific evidence supporting their economic benefits.

Therefore, the second

objective of this research was to estimate the economic value of investing in different
lameness prevention strategies. For our study, we chose to focus on 2 broad categories of
lameness prevention: infectious hoof disease prevention and non-infectious hoof disease
prevention. The same stochastic simulation model used for estimating hoof disease costs
was used to calculate the herd-level total cost of digital dermatitis, sole ulcer, and white
line disease with and without prevention implementation. We also evaluated how changes
in pre- lameness prevention implementation hoof disease incidence and the effectiveness
of the prevention strategy changed the estimated value of lameness prevention.
Overall, the greater the incidence of hoof diseases and the more effective the prevention
strategy, the greater the value of implementing lameness prevention strategies. However,
each lameness prevention strategy would only be economically beneficial if the change in
the herd-level total cost of lameness was enough to offset the cost of the selected prevention
strategy or if non-economic factors (like improved animal welfare) could be used to justify
implementation.

Individual farm managers could use this model to help identify the

potential value of different lameness prevention strategies if they know the current herdlevel incidence of hoof diseases and the expected effectiveness of the lameness prevention
strategy of interest.
Compared to other dairy diseases, hoof diseases are understudied.

Many

opportunities exist for further research in this area; particularly field trials focused on the
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direct effect of individual hoof diseases on cow performance and on how prevention
strategies effect specific hoof diseases, including those beyond digital dermatitis, sole
ulcers, and white line disease.
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APPENDIX
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Table A1. Questions included in a survey of hoof trimmers and veterinarians aimed at
collecting and summarizing information on hoof disease treatment costs
Question
number
Q1

Question
What role do you serve for dairy farmers? (hoof trimmer, veterinarian, other)

Q2

If in the United States, which states do you practice in? If outside the United States, in which
country/countries do you practice?

Q3

Estimate the number of farms you perform preventative or corrective trimming for each year
that would fall under each category:
Small herds (fewer than 100 lactating cows): __________
Medium herds (between 100 and 500 lactating cows): __________
Large herds (over 500 lactating cows): __________
What is the smallest herd size for which you perform preventative or corrective trimming?
___________ lactating cows

Q4
Q5

What is the largest herd size for which you perform preventative or corrective trimming?
____________ lactating cows

Q6

On average, how many dairy cows do you conduct preventative trimming for weekly (i.e.
routine trimming)? __________

Q7

On average, how many dairy cows do you treat for lameness weekly (i.e. treatment of existing
lameness)? __________

Q8

Do you charge a set-up fee, visit fee, or set daily rate to come to a dairy farm? Circle one:
NO
YES If yes, what is your rate: $__________ set-up fee (on average)
$__________ visit fee (on average)
$__________ set daily rate (on average)
What is your on-farm rate for dairy preventative trimming (i.e. routine trimming)?
_________ $/hour OR _________ $/cow

Q9
Q10

On average, how many dairy cows do you trim per hour when conducting preventative trims?
__________

Q11

In your opinion, rank the following dairy lameness diseases from (1) most costly to (6) least
costly in terms of total costs per case to the producer (treatment and labor costs plus reduction
in milk yield, reduced reproductive performance, etc.). Use each number only once.
_______ Digital Dermatitis
_______ Foot Rot
_______ Sole Ulcer
_______ Thin Sole
_______ Toe Ulcer
_______ White Line Lesion
In your opinion, rank the following potential benefits of reducing dairy cow lameness to dairy
producers from (1) most important to (8) least important. Use each number only once.
____ Decreased incidence of other diseases (not lameness)
____ Enhanced animal welfare
____ Increased milk production
____ Increased reproductive performance
____ Increased cow longevity
____ Reduced drug and supply costs
____ Reduced producer labor costs
____ Reduced veterinary/hoof trimmer fees

Q12
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Table A1. Continued
Q13

Q14

Q15

Q16

Of all dairy cow lameness cases that you have treated in the past 12 months, what is your best
estimate of the percent that would fall under each of the following classifications (the total
should equal 100%).
_________% Digital Dermatitis
_________% Foot Rot
_________% Sole Ulcer
_________% Thin Sole
_________% Toe Ulcer
_________% White Line Lesion
_________% Other (For example: corkscrew, axial wall cracks, overgrowth, and corns)
100 % = TOTAL OF ALL
Approximately how much time do you spend per hoof to treat a case of:
Digital Dermatitis:
_________ minutes
Foot Rot:
_________ minutes
Sole Ulcer:
_________ minutes
Thin Sole:
_________ minutes
Toe Ulcer:
_________ minutes
White Line Lesion:
_________ minutes
Do you generally recommend milk withholding following treatment of each of the following
diseases (mark “Yes” or “No”)? If “Yes”, indicate for how many days milk withholding is
recommended:
If yes, days withhold is recommended after
Disease
No
Yes
treatment:
Digital Dermatitis
Foot Rot
Sole Ulcer
Thin Sole
Toe Ulcer
White Line Lesion
In the first blank column, list how much you charge a dairy producer to treat one case of each
of the diseases listed.
Then indicate what percent of the total charge of each case is for labor vs. supplies. The total
of “% Labor” and “% Supplies” for each row should equal 100%.
Total amount
charged to the %
%
Total
Disease
producer
Labor
Supplies
%
$
Digital
100%
Dermatitis
Foot Rot
100%
Sole Ulcer
100%
Thin Sole
100%
Toe Ulcer
100%
White
Line
100%
Lesion

124

Table A2. Veterinarian responses to a survey regarding dairy hoof disease prevalence, time
to treat, treatment costs, and the percentage of costs attributed to labor or supplies
Number of
Response
responses
(mean ± SD)
Hoof disease
(n)
Digital dermatitis
% of total
16
24.7 ± 12.7
Time to treat (min)
12
11.4 ± 6.8
Total charged ($/case)
12
46.3 ± 26.5
% attributed to labor
12
75.6 ± 16.7
% attributed to supplies
12
24.4 ± 16.7
Foot rot
% of total
16
17.0 ± 10.4
Time to treat (min)
12
11.4 ± 6.1
Total charged ($/case)
12
65.1 ± 38.1
% attributed to labor
12
57.5 ± 23.6
% attributed to supplies
12
42.5 ± 23.6
Sole ulcer
% of total
16
27.4 ± 14.3
Time to treat (min)
12
21.3 ± 10.1
Total charged ($/case)
12
69.8 ± 30.8
% attributed to labor
12
73.4 ± 18.3
% attributed to supplies
11
26.6 ± 18.3
Thin sole
% of total
16
3.3 ± 5.0
Time to treat (min)
12
9.6 ± 6.2
Total charged ($/case)
10
53.1 ± 35.8
% attributed to labor
12
64.8 ± 37.1
% attributed to supplies
12
18.5 ± 23.1
Toe ulcer
% of total
16
2.8 ± 3.0
Time to treat (min)
12
16.9 ± 8.0
Total charged ($/case)
11
78.2 ± 48.9
% attributed to labor
12
66.7 ± 27.1
% attributed to supplies
12
25.0 ± 18.8
White line disease
% of total
16
18.3 ± 14.8
Time to treat (min)
12
18.8 ± 7.6
Total charged ($/case)
12
65.3 ± 33.6
% attributed to labor
12
77.1 ± 17.2
% attributed to supplies
12
22.9 ± 17.2
Other lameness
% of total treatments
16
6.6 ± 6.7
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Table A3. Ranking frequency of the estimated total cost per case to the producer (treatment
and labor costs plus the reduction in milk yield, reduced reproductive performance, etc.) of
selected hoof diseases as evaluated by a survey of veterinarians. Ranking was from most
expensive (1) to least expensive (6).
Response frequency (%)
Disease
n
1
2
3
4
5
6
Sole ulcer
16
31.3
31.3
6.3
18.8
12.5
0.0
Digital dermatitis

16

25.0

37.5

25.0

6.3

0.0

6.3

Foot rot

16

18.8

0.0

43.8

12.5

12.5

12.5

Toe ulcer

16

12.5

12.5

0.0

25.0

18.8

31.3

White line disease

16

6.3

18.8

18.8

25.0

18.8

12.5

Thin sole

16

6.3

0.0

6.3

12.5

37.5

37.5
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Table A4. Ranking frequency of the potential benefits to producers of reducing dairy cow
lameness as evaluated by a survey of veterinarians. Ranking was from most important (1)
to least important (8).
Response frequency (%)
Potential benefit
n
1
2
3
4
5
6
7
8
Enhanced animal welfare
16 50.0 18.8
6.3 6.3
6.3
0.0 0.0 12.5
Increased milk production

16

37.5 25.0

Increased cow longevity

16

Increased reproductive
performance

6.3

6.3

0.0

0.0

0.0

12.5 25.0

6.3 18.8

31.3

63.0

0.0

0.0

16

0.0 18.8

37.5 37.5

6.3

0.0

0.0

0.0

Decreased incidence of
other diseases (not
lameness)

16

0.0 6.3

18.8 18.8

31.3

18.8

6.3

0.0

Reduced veterinary and
hoof trimmer fees

16

0.0 6.3

0.0

0.0

12.5

0.0 25.0

56.3

Reduced drug and supply
costs

16

0.0 0.0

6.3

0.0

6.3

75.0 12.5

0.0

Reduced producer labor
costs

16

0.0 0.0

0.0 12.5

0.0

0.0 56.3

31.3
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25.0

Table A5. Input assumptions and resulting simulated distributions of values used in the treatment module of a stochastic simulation
model developed to estimate the cost per case of 3 hoof diseases.
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Simulated data1
(mean ± SD)

Survey of hoof trimmers (Chapter 2)
Survey of hoof trimmers (Chapter 2)
Survey of hoof trimmers (Chapter 2)

Log logistic
Log logistic
Log logistic

4.91 ± 8.99
12.01 ± 6.16
11.86 ± 5.85

2.74 ± 8.92
8.13 ± 5.07
8.16 ± 5.47

Survey of hoof trimmers (Chapter 2)
Survey of hoof trimmers (Chapter 2)
Survey of hoof trimmers (Chapter 2)

Log logistic
Extreme values
Log logistic

1.73 ± 0.43
20.81 ± 5.20
13.88 ± 3.47
20.81 ± 5.20
13.88 ± 3.47
20.81 ± 5.20

Charfeddine and Pérez-Cabal (2017)
Charfeddine and Pérez-Cabal (2017)
Charfeddine and Pérez-Cabal (2017)
Charfeddine and Pérez-Cabal (2017)
Charfeddine and Pérez-Cabal (2017)
Charfeddine and Pérez-Cabal (2017)

Normal
Normal
Normal
Normal
Normal
Normal

0.95 ± 1.86

Survey of hoof trimmers (Chapter 2)

Exponential

Input source

4.67 ± 4.61
11.81 ± 6.74
11.60 ± 6.49

Variable
Outside labor ($/case)
Digital dermatitis
Sole ulcer
White line disease
Therapeutics ($/case)
Digital dermatitis
Sole ulcer
White line disease
On-farm labor ($/case)2
Mild digital dermatitis
Severe digital dermatitis
Mild sole ulcer
Severe sole ulcer
Mild white line disease
Severe white line disease
Days of discarded milk (per case)3
Severe digital dermatitis
1

Simulation
distribution type

Input assumption
(mean ± SD)

1.98 ± 2.41
8.01 ± 4.69
8.19 ± 6.74
1.73 ± 0.43
20.81 ± 5.20
13.88 ± 3.48
20.81 ± 5.20
13.88 ± 3.47
20.81 ± 5.20
0.91 ± 0.96

n = 1,000 iterations
Input source only reported a mean; the SD was calculated as a 10% coefficient of variation from the mean
3
An assumption was made that only severe cases of digital dermatitis would result in discarded milk; no discarded milk was assumed
for mild digital dermatitis cases or cases of other diseases
2

Table A6. Input assumptions and resulting simulated distributions of values used in the
milk loss module of a stochastic simulation model developed to estimate the cost per case
of 3 hoof diseases. Input assumptions were taken from Charfeddine and Pérez-Cabal
(2017) and used in PERT (program evaluation and review technique) distributions to
calculate the simulated data (n = 1,000 iterations).
Input
Simulated
assumption1
data
Variable
(mean ± SE) (mean ± SD)
Primiparous mild digital dermatitis (ECM kg lost/d)
28 to 15 d before incidence
NA
14 to 1 d before incidence
NA
1 to 14 d after incidence
-0.07 ± 0.25 -0.20 ± 0.15
≥ 15 d after incidence
NA
Primiparous severe digital dermatitis (ECM kg lost/d)
28 to 15 d before incidence
NA
14 to 1 d before incidence
-0.37 ± 1.27 -1.03 ± 0.77
1 to 14 d after incidence
-0.56 ± 1.34 -1.20 ± 0.86
≥ 15 d after incidence
-0.64 ± 1.14 -1.14 ± 0.77
Multiparous mild digital dermatitis (ECM kg lost/d)
28 to 15 d before incidence
-0.52 ± 0.19 -0.52 ± 0.20
14 to 1 d before incidence
-0.77 ± 0.18 -0.77 ± 0.19
1 to 14 d after incidence
-0.90 ± 0.20 -0.90 ± 0.21
≥ 15 d after incidence
-0.39 ± 0.18 -0.39 ± 0.19
Multiparous severe digital dermatitis (ECM kg lost/d)
28 to 15 d before incidence
-1.52 ± 1.08 -1.71 ± 0.97
14 to 1 d before incidence
-2.22 ± 0.95 -2.22 ± 1.00
1 to 14 d after incidence
-0.54 ± 1.07 -1.03 ± 0.71
≥ 15 d after incidence
-2.77 ± 0.90 -2.77 ± 0.94
Primiparous mild sole ulcer (ECM kg lost/d)
28 to 15 d before incidence
-0.72 ± 0.30 -0.72 ± 0.31
14 to 1 d before incidence
-0.42 ± 0.29 -0.47 ± 0.26
1 to 14 d after incidence
-0.63 ± 0.31 -0.63 ± 0.32
≥ 15 d after incidence
-1.07 ± 0.35 -1.07 ± 0.37
Primiparous severe sole ulcer (ECM kg lost/d)
28 to 15 d before incidence
-1.16 ± 0.82 -1.30 ± 0.74
14 to 1 d before incidence
-0.87 ± 0.80 -1.09 ± 0.65
1 to 14 d after incidence
-1.80 ± 0.83 -1.80 ± 0.87
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Table A6. Continued
≥ 15 d after incidence

-0.23 ± 0.86

-0.69 ± 0.52

Multiparous mild sole ulcer (ECM kg lost/d)
28 to 15 d before incidence
-1.14 ± 0.14 -1.14 ± 0.15
14 to 1 d before incidence
-1.52 ± 0.14 -1.52 ± 0.15
1 to 14 d after incidence
-1.04 ± 0.15 -1.04 ± 0.16
≥ 15 d after incidence
-0.93 ± 0.17 -0.93 ± 0.18
Multiparous severe sole ulcer (ECM kg lost/d)
28 to 15 d before incidence
-2.48 ± 0.44 -2.48 ± 0.46
14 to 1 d before incidence
-2.28 ± 0.43 -2.28 ± 0.45
1 to 14 d after incidence
-2.36 ± 0.44 -2.36 ± 0.46
≥ 15 d after incidence
-1.47 ± 0.50 -1.47 ± 0.52
Primiparous mild white line disease (ECM kg lost/d)
28 to 15 d before incidence
-0.36 ± 0.34 -0.46 ± 0.27
14 to 1 d before incidence
-0.68 ± 0.32 -0.68 ± 0.33
1 to 14 d after incidence
-0.41 ± 0.35 -0.50 ± 0.29
≥ 15 d after incidence
-0.38 ± 0.38 -0.49 ± 0.30
Primiparous severe white line disease (ECM kg lost/d)
28 to 15 d before incidence
-1.24 ± 1.02 -1.48 ± 0.86
14 to 1 d before incidence
-1.29 ± 0.93 -1.46 ± 0.83
1 to 14 d after incidence
-1.71 ± 0.92 -1.74 ± 0.93
≥ 15 d after incidence
-0.07 ± 1.02 -0.68 ± 0.56
Multiparous mild white line disease (ECM kg lost/d)
28 to 15 d before incidence
-1.16 ± 0.16 -1.16 ± 0.17
14 to 1 d before incidence
-1.02 ± 0.16 -1.02 ± 0.17
1 to 14 d after incidence
-0.65 ± 0.17 -0.65 ± 0.18
≥ 15 d after incidence
-0.20 ± 0.19 -0.25 ± 0.15
Multiparous severe white line disease (ECM kg lost/d)
28 to 15 d before incidence
-2.37 ± 0.58 -2.37 ± 0.61
14 to 1 d before incidence
-2.66 ± 0.54 -2.66 ± 0.57
1 to 14 d after incidence
-2.07 ± 0.57 -2.07 ± 0.60
≥ 15 d after incidence
-1.56 ± 0.61 -1.56 ± 0.64
1
NA indicates that the value reported by the input source was positive (indicating an
increase in milk yield); positive values were adjusted to 0 (i.e. no change in milk
production)
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Table A7. Input assumptions and resulting simulated distributions of values used in the
days open module of a stochastic simulation model developed to estimate the cost per case
of 3 hoof diseases. Input assumptions were taken from Charfeddine and Pérez-Cabal
(2017) and used in PERT (program evaluation and review technique) distributions to
calculate the simulated data (n = 1,000 iterations).
Variable
Increase in days open (d)
Mild digital dermatitis
Severe digital dermatitis
Mild sole ulcer
Severe sole ulcer
Mild white line disease
Severe white line disease

Input assumption1
[mean (min – max)]

Simulated data
(mean ± SD)

0.0 (0.0 – 3.6)
5.4 (0.0 – 39.5)
1.6 (0.0 – 6.3)
17.4 (1.4 – 33.3)
3.0 (0.0 – 7.7)

0.6 ± 0.5
10.2 ± 6.6
2.1 ± 1.1
17.4 ± 6.0
3.3 ± 1.5

8.6 (0.0 – 27.4)

10.3 ± 5.0

1

If parameters (mean, min, or max) reported by the input source were positive (indicating
an improvement in reproductive performance) they were adjusted to 0 (i.e. no change in
days open)
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Table A8. Input assumptions and resulting simulated distributions of values used in the
culling module of a stochastic simulation model developed to estimate the cost per case of
3 hoof diseases. Input assumptions were taken from Booth et al. (2004)1 who reported
culling hazard ratios based on both time of disease incidence and time of culling. Input
assumptions were used in PERT (program evaluation and review technique) distributions2
to calculate the simulated data (n = 1,000 iterations).
Time interval of culling
Disease and data type
Digital dermatitis
input assumptions
[HR (95% CI)]

Incidence
timing
≤ 60
61 to 120
121 to 240
> 240

Mild digital
dermatitis simulated
data
(mean ± SD)

≤60

61 to 120

121 to 240

>240

0.4 (0.0 – 2.5)

0.9 (0.3 – 2.8)
2.7 (1.3 – 6.0)

1.4 (0.6 - 2.9)
1.5 (0.8 – 3.0)
1.5 (0.8 – 3.5)

0.8 (0.3 – 2.1)
1.9 (1.0 – 3.6)
1.1 (0.5 – 2.5)
2.2 (0.7 – 7.1)

≤ 60
61 to 120
121 to 240
> 240

1.7 ± 0.6

1.8 ± 0.7
2.9 ± 1.5

1.8 ± 0.7
1.4 ± 0.4
1.6 ± 0.5

1.5 ± 0.5
1.5 ± 0.4
1.5 ± 0.4
2.7 ± 1.3

Severe digital
dermatitis simulated
data
(mean ± SD)

≤ 60
61 to 120
121 to 240
> 240

1.7 ± 0.6

1.9 ± 0.6
2.9 ± 1.4

2.0 ± 0.6
1.4 ± 0.3
1.6 ± 0.5

1.5 ± 0.4
1.5 ± 0.3
1.4 ± 0.3
3.2 ± 1.2

Sole ulcer and white
line disease input
assumptions
[HR (95% CI)]

≤ 60
61 to 120
121 to 240
> 240

2.0 (0.9 – 4.3)

2.4 (1.2 – 5.0)
2.7 (1.3 – 6.0)

2.6 (1.4 – 4.9)
1.5 (0.8 – 3.0)
1.5 (0.8 – 3.5)

1.3 (0.5 – 3.1)
1.9 (1.0 – 3.6)
1.1 (0.5 – 2.5)
2.2 (0.7 – 7.1)

Mild sole ulcer and
white line disease
simulated data
(mean ± SD)

≤ 60
61 to 120
121 to 240
> 240

1.8 ± 0.6

2.6 ± 1.2
3.0 ± 1.5

2.7 ± 1.1
1.8 ± 0.7
2.0 ± 0.8

1.9 ± 0.7
2.0 ± 0.8
1.7 ± 0.6
3.5 ± 1.9

Severe sole ulcer and
white line disease
simulated data
(mean ± SD)

≤ 60
61 to 120
121 to 240
> 240

2.4 ± 0.5

3.3 ± 1.1
3.9 ± 1.3

3.4 ± 1.0
2.1 ± 0.6
2.3 ± 0.7

2.1 ± 0.6
2.6 ± 0.7
1.8 ± 0.5
4.0 ± 1.8

1

White line disease culling hazard ratio inputs were assumed identical to sole ulcers
To account for severity, two different stochastic distributions were created for each
disease. For the mild distributions, a mean 0.5 times that of the mean reported by Booth et
al. (2004) was used whereas for the severe distributions, a mean 1.5 times that of the
reported mean was used. The same 5th and 95th percentiles were used in both mild and
severe distributions for each disease.
2
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Table A9. Input assumptions and resulting simulated distributions of values used in the
disease recurrence module of a stochastic simulation model developed to estimate the cost
per case of 3 hoof diseases. Input assumptions for relapse rates were collected from
Charfeddine and Pérez-Cabal (2017) and used in PERT (program evaluation and review
technique) distributions to calculate the simulated data (n = 1,000 iterations). Input
assumptions for disease length were collected from Bruijnis et al. (2010) and used in PERT
(program evaluation and review technique) distributions to calculate the simulated data (n
= 1,000 iterations).
Variable
Relapse rate (episodes per infected cow)
Primiparous mild digital dermatitis
Primiparous severe digital dermatitis
Multiparous mild digital dermatitis
Multiparous severe digital dermatitis
Primiparous mild sole ulcer
Primiparous severe sole ulcer
Multiparous mild sole ulcer
Multiparous severe sole ulcer
Primiparous mild white line disease
Primiparous severe white line disease
Multiparous mild white line disease
Multiparous severe white line disease
Disease length (months)2

Input assumption
Mean1
1.97
2.02
2.24
2.60
2.38
3.13
2.46
3.14
2.50
2.89
2.65
2.98
Mean
(5th – 95th percentile)

Mild digital dermatitis
Severe digital dermatitis
Mild sole ulcer
Severe sole ulcer
Mild white line disease
Severe white line disease

3.65 (2.68 – 4.78)
3.54 (2.38 – 5.00)
2.50 (1.37 – 4.00)3
2.50 (1.37 – 4.00)
4.43 (2.50 – 6.42)
2.90 (1.00 – 6.33)

1

Simulated data
(mean ± SD)
2.23 ± 0.43
2.26 ± 0.44
2.41 ± 0.46
2.65 ± 0.47
2.50 ± 0.46
3.00 ± 0.46
2.56 ± 0.47
3.01 ± 0.46
2.58 ± 0.47
2.84 ± 0.47
2.68 ± 0.47
2.90 ± 0.47

3.68 ± 0.40
3.59 ± 0.49
2.56 ± 0.50
2.56 ± 0.50
4.44 ± 0.74
3.16 ± 0.99

The input assumption source only reported mean relapse rates. Relapse rate minimum
and maximum values were assumed the same for all diseases and severity levels for
stochastic modeling purposes. Minimum and maximum were set to 1.50 and 4.00 based
on results from Ettema et al. (2010).
2
The input assumption source reported disease length for subclinical and clinical cases of
each disease. For this study, subclinical cases were assumed to represent mild cases and
clinical cases were assumed to represent severe cases.
3
The input assumption source did not report disease length for subclinical sole ulcers; an
assumption was made that this length would be identical to clinical sole ulcers.
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Figure A1. Hoof disease definitions provided to respondents in a survey of hoof trimmers
and veterinarians aimed at collecting and summarizing information on hoof disease
treatment costs
Lesion Descriptions: For the remaining questions, please consider the below dairy lameness
disease definitions and refer to the “Claw Zones” indicated in the figure:

Digital Dermatitis (also called Hairy Heel Warts or Mortellaro Disease)
Claw Zones affected: any zones along the coronary band including zones 0, 9, and 10
Common signs include:
• Typically located at the end of the interdigital cleft
• Acute cases have bright-red lesions > 0.75 inches (2 cm) that are painful and raw
• Chronic cases have lesions with lots of skin/hair around them, but are not painful
Foot Rot (also called Foot Foul, Interdigital Phlegmon, or Interdigital Necrobacillosis)
Claw Zones affected: 9
Common signs include:
• Symmetrical hard swelling of tissue above the claws (acute onset, “overnight”)
• Can occur with dead, smelly skin between the claws
Sole ulcer (also called Pododermatitis Circumscripta, Rusterholz Disease)
Claw Zones affected: 4
Common signs include:
• Localized defect in sole horn that exposes corium
• Can also be a hemorrhage that is painful to hoof test
• Typically occurs on the inner side of the sole on the outer claw, but can occur in
the heel
Thin Sole
Claw Zones affected: 4, 5
Common signs include:
• Sole moves when thumb pressure is applied at the toe
• Dorsal wall length is < 3 inches (7.5 cm)
Toe Ulcer
Claw Zones affected: 1
Common signs include:
• Penetration or separation of the horn in the toe triangle that results in exposure or
infection of the corium
White line lesion (also called White Line Separation or White Line Disease)
Claw Zones affected: 1, 2, 3
Common signs include:
• Separation of the white line, which may result in abscesses (pus filled cavity) in
the white line region
If severe this can be accompanied by swelling of the affected claw
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